data_1oma_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oma _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 12' ' ' CYS . 4.2 mt -89.79 82.88 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.415 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . . . -95.53 27.05 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.23 153.75 20.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 2.6 p30 -66.39 124.31 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 72.1 m-85 62.39 13.04 5.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.1 127.88 9.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -60.68 124.98 22.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -1.105 . . . . 0.0 109.364 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 11.8 p -112.48 -175.98 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.699 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . 2.4 m -150.92 101.46 2.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -0.79 . . . . 0.0 109.281 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 13' ' ' THR . 23.2 m0 -43.5 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 175.76 -37.85 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 18' ' ' LYS . . . -167.06 -70.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.61 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.859 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.6 ttpt -103.81 159.93 15.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 108.844 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.18 140.1 58.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.054 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -60.82 -35.46 76.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 109.68 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' GLY . 1.9 mmt-85 -86.93 23.87 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ARG . . . 43.97 77.77 0.08 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 49.8 mtt180 -120.94 149.57 51.26 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.153 . . . . 0.0 109.67 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.98 108.51 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.384 2.056 . . . . 0.0 110.54 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 150.71 22.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.994 . . . . 0.0 108.949 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.85 168.43 19.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -145.8 -172.37 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.453 ' HB2' HG12 ' A' ' 30' ' ' ILE . 61.1 m -93.35 -164.62 1.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.7 31.3 1.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 28' ' ' SER . 1.8 pt -115.15 -22.75 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.578 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.77 18.57 47.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.439 ' OG1' HD13 ' A' ' 30' ' ' ILE . 63.2 p -152.74 161.35 42.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -1.155 . . . . 0.0 109.43 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER 70.87 86.69 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 55.5 m -117.48 156.76 27.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -135.74 130.78 34.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 9.6 t -70.97 123.58 22.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.075 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.19 123.65 46.04 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.664 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.29 141.54 75.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.876 1.717 . . . . 0.0 109.975 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.547 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 11.1 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.314 0.578 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.511 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 49.5 mt -79.87 75.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.63 15.44 18.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.278 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -84.78 149.82 25.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.402 -0.811 . . . . 0.0 109.59 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.9 OUTLIER -65.3 123.68 20.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 30.6 m-85 62.34 20.69 12.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.65 124.58 35.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' O ' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -48.43 127.7 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.542 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -114.87 -168.32 1.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 109.724 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 14' ' ' TRP . 38.0 m -149.62 105.56 3.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.413 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -44.01 106.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.64 35.33 4.94 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.7 -131.3 1.91 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.49 108.36 17.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.436 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.73 -165.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 109.703 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 139.54 40.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -64.58 -50.05 68.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -18.73 8.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 109.35 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 57.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 38' ' ' PRO . 5.4 mtt85 -124.45 145.12 48.0 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.541 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.22 -169.76 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.283 1.989 . . . . 0.0 110.379 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -133.6 155.01 50.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.414 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.78 124.09 45.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.895 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.487 ' CB ' ' HA2' ' A' ' 31' ' ' GLY . 71.9 m -91.52 -171.2 2.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.1 OUTLIER -98.5 39.96 1.22 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.767 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' SER . 2.3 ttt 83.07 -43.24 0.11 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 32' ' ' THR . 4.3 pt -104.52 32.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.525 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.487 ' HA2' ' CB ' ' A' ' 27' ' ' CYS . . . 47.67 65.96 2.17 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 30' ' ' ILE . 39.3 p -139.13 126.35 21.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.513 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 47.51 64.67 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.8 m -79.87 158.79 26.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.184 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -141.52 138.48 32.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.593 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 50.6 t -54.48 130.96 41.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.256 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.97 123.62 32.44 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.025 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -63.57 157.64 50.09 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.608 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.463 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 10.4 p . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.281 0.562 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.514 ' CD1' ' O ' ' A' ' 11' ' ' LYS . 74.8 mt -79.51 84.49 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.08 13.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.09 164.72 24.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.583 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 9.0 m-20 -85.27 121.35 27.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' GLY . 22.9 m-85 60.86 23.31 13.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.572 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -51.78 -175.78 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.514 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 3.9 ptpp? -99.74 126.44 45.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.112 -1.228 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 26.8 p -119.55 -170.25 1.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 14' ' ' TRP . 17.1 m -147.25 161.22 41.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.469 ' N ' ' CG2' ' A' ' 13' ' ' THR . 0.1 OUTLIER -80.59 88.56 5.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.45 15.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 -151.58 28.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.463 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 74.7 m -61.81 90.74 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.224 -1.162 . . . . 0.0 109.531 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -165.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.99 -164.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 85.7 m -116.48 134.53 54.75 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER 77.74 -6.8 1.92 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.958 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.468 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . 102.5 95.37 2.29 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.421 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.585 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -157.28 154.33 25.56 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.381 -1.07 . . . . 0.0 109.383 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.36 178.54 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.287 1.991 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -139.89 85.16 2.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 23.8 ttp85 -53.2 146.53 11.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 109.955 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -117.88 -170.08 1.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.584 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.11 39.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.7 OUTLIER 74.57 1.87 3.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.72 -81.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.98 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.06 45.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.36 -41.21 2.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.537 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -128.35 84.66 2.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 1.3 m -80.08 173.21 12.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.7 mp0 -141.24 150.45 42.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.789 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -73.77 107.53 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 124.41 59.09 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.474 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' ARG . 2.2 Cg_endo -63.63 159.17 42.21 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.873 1.715 . . . . 0.0 110.135 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' PRO . 1.6 mmm180 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.708 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.0 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 12' ' ' CYS . 6.5 mt -87.14 95.16 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.65 -5.78 50.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.642 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.9 166.65 22.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 9' ' ' TYR . 79.0 m-20 -89.84 136.64 32.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.604 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.531 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 59.9 m-85 64.79 10.67 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.4 126.42 42.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' O ' HD12 ' A' ' 5' ' ' ILE . 20.5 tttt -45.66 120.33 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 5' ' ' ILE . 28.7 p -100.64 -169.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.623 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -147.48 121.16 9.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.36 -0.838 . . . . 0.0 109.356 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -69.46 94.63 0.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.08 14.02 25.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.04 -113.28 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.9 90.58 8.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -1.147 . . . . 0.0 109.633 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.582 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.85 154.8 38.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.582 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -37.77 147.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.691 -0.63 . . . . 0.0 110.193 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 86.3 m -43.64 -92.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -42.89 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.457 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 165.91 93.62 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -136.72 147.63 60.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.137 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.75 -171.29 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.266 1.978 . . . . 0.0 110.311 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 153.44 43.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.81 . . . . 0.0 109.339 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.424 ' HD2' HG22 ' A' ' 37' ' ' THR . 1.3 ptm180 -119.68 134.28 55.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.78 -171.45 1.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.535 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 29' ' ' MET . 70.7 m -87.86 20.13 3.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.448 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 71.05 5.54 5.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.31 14.81 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.35 87.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.14 -54.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -142.8 103.83 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.56 132.44 39.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -121.45 127.44 51.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.57 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 29.1 t -54.51 121.99 9.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.144 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.424 HG22 ' HD2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -80.14 125.4 81.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.636 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 2.4 Cg_endo -62.75 135.89 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.909 1.74 . . . . 0.0 110.068 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 38' ' ' PRO . 7.0 mtt180 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.196 -0.94 . . . . 0.0 109.688 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.496 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 25.7 mt -81.9 119.79 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.29 -19.31 10.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.463 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.44 173.82 0.64 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.22 -0.925 . . . . 0.0 109.581 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 58.3 m-20 -89.88 141.7 28.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 46.9 m-85 61.66 13.45 5.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 109.528 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -50.55 151.53 5.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -72.74 98.15 2.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -1.204 . . . . 0.0 109.568 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 34' ' ' CYS . 6.3 p -102.16 -178.44 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.8 m -160.18 146.25 15.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.406 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -74.11 89.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLY . . . 137.45 -59.57 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 15' ' ' GLY . . . -63.06 -124.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.45 129.46 34.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -99.34 -164.45 1.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.664 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 130.85 34.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.1 m -55.86 -58.71 6.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -44.75 -25.84 0.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.55 20.64 12.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.436 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.8 mtp85 -85.94 161.4 50.1 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.49 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 23' ' ' ARG . 1.8 Cg_endo -62.87 -170.76 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.221 1.947 . . . . 0.0 110.215 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 36.5 t -134.11 85.41 2.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.324 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 3.8 ttt180 -43.65 140.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.621 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 93.5 m -153.06 173.6 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -77.84 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtp 177.64 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.1 pt -88.23 -22.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' HG21 ' A' ' 32' ' ' THR . . . 119.85 57.88 0.25 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.437 HG21 ' O ' ' A' ' 31' ' ' GLY . 1.1 p -160.03 169.36 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 109.524 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 49.6 51.6 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 10.8 m -91.82 117.68 30.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.44 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 34' ' ' CYS . 6.6 mm-40 -134.01 114.34 13.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.723 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.5 t -60.62 136.43 58.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.226 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 124.68 28.29 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.571 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.82 142.14 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.963 1.776 . . . . 0.0 110.181 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.7 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 3.7 mm -85.88 59.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.37 14.52 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.1 155.29 18.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -64.17 124.45 21.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.302 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 11.0 m-85 62.38 22.84 13.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -49.05 107.89 0.35 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -44.21 113.64 0.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.625 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -127.1 -169.09 1.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.516 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.563 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 55.7 m -134.93 127.28 30.32 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.286 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.54 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -0.982 . . . . 0.0 109.384 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 105.78 -41.89 2.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.35 -103.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.87 104.12 16.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.657 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 149.14 32.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -0.929 . . . . 0.0 109.017 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.474 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -53.96 140.63 30.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.98 -83.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 20' ' ' CYS . 5.0 mmm180 -43.48 -72.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 109.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.63 81.47 0.04 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.459 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 54.9 mtt180 -132.06 150.46 76.15 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.21 -1.171 . . . . 0.0 109.609 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.22 174.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.3 77.66 1.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 154.8 22.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.205 -0.935 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 20.4 m -81.13 161.63 24.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.174 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -89.45 52.9 2.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.628 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 44.59 26.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.542 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 32' ' ' THR . 4.5 pt -98.19 -10.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.362 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.456 ' C ' ' CG2' ' A' ' 32' ' ' THR . . . 64.9 25.27 70.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 17.7 p -156.36 121.52 4.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -1.153 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' THR . 1.4 m-80 58.89 151.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -119.58 154.25 34.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG3' ' HA ' ' A' ' 11' ' ' LYS . 2.6 mp0 -123.71 155.24 38.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 49.6 t -72.73 106.8 4.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.92 123.57 77.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.64 155.68 57.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.91 1.74 . . . . 0.0 110.129 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.208 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 12.5 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 11' ' ' LYS . 40.5 mt -138.25 67.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.95 4.99 15.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.62 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -84.35 149.67 25.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.7 m-20 -65.17 129.99 41.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 34.9 m-85 60.0 15.13 4.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.847 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -50.0 134.59 27.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 31.4 mttm -54.67 155.9 3.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -1.208 . . . . 0.0 109.693 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' HB3' HD11 ' A' ' 5' ' ' ILE . 19.1 p -160.29 -166.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' TRP . 4.1 m -150.69 124.5 9.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.707 . . . . 0.0 109.112 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' THR . 5.9 m0 -43.95 108.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.605 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.46 46.47 6.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.46 -111.41 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -89.08 129.32 35.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -1.126 . . . . 0.0 109.429 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -80.51 -166.76 1.14 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.357 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -104.41 19.29 20.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER 68.27 -90.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 0.0 110.127 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.95 -37.62 1.94 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.454 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . 124.17 51.1 0.2 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.553 ' CG ' ' HA ' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -103.51 135.27 19.4 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.043 . . . . 0.0 109.488 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 5.7 Cg_exo -58.97 -169.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.079 1.853 . . . . 0.0 110.117 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.2 124.99 9.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -115.58 136.77 52.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.474 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 84.1 m -84.42 178.64 7.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.525 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -113.22 36.06 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 109.69 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 79.79 6.45 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -90.33 -29.02 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.807 -1.183 . . . . 0.0 109.099 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.421 ' C ' HG21 ' A' ' 32' ' ' THR . . . 83.46 10.55 81.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -147.5 -73.34 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 0.0 108.667 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.545 ' N ' ' OG1' ' A' ' 32' ' ' THR . 6.7 m120 -69.45 113.96 7.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.829 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' CB ' ' HA ' ' A' ' 27' ' ' CYS . 4.2 m -129.45 155.03 46.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -111.75 153.2 26.86 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 23' ' ' ARG . 1.9 t -70.73 173.31 7.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.114 -0.991 . . . . 0.0 108.726 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.63 124.55 3.53 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.805 -1.185 . . . . 0.0 110.117 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -68.5 135.89 34.92 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.965 1.777 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 6.9 ttt-85 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CG2' ' OE2' ' A' ' 7' ' ' GLU . 19.5 mt -87.39 109.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.88 -16.1 14.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.531 ' CG ' ' HA3' ' A' ' 10' ' ' GLY . 6.6 pt-20 -52.26 170.63 0.06 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.34 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.559 ' OD1' ' CE1' ' A' ' 9' ' ' TYR . 2.3 t0 -90.04 129.7 36.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.559 ' CE1' ' OD1' ' A' ' 8' ' ' ASP . 70.8 m-85 66.32 7.65 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 109.932 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.531 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -51.2 133.83 33.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.92 109.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.392 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 17.8 p -88.39 -167.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.1 151.42 19.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.476 -0.765 . . . . 0.0 109.385 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.579 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -93.75 77.26 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.77 -55.86 0.7 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.26 -143.33 0.14 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.41 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -64.17 98.28 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -1.094 . . . . 0.0 109.509 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -164.0 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' HB3' ' HG3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -95.22 129.27 42.4 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 109.46 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 35.1 m -44.55 157.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 63.54 11.79 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.617 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.78 92.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -117.64 155.43 50.54 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.237 -1.155 . . . . 0.0 109.358 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.73 136.72 68.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.158 1.905 . . . . 0.0 109.9 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.579 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -91.34 87.8 6.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -0.969 . . . . 0.0 108.558 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -57.82 124.0 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.698 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -152.65 -172.5 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 0.0 109.455 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.94 -92.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mmt -135.11 65.02 1.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.97 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -50.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.85 22.91 22.16 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -123.07 -87.2 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -1.109 . . . . 0.0 109.36 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.8 m-80 -59.67 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.226 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 21.4 m -120.95 141.42 50.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -103.41 112.58 25.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.359 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 12' ' ' CYS . 41.2 t -53.16 119.68 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.598 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.96 130.95 30.01 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 2.5 Cg_endo -61.94 -171.65 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.878 1.719 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.457 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.296 0.57 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 14.0 mt -82.7 129.06 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.385 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.59 -11.94 13.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.09 172.05 3.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -89.48 137.88 31.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.855 . . . . 0.0 109.356 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 61.6 m-85 58.91 14.88 3.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' N ' ' HB3' ' A' ' 36' ' ' CYS . . . -53.74 121.55 18.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -43.81 122.0 2.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 109.743 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.67 174.27 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.09 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -149.77 149.79 31.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.161 -0.962 . . . . 0.0 109.594 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -79.96 89.46 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.62 3.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.83 -127.05 1.58 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' HD13 ' A' ' 5' ' ' ILE . 2.3 m -90.16 87.87 7.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -1.15 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.566 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -89.18 155.17 19.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 109.0 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.566 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -49.05 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 21' ' ' ARG . 94.5 m -90.55 114.7 26.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.03 -1.044 . . . . 0.0 110.737 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 5.76 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.248 0.547 . . . . 0.0 111.912 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . -165.15 -35.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.558 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -112.88 117.27 46.54 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.193 -1.18 . . . . 0.0 109.655 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.509 ' O ' ' O ' ' A' ' 25' ' ' CYS . 12.2 Cg_endo -79.76 37.25 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.146 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 24' ' ' PRO . 4.7 t 46.33 178.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 109.635 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER 178.16 142.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.811 -1.18 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -121.75 175.53 6.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.417 ' C ' ' HG3' ' A' ' 29' ' ' MET . 1.2 m -83.32 -93.46 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.722 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.417 ' HG3' ' C ' ' A' ' 28' ' ' SER . 61.5 mtp -143.54 14.34 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.525 HD11 ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -107.22 -14.96 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.311 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.89 83.89 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.92 161.67 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -1.105 . . . . 0.0 109.354 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 32' ' ' THR . 9.7 m120 63.9 63.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 26' ' ' ARG . 4.8 m -98.1 135.99 38.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 0.0 109.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 2.1 mt-10 -101.55 166.05 10.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 23' ' ' ARG . 1.9 t -78.6 109.4 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.421 -0.799 . . . . 0.0 109.052 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -88.54 137.06 30.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.912 -1.118 . . . . 0.0 109.408 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 39' ' ' ARG . 4.1 Cg_exo -57.26 176.39 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.11 1.873 . . . . 0.0 110.556 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 20.7 mtt180 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.569 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 19' ' ' CYS . 3.2 p . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.454 HG13 HG21 ' A' ' 17' ' ' THR . 16.6 mt -83.31 104.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -0.976 . . . . 0.0 109.585 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.01 -4.47 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.53 142.13 46.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 42.3 m-20 -70.45 127.71 33.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.13 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 11.1 m-85 61.94 26.86 16.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -0.943 . . . . 0.0 109.392 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -69.67 125.04 16.22 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -42.74 124.07 2.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -1.115 . . . . 0.0 109.268 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 17' ' ' THR . 22.5 p -111.31 -167.25 1.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.966 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.6 m -144.35 144.18 31.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.408 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 41.1 m0 -68.95 86.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.76 37.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 -110.94 1.83 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.454 HG21 HG13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -80.03 84.59 5.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.154 . . . . 0.0 109.7 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.584 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.1 tppp? -83.79 166.08 18.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.823 . . . . 0.0 108.889 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.584 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -56.98 -144.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 109.717 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 69.7 m -133.54 118.84 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 25.0 mmm180 75.89 57.68 0.05 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . . . 78.11 -30.38 1.84 Allowed Glycine 0 N--CA 1.496 2.674 0 O-C-N 121.106 -0.996 . . . . 0.0 113.826 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -41.75 103.57 0.31 Allowed Pre-proline 0 N--CA 1.505 2.308 0 CA-C-N 119.751 1.776 . . . . 0.0 109.146 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 22' ' ' GLY . 6.1 Cg_endo -66.04 -163.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.46 2.107 . . . . 0.0 111.02 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -130.02 154.33 47.52 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.437 ' HD3' ' CG2' ' A' ' 37' ' ' THR . 0.5 OUTLIER -138.26 122.0 17.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.492 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 -170.54 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 108.768 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 66.96 -175.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.735 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 77.83 -4.3 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -0.85 . . . . 0.0 109.41 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.455 HG21 ' O ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -160.71 -38.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.244 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 76.64 1.32 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -159.99 -61.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -1.223 . . . . 0.0 109.637 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 170.57 173.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.58 132.08 35.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.21 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.448 ' HB3' ' CA ' ' A' ' 9' ' ' TYR . 2.2 mm-40 -113.13 122.57 47.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -51.95 117.86 3.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -0.788 . . . . 0.0 109.259 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.474 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -85.0 145.99 44.64 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.626 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.85 -170.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.093 1.862 . . . . 0.0 110.092 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 39' ' ' ARG . 2.6 ptm180 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 109.628 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -80.09 90.2 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.29 -13.79 51.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -72.32 147.12 46.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.455 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 57.4 m-20 -78.48 137.32 37.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.454 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 40.0 m-85 61.53 13.18 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.05 129.31 49.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 137.27 10.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -1.183 . . . . 0.0 109.411 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -135.43 -169.45 2.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.669 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.55 135.76 21.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.2 87.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.88 40.3 1.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.67 -122.34 1.3 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -62.91 91.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.398 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 148.99 38.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.135 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.47 147.6 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -56.08 141.43 40.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 12.5 mtt-85 72.79 10.51 5.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.843 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . 55.37 90.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 26.2 mmm180 -128.62 149.43 71.9 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.419 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.45 172.84 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.174 1.916 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -137.74 104.09 5.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -52.95 143.87 16.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.2 m -144.18 176.24 9.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 0.0 109.389 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 5.0 m -82.88 -91.19 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.99 -83.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -80.18 -30.24 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.66 77.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -101.33 -62.7 1.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -1.124 . . . . 0.0 109.327 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.461 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 50.6 t-20 -125.09 84.05 2.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 90.5 m -80.51 146.5 31.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 2.1 mp0 -144.03 118.8 9.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.412 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.0 t -46.46 113.03 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 109.273 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.94 131.87 32.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.518 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.8 Cg_endo -63.95 -169.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.989 1.793 . . . . 0.0 109.977 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 31.8 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 4.2 mm -80.02 75.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.56 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.15 20.31 11.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.24 152.65 32.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 85.5 m-20 -66.04 128.64 36.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 74.9 m-85 62.97 12.25 5.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -52.51 115.76 4.6 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' GLY . 14.4 ttpt -44.04 126.8 5.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.136 . . . . 0.0 109.422 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 16.6 p -118.54 -165.66 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.678 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -145.66 122.22 11.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.446 -0.784 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 98.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.08 46.21 1.92 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.7 -119.92 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 2.4 m -76.05 107.47 8.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 6.7 tttt -94.9 167.73 11.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.563 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.81 125.47 24.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -44.24 -67.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -42.71 -65.79 0.44 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.437 -0.789 . . . . 0.0 109.54 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.26 52.62 0.04 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 21' ' ' ARG . 8.5 mmt180 -108.35 145.0 30.62 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.196 -1.179 . . . . 0.0 109.376 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.22 179.07 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.09 1.86 . . . . 0.0 110.282 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -131.04 155.0 47.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.339 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -111.21 133.05 53.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 m -126.22 -172.48 2.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.499 ' O ' ' CB ' ' A' ' 29' ' ' MET . 1.9 m -89.98 19.47 4.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 76.11 -0.18 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.597 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.493 ' CG1' ' HB2' ' A' ' 28' ' ' SER . 2.0 pt -114.26 1.38 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.567 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 38.8 45.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' ASN . 27.8 p -135.68 124.47 23.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' THR . 11.1 t30 59.27 116.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 61.1 m -135.89 171.24 14.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -143.47 120.41 11.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.508 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.489 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 25.0 t -60.08 117.25 4.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.74 132.57 29.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.39 -174.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.983 1.789 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.43 ' HG3' ' HD2' ' A' ' 23' ' ' ARG . 26.7 mtp180 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.288 0.566 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.529 ' CG2' ' HA3' ' A' ' 10' ' ' GLY . 6.5 mt -85.55 106.44 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.447 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . . . -119.62 -2.04 10.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.561 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 156.93 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 3.6 m-20 -64.61 138.74 58.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.426 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 56.6 m-85 62.03 12.78 5.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -46.09 107.12 0.16 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' O ' HD11 ' A' ' 5' ' ' ILE . 26.2 mttt -42.85 130.78 4.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -1.098 . . . . 0.0 109.851 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 14.0 p -134.54 -164.39 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.354 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -157.11 137.77 13.18 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.537 -0.727 . . . . 0.0 109.319 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.6 107.97 2.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.615 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.79 12.99 33.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.55 -127.71 2.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.2 111.83 23.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -1.147 . . . . 0.0 109.72 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -92.69 170.5 9.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 108.684 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -47.34 88.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 109.918 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 18' ' ' LYS . 2.0 m 34.63 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.342 0.591 . . . . 0.0 110.251 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -169.55 58.46 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.046 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.5 -35.06 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.452 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -119.17 137.58 25.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.969 -1.312 . . . . 0.0 109.876 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.7 -166.04 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.053 1.835 . . . . 0.0 109.896 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.82 40.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -146.26 144.62 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.52 ' N ' ' HG2' ' A' ' 26' ' ' ARG . 1.2 m -116.28 167.15 11.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' MET . 0.7 OUTLIER -89.5 66.4 7.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 mtp 43.79 28.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.96 -74.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.5 29.36 1.31 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -153.63 -66.27 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.442 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.78 114.31 19.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -120.88 156.43 32.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -135.65 113.9 11.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.385 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 22.9 t -43.88 117.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 122.13 52.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.705 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.38 -166.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.985 1.79 . . . . 0.0 110.104 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.802 . . . . 0.0 109.45 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 17.0 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.538 ' CG2' ' HA3' ' A' ' 10' ' ' GLY . 7.1 mt -113.3 91.11 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.06 35.62 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.05 166.43 11.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.56 123.31 15.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.202 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER 43.64 31.9 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.775 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.54 129.69 7.4 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -36.7 133.16 0.59 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.589 -0.948 . . . . 0.0 110.316 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 1.6 p -122.4 -176.22 3.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.19 136.61 8.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -76.85 85.27 3.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.27 -17.93 7.43 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.32 -128.22 3.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' HD13 ' A' ' 5' ' ' ILE . 30.1 m -89.78 106.34 18.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -1.148 . . . . 0.0 109.408 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -166.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.691 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.524 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -97.44 175.97 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.091 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 1.1 m -104.78 149.38 25.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.988 . . . . 0.0 109.885 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER 77.61 -7.41 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.246 -0.909 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.52 46.76 2.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.524 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -93.06 124.48 58.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.165 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 4.6 Cg_exo -59.89 168.26 5.99 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.997 1.798 . . . . 0.0 110.584 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.5 t -120.98 106.4 11.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.485 -0.759 . . . . 0.0 109.087 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 35' ' ' GLU . 3.4 ttm180 -111.21 177.52 4.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -110.79 -177.85 3.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.95 28.73 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.469 ' CB ' ' O ' ' A' ' 28' ' ' SER . 12.5 ttm 72.73 29.54 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.656 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -51.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 109.539 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.43 10.7 9.3 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -123.96 -99.25 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -1.186 . . . . 0.0 109.322 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 2.2 m120 -55.19 128.91 36.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.983 -1.073 . . . . 0.0 108.75 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -120.64 124.7 45.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.2 OUTLIER -110.37 167.44 10.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.489 ' C ' ' HA ' ' A' ' 9' ' ' TYR . 3.6 t -69.81 -173.93 0.68 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.77 127.41 0.47 Allowed Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 120.686 -1.258 . . . . 0.0 109.956 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.92 159.55 45.55 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.792 1.662 . . . . 0.0 109.228 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.247 -0.908 . . . . 0.0 109.751 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.294 0.569 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.527 ' CG2' ' HA3' ' A' ' 10' ' ' GLY . 20.4 mt -120.07 82.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.21 69.48 0.74 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 0.0 109.68 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 -178.7 6.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.282 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 9' ' ' TYR . 2.0 m-20 -61.1 89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.951 . . . . 0.0 109.196 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 62.52 46.32 5.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.84 146.17 1.94 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 105.17 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 109.787 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.519 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.6 p -115.08 176.1 5.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 109.02 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 14' ' ' TRP . 22.8 m -159.81 73.76 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.964 -1.085 . . . . 0.0 110.382 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.553 ' O ' ' N ' ' A' ' 16' ' ' GLY . 4.1 m-90 40.64 -147.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.428 -0.795 . . . . 0.0 110.451 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 14' ' ' TRP . . . -22.95 -42.39 0.01 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 14' ' ' TRP . . . -54.36 -165.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.469 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -43.61 100.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.054 -1.262 . . . . 0.0 109.353 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.0 tttt -70.94 -164.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.957 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -96.18 134.47 39.22 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.32 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.165 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -44.34 -26.74 0.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' ARG . . . 105.18 95.84 2.41 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.512 ' HB3' ' NH1' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -157.75 154.5 25.0 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.246 -1.149 . . . . 0.0 109.696 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -167.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.467 2.111 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 6.3 t -142.08 78.62 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 156.75 17.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.58 179.64 3.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.356 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.527 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.3 OUTLIER -58.73 171.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.48 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.426 ' HG3' HG21 ' A' ' 30' ' ' ILE . 5.3 ptp -78.34 -2.84 40.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.426 HG21 ' HG3' ' A' ' 29' ' ' MET . 9.6 pt -117.25 -26.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.988 . . . . 0.0 109.435 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.92 67.02 0.29 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -127.82 -158.56 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' C ' ' OE2' ' A' ' 35' ' ' GLU . 2.9 m-80 -42.97 150.12 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.789 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -107.58 127.35 53.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.295 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 8.6 mp0 -119.77 163.32 17.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.032 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.8 t -86.11 116.53 24.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 108.991 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.27 112.78 58.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 110.034 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -66.72 -167.17 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.857 1.705 . . . . 0.0 110.006 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 108.981 179.922 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.288 0.566 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.469 HG13 ' CG2' ' A' ' 17' ' ' THR . 3.8 mt -95.03 80.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.354 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.12 5.22 52.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.697 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.05 170.8 10.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.161 -0.962 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 1.4 p30 -79.98 123.33 27.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.835 . . . . 0.0 109.365 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 61.5 m-85 61.16 13.39 4.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' TYR . . . -44.32 132.33 7.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' O ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -52.08 151.56 3.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -1.137 . . . . 0.0 109.176 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -150.12 -167.87 2.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.79 134.97 10.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.44 84.24 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 109.372 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.88 -4.48 4.28 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.44 -125.95 3.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.469 ' CG2' HG13 ' A' ' 5' ' ' ILE . 11.9 m -65.01 118.35 8.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.145 . . . . 0.0 109.735 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.569 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.3 tppt? -93.49 160.69 14.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.161 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.569 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -66.74 156.93 34.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 110.324 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -82.9 158.16 22.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 2.6 mmp_? 65.34 8.3 4.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.828 . . . . 0.0 109.849 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . 74.6 98.29 0.1 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -150.94 131.03 6.9 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 108.724 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.15 -174.83 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.052 1.835 . . . . 0.0 110.62 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -145.33 111.67 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.085 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -84.89 163.21 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.9 m -138.54 -168.56 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 29' ' ' MET . 89.6 p -73.5 -2.22 21.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.483 ' HB2' ' O ' ' A' ' 28' ' ' SER . 2.1 mtt 67.59 7.18 5.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 109.689 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.504 HG13 ' N ' ' A' ' 31' ' ' GLY . 1.4 pp -131.44 -29.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 110.001 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.504 ' N ' HG13 ' A' ' 30' ' ' ILE . . . 123.21 90.29 0.95 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.461 ' OG1' ' OG ' ' A' ' 28' ' ' SER . 6.8 p -159.74 -74.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -144.56 151.63 39.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.456 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.31 132.74 54.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -126.48 138.74 53.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.413 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 34.6 t -73.16 144.15 46.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.887 . . . . 0.0 109.413 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 136.94 21.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.003 -1.061 . . . . 0.0 109.488 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.5 Cg_endo -65.16 117.22 4.36 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 21.4 mtm-85 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 110.359 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 9.2 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.423 0.63 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.545 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 11.4 mt -160.95 64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.82 56.24 3.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -150.28 151.95 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.2 OUTLIER -78.87 146.27 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 109.33 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.1 m-85 54.75 19.65 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.64 128.97 24.52 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 10.5 tttt -52.47 151.35 4.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.124 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 29.0 p -145.96 -167.68 2.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.8 m -157.4 123.56 4.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.297 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -53.35 110.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.485 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.46 -36.33 4.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.97 -133.38 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.462 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 1.3 m -74.52 84.23 2.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -1.164 . . . . 0.0 109.601 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 20.6 ttpt -65.64 163.65 15.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -60.37 120.65 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.471 -0.768 . . . . 0.0 109.582 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 2.1 m -50.06 146.07 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 1.6 mtt180 77.53 3.01 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.704 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.93 99.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.444 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -139.2 155.96 72.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.289 -1.124 . . . . 0.0 109.345 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HD3' ' NE ' ' A' ' 39' ' ' ARG . 2.7 Cg_endo -61.37 144.41 98.33 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.206 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.25 116.07 10.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 148.52 25.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.502 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 36.0 m -119.45 -172.37 2.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -117.25 44.88 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.554 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 61.42 22.35 12.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -124.47 -30.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.73 36.52 47.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -45.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -1.184 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -106.43 72.0 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.893 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 58.3 m -92.85 114.26 26.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.85 . . . . 0.0 109.299 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 125.39 33.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 37' ' ' THR . 16.0 t -81.43 159.47 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.481 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -119.71 148.24 45.71 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.638 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.1 176.28 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.229 1.953 . . . . 0.0 110.331 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.48 ' NE ' ' HD3' ' A' ' 24' ' ' PRO . 7.6 mtt180 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.294 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 17' ' ' THR . 5.3 mt -81.49 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.512 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . . . -98.99 47.76 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.95 176.82 7.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.1 130.25 36.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 47.2 m-85 58.34 19.54 6.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 133.48 52.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -46.78 144.5 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -1.182 . . . . 0.0 109.491 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.45 -168.42 3.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.569 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 m -154.71 137.49 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -63.36 92.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.35 43.79 1.96 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.28 -116.45 0.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.462 ' O ' HD13 ' A' ' 5' ' ' ILE . 12.2 m -84.48 96.95 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -1.132 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 1.9 ttmt -70.59 167.82 17.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.334 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -65.48 139.22 58.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.797 . . . . 0.0 109.257 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.512 ' SG ' ' CB ' ' A' ' 6' ' ' ALA . 73.9 m -44.17 -62.47 1.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.147 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.66 -73.72 0.05 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.462 -0.774 . . . . 0.0 109.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.29 82.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 39' ' ' ARG . 3.2 mmt-85 -138.38 155.16 74.04 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.133 -1.216 . . . . 0.0 109.546 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.42 -174.82 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.23 1.954 . . . . 0.0 110.195 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -150.11 153.72 36.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.379 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -126.74 164.44 21.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.566 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 m -136.4 -172.01 3.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -85.28 5.06 32.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.688 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER 75.2 17.63 2.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.414 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.411 ' CG1' ' HB3' ' A' ' 28' ' ' SER . 0.3 OUTLIER -141.83 26.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 30' ' ' ILE . . . 43.51 86.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 p -158.28 -41.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.104 . . . . 0.0 109.434 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.92 139.44 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.59 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 26' ' ' ARG . 28.2 m -130.2 168.56 16.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.3 mm-40 -142.44 155.89 45.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 109.717 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 36.4 t -86.91 145.27 26.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.48 123.57 36.95 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.001 . . . . 0.0 109.613 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.07 -169.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.898 1.732 . . . . 0.0 110.106 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 1.2 tmm_? . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.408 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.503 ' CG2' ' HA3' ' A' ' 10' ' ' GLY . 88.2 mt -99.56 73.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.91 -12.39 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.75 146.42 52.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.243 -0.911 . . . . 0.0 109.508 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 7.7 p-10 -65.97 130.19 42.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 52.5 m-85 62.86 12.2 5.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -45.09 121.78 4.74 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -42.78 125.19 3.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -1.069 . . . . 0.0 109.563 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.4 p -115.59 -170.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.09 134.2 7.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.332 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -72.09 100.29 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.47 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.3 -8.52 13.83 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.51 -140.3 8.79 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.58 148.02 35.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.198 -1.178 . . . . 0.0 109.531 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -164.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.816 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.479 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.8 139.21 32.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.553 -0.717 . . . . 0.0 109.57 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -53.51 145.34 15.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.216 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 25.6 mtp180 83.02 -42.59 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.553 -0.717 . . . . 0.0 109.735 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 83.18 0.84 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.479 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 6.9 mmt-85 -124.79 141.45 38.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.234 -1.156 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HG2' ' HG3' ' A' ' 39' ' ' ARG . 1.4 Cg_endo -64.01 169.84 9.87 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.094 1.863 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.04 172.3 13.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.3 ttm-85 -140.81 139.0 34.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.342 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 31' ' ' GLY . 64.3 m -133.64 -167.99 2.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 109.743 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.3 m -67.89 -36.27 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 0.0 109.745 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.457 ' O ' HG21 ' A' ' 30' ' ' ILE . 2.5 ptp -43.32 -27.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.457 HG21 ' O ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -156.2 27.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' CYS . . . -169.72 -93.48 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' SER . 1.1 p -160.4 -92.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -1.148 . . . . 0.0 109.332 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 26' ' ' ARG . 30.7 m120 -102.57 162.54 12.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.172 -0.955 . . . . 0.0 108.907 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 72.7 m -79.66 104.09 10.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 3.3 mt-10 -136.26 143.42 44.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 53.9 t -60.57 121.29 11.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.02 120.33 60.2 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.558 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 85.58 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.868 1.712 . . . . 0.0 110.079 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HG2' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.708 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.405 ' O ' HG21 ' A' ' 5' ' ' ILE . 26.7 mt -87.6 63.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.12 -11.16 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.531 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -54.99 152.5 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -64.08 127.02 29.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.883 . . . . 0.0 109.411 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 18.6 m-85 53.05 24.55 3.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.66 123.3 10.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -49.36 123.26 7.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 15.9 p -113.87 -171.65 1.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.13 148.94 45.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -77.17 89.26 3.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.14 9.66 19.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.9 -136.92 9.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -84.92 116.38 23.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 109.437 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -166.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -92.62 155.46 17.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -44.17 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.537 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -23.31 1.03 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.29 57.59 1.0 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HD2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 mtt-85 -96.38 152.06 38.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.44 173.36 3.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.23 1.953 . . . . 0.0 110.303 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -139.96 86.12 2.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -68.96 163.98 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 32' ' ' THR . 1.2 m -117.94 -171.9 2.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -68.9 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.42 41.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.87 -38.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.364 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.18 45.92 0.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -105.73 -156.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -1.089 . . . . 0.0 109.469 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 32' ' ' THR . 9.2 m-80 -42.4 150.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -118.02 165.33 13.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.435 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -141.33 142.3 33.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 t -68.14 120.75 14.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 121.51 55.58 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 2.0 Cg_endo -64.51 119.32 6.33 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.875 1.716 . . . . 0.0 110.245 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 3.7 ttm180 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.638 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 44.7 mt -78.97 83.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.71 -5.02 59.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.66 167.81 14.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 0.0 109.404 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 44.2 p-10 -88.17 128.41 35.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m-85 55.33 21.42 4.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.861 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -53.28 135.99 39.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 24.9 ttmt -42.54 111.69 0.28 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.422 -1.046 . . . . 0.0 109.445 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 36' ' ' CYS . 16.8 p -94.06 -167.58 1.71 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -158.38 156.52 30.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.436 -0.79 . . . . 0.0 109.641 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.522 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -99.16 51.71 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.54 39.7 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.24 -139.75 3.3 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 m -69.91 85.14 0.5 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -1.156 . . . . 0.0 109.307 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 16.8 ttmt -48.03 167.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -158.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -0.762 . . . . 0.0 109.667 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 73.8 m -106.35 141.59 37.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER 71.48 0.58 3.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 110.156 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.478 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 91.88 109.09 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.126 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -150.66 140.06 13.54 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.31 -1.112 . . . . 0.0 109.301 179.906 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.51 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.332 2.021 . . . . 0.0 110.724 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -120.27 99.28 6.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.963 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 36.4 ttt85 -71.15 152.68 43.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.033 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -137.99 -171.85 3.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.428 -0.795 . . . . 0.0 109.367 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.513 ' HB2' ' CG1' ' A' ' 30' ' ' ILE . 0.9 OUTLIER -93.99 28.04 2.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 66.07 25.82 10.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -128.42 -35.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.2 8.73 11.19 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -130.94 165.24 23.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -1.189 . . . . 0.0 108.997 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 32' ' ' THR . 23.2 t-20 45.33 85.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -102.45 107.93 19.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.698 -179.834 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 26' ' ' ARG . 6.2 mm-40 -85.43 156.43 20.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 42.6 t -76.48 157.44 32.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.39 116.16 35.46 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.18 100.23 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.719 1.613 . . . . 0.0 110.183 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.376 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.287 0.565 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 3' ' ' ASN . 9.8 p30 -175.0 29.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.64 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 2' ' ' ASP . 2.4 p30 -55.95 -164.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.4 p -113.41 156.19 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 12' ' ' CYS . 4.2 mt -89.79 82.88 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.415 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . . . -95.53 27.05 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.23 153.75 20.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 2.6 p30 -66.39 124.31 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 72.1 m-85 62.39 13.04 5.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.1 127.88 9.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -60.68 124.98 22.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -1.105 . . . . 0.0 109.364 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 11.8 p -112.48 -175.98 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.699 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . 2.4 m -150.92 101.46 2.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -0.79 . . . . 0.0 109.281 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 13' ' ' THR . 23.2 m0 -43.5 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 175.76 -37.85 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 18' ' ' LYS . . . -167.06 -70.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.61 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.859 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.6 ttpt -103.81 159.93 15.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 108.844 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.18 140.1 58.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.054 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -60.82 -35.46 76.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 109.68 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' GLY . 1.9 mmt-85 -86.93 23.87 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ARG . . . 43.97 77.77 0.08 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 49.8 mtt180 -120.94 149.57 51.26 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.153 . . . . 0.0 109.67 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.98 108.51 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.384 2.056 . . . . 0.0 110.54 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 150.71 22.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.994 . . . . 0.0 108.949 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.85 168.43 19.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -145.8 -172.37 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.453 ' HB2' HG12 ' A' ' 30' ' ' ILE . 61.1 m -93.35 -164.62 1.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.7 31.3 1.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 28' ' ' SER . 1.8 pt -115.15 -22.75 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.578 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.77 18.57 47.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.439 ' OG1' HD13 ' A' ' 30' ' ' ILE . 63.2 p -152.74 161.35 42.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -1.155 . . . . 0.0 109.43 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER 70.87 86.69 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 55.5 m -117.48 156.76 27.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -135.74 130.78 34.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 9.6 t -70.97 123.58 22.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.075 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.19 123.65 46.04 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.664 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.29 141.54 75.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.876 1.717 . . . . 0.0 109.975 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.459 ' O ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -159.75 66.33 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.547 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -165.01 -76.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.378 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' LEU . 12.5 mt 54.71 166.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 109.644 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.463 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -95.71 170.64 9.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.49 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.72 151.98 21.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.449 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.36 -125.62 8.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -140.73 -159.73 0.99 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -1.17 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 47' ' ' PHE . 5.4 p -92.75 -149.66 0.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.491 ' CE2' ' HB1' ' A' ' 48' ' ' ALA . 22.8 p90 -67.5 -164.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 109.523 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' HB1' ' CE2' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -117.74 127.99 54.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.77 -54.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.733 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 11.1 p -67.18 -150.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.511 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 49.5 mt -79.87 75.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.63 15.44 18.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.278 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -84.78 149.82 25.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.402 -0.811 . . . . 0.0 109.59 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.9 OUTLIER -65.3 123.68 20.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 30.6 m-85 62.34 20.69 12.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.65 124.58 35.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' O ' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -48.43 127.7 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.542 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -114.87 -168.32 1.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 109.724 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 14' ' ' TRP . 38.0 m -149.62 105.56 3.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.413 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -44.01 106.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.64 35.33 4.94 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.7 -131.3 1.91 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.49 108.36 17.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.436 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.73 -165.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 109.703 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 139.54 40.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -64.58 -50.05 68.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -18.73 8.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 109.35 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 57.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 38' ' ' PRO . 5.4 mtt85 -124.45 145.12 48.0 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.541 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.22 -169.76 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.283 1.989 . . . . 0.0 110.379 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -133.6 155.01 50.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.414 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.78 124.09 45.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.895 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.487 ' CB ' ' HA2' ' A' ' 31' ' ' GLY . 71.9 m -91.52 -171.2 2.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.1 OUTLIER -98.5 39.96 1.22 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.767 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' SER . 2.3 ttt 83.07 -43.24 0.11 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 32' ' ' THR . 4.3 pt -104.52 32.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.525 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.487 ' HA2' ' CB ' ' A' ' 27' ' ' CYS . . . 47.67 65.96 2.17 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 30' ' ' ILE . 39.3 p -139.13 126.35 21.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.513 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 47.51 64.67 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.8 m -79.87 158.79 26.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.184 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -141.52 138.48 32.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.593 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 50.6 t -54.48 130.96 41.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.256 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.97 123.62 32.44 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.025 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -63.57 157.64 50.09 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.29 144.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.608 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.5 39.53 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.54 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 mt -118.77 -151.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.478 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -163.83 136.1 5.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 109.508 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 42' ' ' MET . 4.0 pt-20 164.75 -35.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 109.074 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -133.13 114.01 1.32 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER 74.43 135.8 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -1.129 . . . . 0.0 109.159 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 92.2 p -145.0 -172.04 3.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.0 109.779 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 19.6 p90 -164.16 147.44 9.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.436 -0.79 . . . . 0.0 109.275 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.593 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 18.9 t70 -131.09 -47.4 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.901 -1.124 . . . . 0.0 109.968 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 40.5 t-20 178.73 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.955 . . . . 0.0 110.574 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 3' ' ' ASN . 10.4 p -44.09 169.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.939 -1.101 . . . . 0.0 109.872 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.514 ' CD1' ' O ' ' A' ' 11' ' ' LYS . 74.8 mt -79.51 84.49 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.08 13.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.09 164.72 24.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.583 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 9.0 m-20 -85.27 121.35 27.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' GLY . 22.9 m-85 60.86 23.31 13.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.572 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -51.78 -175.78 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.514 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 3.9 ptpp? -99.74 126.44 45.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.112 -1.228 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 26.8 p -119.55 -170.25 1.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 14' ' ' TRP . 17.1 m -147.25 161.22 41.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.469 ' N ' ' CG2' ' A' ' 13' ' ' THR . 0.1 OUTLIER -80.59 88.56 5.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.45 15.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 -151.58 28.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.463 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 74.7 m -61.81 90.74 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.224 -1.162 . . . . 0.0 109.531 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -165.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.99 -164.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 85.7 m -116.48 134.53 54.75 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER 77.74 -6.8 1.92 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.958 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.468 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . 102.5 95.37 2.29 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.421 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.585 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -157.28 154.33 25.56 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.381 -1.07 . . . . 0.0 109.383 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.36 178.54 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.287 1.991 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -139.89 85.16 2.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 23.8 ttp85 -53.2 146.53 11.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 109.955 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -117.88 -170.08 1.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.584 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.11 39.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.7 OUTLIER 74.57 1.87 3.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.72 -81.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.98 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.06 45.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.36 -41.21 2.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.537 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -128.35 84.66 2.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 1.3 m -80.08 173.21 12.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.7 mp0 -141.24 150.45 42.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.789 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -73.77 107.53 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 124.41 59.09 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.474 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' ARG . 2.2 Cg_endo -63.63 159.17 42.21 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.873 1.715 . . . . 0.0 110.135 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' PRO . 1.6 mmm180 52.92 172.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.708 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.12 168.68 11.69 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.328 -0.857 . . . . 0.0 109.54 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -157.04 73.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.532 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.456 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 3.9 ttt -143.24 120.04 11.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 42' ' ' MET . 36.6 tt0 66.96 159.69 0.14 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.907 . . . . 0.0 109.455 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.0 -85.49 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.07 164.22 12.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 109.405 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 57.4 p -129.82 133.39 46.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.953 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -61.61 126.98 29.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.246 -0.909 . . . . 0.0 109.452 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.481 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 2' ' ' ASP . 7.7 pt-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 1' ' ' GLU . 0.1 OUTLIER 39.18 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.737 . . . . 0.0 109.932 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 2' ' ' ASP . 1.8 t-20 -43.65 -57.8 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.513 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.455 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.0 p -87.45 164.54 16.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 12' ' ' CYS . 6.5 mt -87.14 95.16 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.65 -5.78 50.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.642 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.9 166.65 22.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 9' ' ' TYR . 79.0 m-20 -89.84 136.64 32.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.604 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.531 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 59.9 m-85 64.79 10.67 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.4 126.42 42.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' O ' HD12 ' A' ' 5' ' ' ILE . 20.5 tttt -45.66 120.33 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 5' ' ' ILE . 28.7 p -100.64 -169.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.623 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -147.48 121.16 9.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.36 -0.838 . . . . 0.0 109.356 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -69.46 94.63 0.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.08 14.02 25.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.04 -113.28 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.9 90.58 8.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -1.147 . . . . 0.0 109.633 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.582 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.85 154.8 38.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.582 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -37.77 147.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.691 -0.63 . . . . 0.0 110.193 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 86.3 m -43.64 -92.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -42.89 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.457 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 165.91 93.62 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -136.72 147.63 60.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.137 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.453 ' HG2' HD22 ' A' ' 40' ' ' LEU . 1.9 Cg_endo -62.75 -171.29 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.266 1.978 . . . . 0.0 110.311 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 153.44 43.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.81 . . . . 0.0 109.339 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.424 ' HD2' HG22 ' A' ' 37' ' ' THR . 1.3 ptm180 -119.68 134.28 55.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.78 -171.45 1.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.535 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 29' ' ' MET . 70.7 m -87.86 20.13 3.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.448 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 71.05 5.54 5.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.31 14.81 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.35 87.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.14 -54.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -142.8 103.83 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.56 132.44 39.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -121.45 127.44 51.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.57 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 29.1 t -54.51 121.99 9.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.144 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.424 HG22 ' HD2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -80.14 125.4 81.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.636 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 2.4 Cg_endo -62.75 135.89 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.909 1.74 . . . . 0.0 110.068 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.462 ' O ' HD21 ' A' ' 40' ' ' LEU . 7.0 mtt180 52.15 173.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.196 -0.94 . . . . 0.0 109.688 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD21 ' O ' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -140.01 75.98 1.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.369 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.01 72.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.1 mtt 55.27 90.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.346 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -64.52 130.98 45.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.402 ' C ' HD21 ' A' ' 45' ' ' LEU . . . -137.62 161.61 25.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 46' ' ' SER . 1.2 mm? -119.85 -35.08 3.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -1.105 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.527 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 3.6 p 168.41 -28.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 109.469 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 59.47 14.81 4.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.358 -0.839 . . . . 0.0 109.461 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.395 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 2' ' ' ASP . 2.1 mt-10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.337 0.589 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 1' ' ' GLU . 0.7 OUTLIER 62.97 46.6 4.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.371 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.47 -59.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -129.52 174.94 9.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 108.944 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.496 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 25.7 mt -81.9 119.79 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.421 ' HB2' ' OE1' ' A' ' 1' ' ' GLU . . . -116.29 -19.31 10.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.463 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.44 173.82 0.64 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.22 -0.925 . . . . 0.0 109.581 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 58.3 m-20 -89.88 141.7 28.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 46.9 m-85 61.66 13.45 5.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 109.528 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -50.55 151.53 5.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -72.74 98.15 2.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -1.204 . . . . 0.0 109.568 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 34' ' ' CYS . 6.3 p -102.16 -178.44 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.8 m -160.18 146.25 15.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.406 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -74.11 89.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLY . . . 137.45 -59.57 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 15' ' ' GLY . . . -63.06 -124.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.45 129.46 34.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -99.34 -164.45 1.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.664 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 130.85 34.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.1 m -55.86 -58.71 6.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -44.75 -25.84 0.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.55 20.64 12.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.436 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.8 mtp85 -85.94 161.4 50.1 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.49 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 23' ' ' ARG . 1.8 Cg_endo -62.87 -170.76 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.221 1.947 . . . . 0.0 110.215 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 36.5 t -134.11 85.41 2.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.324 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 3.8 ttt180 -43.65 140.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.621 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 93.5 m -153.06 173.6 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -77.84 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtp 177.64 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.1 pt -88.23 -22.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' HG21 ' A' ' 32' ' ' THR . . . 119.85 57.88 0.25 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.437 HG21 ' O ' ' A' ' 31' ' ' GLY . 1.1 p -160.03 169.36 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 109.524 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 49.6 51.6 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 10.8 m -91.82 117.68 30.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.44 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 34' ' ' CYS . 6.6 mm-40 -134.01 114.34 13.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.723 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.5 t -60.62 136.43 58.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.226 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 124.68 28.29 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.571 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.82 142.14 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.963 1.776 . . . . 0.0 110.181 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.74 138.61 48.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 39' ' ' ARG . 6.8 tp -44.16 144.57 0.93 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.525 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 mt -63.62 139.0 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.403 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.51 98.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.423 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -86.95 -23.53 25.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.92 -175.05 27.98 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.498 HD21 ' N ' ' A' ' 45' ' ' LEU . 3.8 mm? 59.82 15.29 4.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.475 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.5 m -77.51 -67.1 0.75 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -75.82 138.74 41.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.535 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.988 -1.005 . . . . 0.0 109.461 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.12 -95.19 0.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.105 -0.997 . . . . 0.0 109.612 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 4' ' ' CYS . 8.2 t30 -133.2 -148.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.037 -1.039 . . . . 0.0 109.479 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' ASN . 28.7 p -52.16 -174.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.408 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 3.7 mm -85.88 59.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.37 14.52 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.1 155.29 18.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -64.17 124.45 21.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.302 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 11.0 m-85 62.38 22.84 13.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -49.05 107.89 0.35 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -44.21 113.64 0.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.625 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -127.1 -169.09 1.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.516 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.563 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 55.7 m -134.93 127.28 30.32 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.286 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.54 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -0.982 . . . . 0.0 109.384 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 105.78 -41.89 2.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.35 -103.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.87 104.12 16.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.657 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 149.14 32.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -0.929 . . . . 0.0 109.017 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.474 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -53.96 140.63 30.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.98 -83.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 20' ' ' CYS . 5.0 mmm180 -43.48 -72.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 109.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.63 81.47 0.04 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.459 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 54.9 mtt180 -132.06 150.46 76.15 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.21 -1.171 . . . . 0.0 109.609 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.22 174.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.3 77.66 1.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 154.8 22.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.205 -0.935 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 20.4 m -81.13 161.63 24.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.174 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -89.45 52.9 2.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.628 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 44.59 26.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.542 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 32' ' ' THR . 4.5 pt -98.19 -10.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.362 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' C ' ' CG2' ' A' ' 32' ' ' THR . . . 64.9 25.27 70.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 17.7 p -156.36 121.52 4.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -1.153 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' THR . 1.4 m-80 58.89 151.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -119.58 154.25 34.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG3' ' HA ' ' A' ' 11' ' ' LYS . 2.6 mp0 -123.71 155.24 38.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 49.6 t -72.73 106.8 4.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.92 123.57 77.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 40' ' ' LEU . 2.4 Cg_endo -62.64 155.68 57.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.91 1.74 . . . . 0.0 110.129 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -59.64 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.208 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 38' ' ' PRO . 5.8 tp -147.82 -71.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.068 -1.02 . . . . 0.0 109.889 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.458 HD13 ' OE2' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -117.78 -168.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.206 -0.933 . . . . 0.0 109.918 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.532 ' N ' ' SD ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -165.67 29.09 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.281 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -41.67 164.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.805 . . . . 0.0 109.815 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.4 87.21 0.07 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.66 49.31 2.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -1.207 . . . . 0.0 109.687 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 m -99.13 -11.82 21.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.395 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 t80 69.12 20.11 7.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.207 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.493 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.441 ' O ' ' CG ' ' A' ' 2' ' ' ASP . 1.6 pm0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 1' ' ' GLU . 1.4 p30 40.18 57.48 2.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 0.0 109.892 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' O ' ' CG2' ' A' ' 17' ' ' THR . 13.8 p-10 -142.19 8.72 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 109.839 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 12.5 p -110.09 -151.93 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.497 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 11' ' ' LYS . 40.5 mt -138.25 67.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.95 4.99 15.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.62 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -84.35 149.67 25.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.7 m-20 -65.17 129.99 41.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 34.9 m-85 60.0 15.13 4.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.847 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -50.0 134.59 27.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 31.4 mttm -54.67 155.9 3.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -1.208 . . . . 0.0 109.693 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' HB3' HD11 ' A' ' 5' ' ' ILE . 19.1 p -160.29 -166.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' TRP . 4.1 m -150.69 124.5 9.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.707 . . . . 0.0 109.112 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' THR . 5.9 m0 -43.95 108.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.605 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.46 46.47 6.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.46 -111.41 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 3' ' ' ASN . 0.2 OUTLIER -89.08 129.32 35.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -1.126 . . . . 0.0 109.429 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -80.51 -166.76 1.14 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.357 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -104.41 19.29 20.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER 68.27 -90.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 0.0 110.127 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.95 -37.62 1.94 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.454 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . 124.17 51.1 0.2 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.553 ' CG ' ' HA ' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -103.51 135.27 19.4 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.043 . . . . 0.0 109.488 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 5.7 Cg_exo -58.97 -169.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.079 1.853 . . . . 0.0 110.117 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.2 124.99 9.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -115.58 136.77 52.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.474 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 84.1 m -84.42 178.64 7.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.525 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -113.22 36.06 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 109.69 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 79.79 6.45 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -90.33 -29.02 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.807 -1.183 . . . . 0.0 109.099 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.421 ' C ' HG21 ' A' ' 32' ' ' THR . . . 83.46 10.55 81.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -147.5 -73.34 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 0.0 108.667 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.545 ' N ' ' OG1' ' A' ' 32' ' ' THR . 6.7 m120 -69.45 113.96 7.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.829 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' CB ' ' HA ' ' A' ' 27' ' ' CYS . 4.2 m -129.45 155.03 46.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -111.75 153.2 26.86 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 23' ' ' ARG . 1.9 t -70.73 173.31 7.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.114 -0.991 . . . . 0.0 108.726 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.63 124.55 3.53 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.805 -1.185 . . . . 0.0 110.117 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -68.5 135.89 34.92 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.965 1.777 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 6.9 ttt-85 71.39 158.11 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -105.51 -171.83 1.98 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -116.2 84.78 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.142 -0.974 . . . . 0.0 109.357 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.475 ' CG ' HD11 ' A' ' 40' ' ' LEU . 9.0 ptm 171.04 -179.33 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.583 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -52.14 120.61 5.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -120.03 -121.17 2.88 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.598 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.99 11.96 0.49 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -1.173 . . . . 0.0 110.249 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.437 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.7 m -75.63 -72.2 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.997 -1.065 . . . . 0.0 109.555 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -79.76 169.05 18.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.681 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.554 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -48.14 116.03 1.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.467 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -154.53 44.21 0.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.457 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 p 179.96 178.49 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CG2' ' OE2' ' A' ' 7' ' ' GLU . 19.5 mt -87.39 109.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.88 -16.1 14.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.531 ' CG ' ' HA3' ' A' ' 10' ' ' GLY . 6.6 pt-20 -52.26 170.63 0.06 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.34 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.559 ' OD1' ' CE1' ' A' ' 9' ' ' TYR . 2.3 t0 -90.04 129.7 36.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.559 ' CE1' ' OD1' ' A' ' 8' ' ' ASP . 70.8 m-85 66.32 7.65 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 109.932 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -51.2 133.83 33.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.92 109.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.392 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 17.8 p -88.39 -167.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.1 151.42 19.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.476 -0.765 . . . . 0.0 109.385 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.579 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -93.75 77.26 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.77 -55.86 0.7 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.26 -143.33 0.14 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.41 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -64.17 98.28 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -1.094 . . . . 0.0 109.509 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -164.0 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' HB3' ' HG3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -95.22 129.27 42.4 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 109.46 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 35.1 m -44.55 157.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 63.54 11.79 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.617 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.78 92.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -117.64 155.43 50.54 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.237 -1.155 . . . . 0.0 109.358 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.73 136.72 68.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.158 1.905 . . . . 0.0 109.9 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.579 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -91.34 87.8 6.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -0.969 . . . . 0.0 108.558 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -57.82 124.0 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.698 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -152.65 -172.5 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 0.0 109.455 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.94 -92.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mmt -135.11 65.02 1.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.97 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -50.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.85 22.91 22.16 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -123.07 -87.2 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -1.109 . . . . 0.0 109.36 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.8 m-80 -59.67 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.226 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 21.4 m -120.95 141.42 50.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -103.41 112.58 25.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.359 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 12' ' ' CYS . 41.2 t -53.16 119.68 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.598 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.96 130.95 30.01 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 2.5 Cg_endo -61.94 -171.65 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.878 1.719 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.457 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 166.76 152.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.2 106.78 19.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.576 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -106.42 -34.46 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.375 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.497 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -80.12 -10.12 59.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -0.88 . . . . 0.0 109.417 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 42' ' ' MET . 0.3 OUTLIER 51.98 172.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.672 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.72 116.09 4.38 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.15 87.94 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -1.143 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -162.71 174.71 12.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.354 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -56.02 12.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.216 -0.927 . . . . 0.0 109.493 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.405 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.95 10.08 25.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -91.66 132.1 36.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.432 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -153.13 170.86 19.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 109.583 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 14.0 mt -82.7 129.06 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.385 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.59 -11.94 13.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.09 172.05 3.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -89.48 137.88 31.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.855 . . . . 0.0 109.356 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 61.6 m-85 58.91 14.88 3.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' N ' ' HB3' ' A' ' 36' ' ' CYS . . . -53.74 121.55 18.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -43.81 122.0 2.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 109.743 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.67 174.27 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.09 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -149.77 149.79 31.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.161 -0.962 . . . . 0.0 109.594 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -79.96 89.46 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.62 3.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.83 -127.05 1.58 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' HD13 ' A' ' 5' ' ' ILE . 2.3 m -90.16 87.87 7.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -1.15 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.566 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -89.18 155.17 19.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 109.0 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.566 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -49.05 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 21' ' ' ARG . 94.5 m -90.55 114.7 26.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.03 -1.044 . . . . 0.0 110.737 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 5.76 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.248 0.547 . . . . 0.0 111.912 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . -165.15 -35.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.558 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -112.88 117.27 46.54 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.193 -1.18 . . . . 0.0 109.655 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.509 ' O ' ' O ' ' A' ' 25' ' ' CYS . 12.2 Cg_endo -79.76 37.25 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.146 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 24' ' ' PRO . 4.7 t 46.33 178.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 109.635 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER 178.16 142.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.811 -1.18 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -121.75 175.53 6.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.417 ' C ' ' HG3' ' A' ' 29' ' ' MET . 1.2 m -83.32 -93.46 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.722 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.417 ' HG3' ' C ' ' A' ' 28' ' ' SER . 61.5 mtp -143.54 14.34 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.525 HD11 ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -107.22 -14.96 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.311 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.89 83.89 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.92 161.67 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -1.105 . . . . 0.0 109.354 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 32' ' ' THR . 9.7 m120 63.9 63.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 26' ' ' ARG . 4.8 m -98.1 135.99 38.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 0.0 109.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 2.1 mt-10 -101.55 166.05 10.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 23' ' ' ARG . 1.9 t -78.6 109.4 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.421 -0.799 . . . . 0.0 109.052 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -88.54 137.06 30.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.912 -1.118 . . . . 0.0 109.408 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 39' ' ' ARG . 4.1 Cg_exo -57.26 176.39 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.11 1.873 . . . . 0.0 110.556 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 20.7 mtt180 -43.46 145.46 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 mt -73.59 126.22 29.78 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.281 -0.887 . . . . 0.0 109.772 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -142.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.191 -0.943 . . . . 0.0 109.096 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.79 152.22 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.942 -1.099 . . . . 0.0 109.655 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -79.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 0.0 109.576 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.51 -130.96 38.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -139.15 131.8 28.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -1.147 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t -111.81 15.59 20.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.318 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.66 74.44 1.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.374 -0.829 . . . . 0.0 109.536 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.524 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.275 0.559 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.04 94.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.862 . . . . 0.0 109.65 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.47 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 8.1 t30 -177.94 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.885 . . . . 0.0 109.405 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 19' ' ' CYS . 3.2 p 167.23 -169.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 109.358 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.454 HG13 HG21 ' A' ' 17' ' ' THR . 16.6 mt -83.31 104.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -0.976 . . . . 0.0 109.585 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.01 -4.47 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.53 142.13 46.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 42.3 m-20 -70.45 127.71 33.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.13 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 11.1 m-85 61.94 26.86 16.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -0.943 . . . . 0.0 109.392 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -69.67 125.04 16.22 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -42.74 124.07 2.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -1.115 . . . . 0.0 109.268 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 17' ' ' THR . 22.5 p -111.31 -167.25 1.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.966 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.6 m -144.35 144.18 31.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.408 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 41.1 m0 -68.95 86.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.76 37.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 -110.94 1.83 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.454 HG21 HG13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -80.03 84.59 5.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.154 . . . . 0.0 109.7 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.584 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.1 tppp? -83.79 166.08 18.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.823 . . . . 0.0 108.889 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.584 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -56.98 -144.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 109.717 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 69.7 m -133.54 118.84 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 25.0 mmm180 75.89 57.68 0.05 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . . . 78.11 -30.38 1.84 Allowed Glycine 0 N--CA 1.496 2.674 0 O-C-N 121.106 -0.996 . . . . 0.0 113.826 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -41.75 103.57 0.31 Allowed Pre-proline 0 N--CA 1.505 2.308 0 CA-C-N 119.751 1.776 . . . . 0.0 109.146 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 22' ' ' GLY . 6.1 Cg_endo -66.04 -163.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.46 2.107 . . . . 0.0 111.02 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -130.02 154.33 47.52 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.437 ' HD3' ' CG2' ' A' ' 37' ' ' THR . 0.5 OUTLIER -138.26 122.0 17.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.492 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 -170.54 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 108.768 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 66.96 -175.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.735 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 77.83 -4.3 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -0.85 . . . . 0.0 109.41 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.455 HG21 ' O ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -160.71 -38.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.244 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 76.64 1.32 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -159.99 -61.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -1.223 . . . . 0.0 109.637 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 170.57 173.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.58 132.08 35.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.21 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.448 ' HB3' ' CA ' ' A' ' 9' ' ' TYR . 2.2 mm-40 -113.13 122.57 47.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -51.95 117.86 3.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -0.788 . . . . 0.0 109.259 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.474 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -85.0 145.99 44.64 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.626 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.85 -170.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.093 1.862 . . . . 0.0 110.092 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 39' ' ' ARG . 2.6 ptm180 -85.89 103.4 14.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 109.628 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.09 140.34 49.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.251 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.521 ' O ' ' CG ' ' A' ' 42' ' ' MET . 8.8 tt -151.28 77.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 109.526 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.521 ' CG ' ' O ' ' A' ' 41' ' ' ILE . 18.1 ptt? 41.06 -162.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.413 -0.804 . . . . 0.0 109.769 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 116.29 19.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.96 -64.72 0.66 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 58.21 27.94 15.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.169 -1.195 . . . . 0.0 109.472 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 p -94.64 -41.78 9.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.535 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -151.96 99.08 2.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.355 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.406 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.281 0.563 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.77 144.2 2.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -0.933 . . . . 0.0 109.445 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -114.83 19.66 15.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 p -74.77 157.61 34.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -80.09 90.2 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.29 -13.79 51.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -72.32 147.12 46.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.455 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 57.4 m-20 -78.48 137.32 37.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.454 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 40.0 m-85 61.53 13.18 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.05 129.31 49.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 137.27 10.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -1.183 . . . . 0.0 109.411 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -135.43 -169.45 2.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.669 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.55 135.76 21.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.2 87.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.88 40.3 1.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.67 -122.34 1.3 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -62.91 91.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.398 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 148.99 38.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.135 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.47 147.6 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -56.08 141.43 40.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 12.5 mtt-85 72.79 10.51 5.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.843 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . 55.37 90.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 26.2 mmm180 -128.62 149.43 71.9 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.419 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.45 172.84 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.174 1.916 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -137.74 104.09 5.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -52.95 143.87 16.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.2 m -144.18 176.24 9.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 0.0 109.389 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 5.0 m -82.88 -91.19 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.99 -83.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -80.18 -30.24 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.66 77.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -101.33 -62.7 1.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -1.124 . . . . 0.0 109.327 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.461 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 50.6 t-20 -125.09 84.05 2.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 90.5 m -80.51 146.5 31.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 2.1 mp0 -144.03 118.8 9.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.412 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.0 t -46.46 113.03 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 109.273 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.94 131.87 32.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.518 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.8 Cg_endo -63.95 -169.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.989 1.793 . . . . 0.0 109.977 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -44.87 113.52 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' A' ' 43' ' ' GLU . 1.6 tt -151.65 102.68 2.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 20.03 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.209 -0.932 . . . . 0.0 109.516 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.5 tpt -127.79 -4.26 5.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HB2' HD23 ' A' ' 40' ' ' LEU . 2.8 mt-10 -94.14 -88.91 0.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.484 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -165.33 -63.65 0.03 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 2.1 tm? 79.37 -73.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.516 -0.991 . . . . 0.0 109.601 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.462 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 31.4 t -73.98 -16.55 61.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.121 -0.987 . . . . 0.0 109.455 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 46' ' ' SER . 2.0 m-85 -173.83 138.29 0.63 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.445 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.41 32.55 3.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.43 161.96 37.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.474 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 31.8 p -110.16 176.08 5.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.433 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 4.2 mm -80.02 75.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.56 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.15 20.31 11.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.24 152.65 32.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 85.5 m-20 -66.04 128.64 36.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 74.9 m-85 62.97 12.25 5.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -52.51 115.76 4.6 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' GLY . 14.4 ttpt -44.04 126.8 5.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.136 . . . . 0.0 109.422 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 16.6 p -118.54 -165.66 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.678 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -145.66 122.22 11.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.446 -0.784 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 98.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.08 46.21 1.92 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.7 -119.92 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 2.4 m -76.05 107.47 8.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 6.7 tttt -94.9 167.73 11.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.563 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.81 125.47 24.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -44.24 -67.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -42.71 -65.79 0.44 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.437 -0.789 . . . . 0.0 109.54 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.26 52.62 0.04 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 21' ' ' ARG . 8.5 mmt180 -108.35 145.0 30.62 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.196 -1.179 . . . . 0.0 109.376 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.22 179.07 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.09 1.86 . . . . 0.0 110.282 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -131.04 155.0 47.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.339 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -111.21 133.05 53.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 m -126.22 -172.48 2.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.499 ' O ' ' CB ' ' A' ' 29' ' ' MET . 1.9 m -89.98 19.47 4.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 76.11 -0.18 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.597 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.493 ' CG1' ' HB2' ' A' ' 28' ' ' SER . 2.0 pt -114.26 1.38 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.567 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 38.8 45.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' ASN . 27.8 p -135.68 124.47 23.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' THR . 11.1 t30 59.27 116.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 61.1 m -135.89 171.24 14.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -143.47 120.41 11.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.508 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.489 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 25.0 t -60.08 117.25 4.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.74 132.57 29.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.39 -174.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.983 1.789 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.43 ' HG3' ' HD2' ' A' ' 23' ' ' ARG . 26.7 mtp180 -83.08 118.92 23.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.463 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -174.96 -66.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.958 . . . . 0.0 109.537 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 2.5 mp 61.36 109.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.351 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.446 ' O ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -170.47 -159.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.405 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 42' ' ' MET . 1.8 pt-20 -43.97 166.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.62 -30.44 2.83 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.89 -155.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -1.128 . . . . 0.0 109.398 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 m -109.88 91.55 3.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.454 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -117.72 48.85 1.3 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.444 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.52 114.83 10.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -136.12 61.16 1.65 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 109.516 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p -162.98 -170.19 2.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 109.569 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.529 ' CG2' ' HA3' ' A' ' 10' ' ' GLY . 6.5 mt -85.55 106.44 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . . . -119.62 -2.04 10.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.561 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 156.93 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 3.6 m-20 -64.61 138.74 58.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.426 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 56.6 m-85 62.03 12.78 5.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -46.09 107.12 0.16 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' O ' HD11 ' A' ' 5' ' ' ILE . 26.2 mttt -42.85 130.78 4.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -1.098 . . . . 0.0 109.851 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 14.0 p -134.54 -164.39 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.354 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -157.11 137.77 13.18 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.537 -0.727 . . . . 0.0 109.319 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.6 107.97 2.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.615 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.79 12.99 33.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.55 -127.71 2.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.2 111.83 23.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -1.147 . . . . 0.0 109.72 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -92.69 170.5 9.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 108.684 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -47.34 88.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 109.918 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 18' ' ' LYS . 2.0 m 34.63 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.342 0.591 . . . . 0.0 110.251 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -169.55 58.46 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.046 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.5 -35.06 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.452 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -119.17 137.58 25.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.969 -1.312 . . . . 0.0 109.876 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.7 -166.04 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.053 1.835 . . . . 0.0 109.896 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.82 40.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.52 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -146.26 144.62 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.52 ' N ' ' HG2' ' A' ' 26' ' ' ARG . 1.2 m -116.28 167.15 11.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' MET . 0.7 OUTLIER -89.5 66.4 7.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 mtp 43.79 28.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.96 -74.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.5 29.36 1.31 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -153.63 -66.27 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.442 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.78 114.31 19.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -120.88 156.43 32.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -135.65 113.9 11.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.385 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 22.9 t -43.88 117.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 122.13 52.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.705 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.38 -166.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.985 1.79 . . . . 0.0 110.104 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.01 118.52 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.802 . . . . 0.0 109.45 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.8 mt -46.15 110.6 0.28 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.254 -0.904 . . . . 0.0 109.428 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.504 ' CG2' ' O ' ' A' ' 41' ' ' ILE . 4.8 tt -51.1 103.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.298 -0.877 . . . . 0.0 109.615 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.445 ' HA ' HD21 ' A' ' 45' ' ' LEU . 2.4 ttm 174.13 -175.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 42' ' ' MET . 1.6 tm-20 62.31 13.74 6.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.499 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.52 57.47 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -88.84 174.1 8.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -1.185 . . . . 0.0 109.412 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER 73.84 131.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.873 . . . . 0.0 109.499 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 54.42 -176.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 109.488 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.43 -179.95 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER -97.95 -63.74 1.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.88 . . . . 0.0 109.501 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 2' ' ' ASP . 0.7 OUTLIER -45.42 163.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.942 . . . . 0.0 109.374 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 17.0 p -68.41 -146.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.181 -0.95 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.538 ' CG2' ' HA3' ' A' ' 10' ' ' GLY . 7.1 mt -113.3 91.11 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.06 35.62 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.05 166.43 11.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.56 123.31 15.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.202 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER 43.64 31.9 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.775 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.54 129.69 7.4 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -36.7 133.16 0.59 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.589 -0.948 . . . . 0.0 110.316 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.417 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 1.6 p -122.4 -176.22 3.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.19 136.61 8.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -76.85 85.27 3.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.27 -17.93 7.43 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.32 -128.22 3.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' HD13 ' A' ' 5' ' ' ILE . 30.1 m -89.78 106.34 18.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -1.148 . . . . 0.0 109.408 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -166.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.691 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.524 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -97.44 175.97 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.091 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 1.1 m -104.78 149.38 25.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.988 . . . . 0.0 109.885 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER 77.61 -7.41 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.246 -0.909 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.52 46.76 2.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.524 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -93.06 124.48 58.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.165 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 4.6 Cg_exo -59.89 168.26 5.99 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.997 1.798 . . . . 0.0 110.584 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.5 t -120.98 106.4 11.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.485 -0.759 . . . . 0.0 109.087 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 35' ' ' GLU . 3.4 ttm180 -111.21 177.52 4.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -110.79 -177.85 3.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.95 28.73 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.469 ' CB ' ' O ' ' A' ' 28' ' ' SER . 12.5 ttm 72.73 29.54 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.656 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -51.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 109.539 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.43 10.7 9.3 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -123.96 -99.25 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -1.186 . . . . 0.0 109.322 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 2.2 m120 -55.19 128.91 36.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.983 -1.073 . . . . 0.0 108.75 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -120.64 124.7 45.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.2 OUTLIER -110.37 167.44 10.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.489 ' C ' ' HA ' ' A' ' 9' ' ' TYR . 3.6 t -69.81 -173.93 0.68 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.77 127.41 0.47 Allowed Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 120.686 -1.258 . . . . 0.0 109.956 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.92 159.55 45.55 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.792 1.662 . . . . 0.0 109.228 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -40.65 143.67 0.32 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.247 -0.908 . . . . 0.0 109.751 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 41' ' ' ILE . 9.8 tt 177.96 150.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 109.547 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.5 ' N ' HD22 ' A' ' 40' ' ' LEU . 97.6 mt -150.58 137.41 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.945 . . . . 0.0 109.384 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.414 ' HB2' ' HE1' ' A' ' 42' ' ' MET . 10.1 ptm -160.97 140.87 10.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 53.46 96.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.499 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.99 164.72 43.19 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.499 ' O ' ' CB ' ' A' ' 46' ' ' SER . 27.4 mt -96.72 133.65 41.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -1.099 . . . . 0.0 109.418 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 1.6 t 164.23 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.495 ' O ' ' CB ' ' A' ' 48' ' ' ALA . 61.2 t80 -133.92 104.21 6.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.468 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.247 0.546 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.37 -10.65 14.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.525 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -172.02 -48.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.643 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.2 p -93.84 -155.1 0.43 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -0.993 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.527 ' CG2' ' HA3' ' A' ' 10' ' ' GLY . 20.4 mt -120.07 82.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.21 69.48 0.74 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 0.0 109.68 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 -178.7 6.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.282 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 9' ' ' TYR . 2.0 m-20 -61.1 89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.951 . . . . 0.0 109.196 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 62.52 46.32 5.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.84 146.17 1.94 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 105.17 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 109.787 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.519 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.6 p -115.08 176.1 5.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 109.02 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 14' ' ' TRP . 22.8 m -159.81 73.76 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.964 -1.085 . . . . 0.0 110.382 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.553 ' O ' ' N ' ' A' ' 16' ' ' GLY . 4.1 m-90 40.64 -147.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.428 -0.795 . . . . 0.0 110.451 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 14' ' ' TRP . . . -22.95 -42.39 0.01 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 14' ' ' TRP . . . -54.36 -165.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.469 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -43.61 100.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.054 -1.262 . . . . 0.0 109.353 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.0 tttt -70.94 -164.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.957 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -96.18 134.47 39.22 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.32 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.165 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -44.34 -26.74 0.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' ARG . . . 105.18 95.84 2.41 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.512 ' HB3' ' NH1' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -157.75 154.5 25.0 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.246 -1.149 . . . . 0.0 109.696 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -167.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.467 2.111 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 6.3 t -142.08 78.62 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 156.75 17.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.58 179.64 3.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.356 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.527 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.3 OUTLIER -58.73 171.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.48 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.426 ' HG3' HG21 ' A' ' 30' ' ' ILE . 5.3 ptp -78.34 -2.84 40.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.426 HG21 ' HG3' ' A' ' 29' ' ' MET . 9.6 pt -117.25 -26.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.988 . . . . 0.0 109.435 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.92 67.02 0.29 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -127.82 -158.56 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' C ' ' OE2' ' A' ' 35' ' ' GLU . 2.9 m-80 -42.97 150.12 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.789 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -107.58 127.35 53.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.295 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 8.6 mp0 -119.77 163.32 17.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.032 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.8 t -86.11 116.53 24.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 108.991 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.27 112.78 58.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 110.034 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -66.72 -167.17 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.857 1.705 . . . . 0.0 110.006 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -104.8 -174.18 2.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 108.981 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 tp -47.08 114.02 0.78 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.005 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.0 tt -110.74 172.16 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.965 . . . . 0.0 109.561 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.9 mtm -116.34 -27.77 6.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -85.56 162.94 18.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . 160.18 -90.97 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 3.8 mm? 61.09 161.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -1.136 . . . . 0.0 109.542 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.561 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 177.94 50.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 109.431 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.561 ' CG ' ' C ' ' A' ' 46' ' ' SER . 0.1 OUTLIER 39.77 92.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.542 -0.724 . . . . 0.0 109.814 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.506 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.294 0.568 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.56 -82.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 1.4 m120 -171.95 -92.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 3' ' ' ASN . 31.4 p 177.88 -175.88 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.613 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.469 HG13 ' CG2' ' A' ' 17' ' ' THR . 3.8 mt -95.03 80.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.354 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.12 5.22 52.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.697 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.05 170.8 10.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.161 -0.962 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 1.4 p30 -79.98 123.33 27.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.835 . . . . 0.0 109.365 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 61.5 m-85 61.16 13.39 4.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' TYR . . . -44.32 132.33 7.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' O ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -52.08 151.56 3.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -1.137 . . . . 0.0 109.176 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -150.12 -167.87 2.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.79 134.97 10.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.44 84.24 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 109.372 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.88 -4.48 4.28 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.44 -125.95 3.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.469 ' CG2' HG13 ' A' ' 5' ' ' ILE . 11.9 m -65.01 118.35 8.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.145 . . . . 0.0 109.735 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.569 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.3 tppt? -93.49 160.69 14.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.161 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.569 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -66.74 156.93 34.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 110.324 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -82.9 158.16 22.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 2.6 mmp_? 65.34 8.3 4.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.828 . . . . 0.0 109.849 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . 74.6 98.29 0.1 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -150.94 131.03 6.9 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 108.724 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HG2' ' HG ' ' A' ' 40' ' ' LEU . 1.2 Cg_endo -66.15 -174.83 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.052 1.835 . . . . 0.0 110.62 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -145.33 111.67 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.085 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -84.89 163.21 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.9 m -138.54 -168.56 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 29' ' ' MET . 89.6 p -73.5 -2.22 21.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.483 ' HB2' ' O ' ' A' ' 28' ' ' SER . 2.1 mtt 67.59 7.18 5.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 109.689 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.504 HG13 ' N ' ' A' ' 31' ' ' GLY . 1.4 pp -131.44 -29.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 110.001 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.504 ' N ' HG13 ' A' ' 30' ' ' ILE . . . 123.21 90.29 0.95 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.461 ' OG1' ' OG ' ' A' ' 28' ' ' SER . 6.8 p -159.74 -74.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -144.56 151.63 39.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.456 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.31 132.74 54.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -126.48 138.74 53.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.413 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 34.6 t -73.16 144.15 46.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.887 . . . . 0.0 109.413 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -96.87 136.94 21.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.003 -1.061 . . . . 0.0 109.488 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.5 Cg_endo -65.16 117.22 4.36 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 21.4 mtm-85 40.06 51.21 2.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 110.359 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -51.94 151.32 3.65 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.111 -0.993 . . . . 0.0 109.884 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -137.61 22.91 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.936 -1.102 . . . . 0.0 109.611 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER 44.59 -145.48 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.991 . . . . 0.0 109.415 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' MET . 2.0 tt0 76.3 72.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 0.0 109.35 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 45' ' ' LEU . . . -62.46 154.04 42.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' GLY . 26.4 mt 59.55 154.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.135 . . . . 0.0 109.358 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.9 123.83 20.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.35 -149.27 0.28 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.395 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.437 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 2' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.328 0.585 . . . . 0.0 109.637 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.471 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -58.67 -155.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.182 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -145.43 8.44 1.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.904 -1.123 . . . . 0.0 110.492 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 9.2 p -114.69 -47.71 2.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.804 -1.185 . . . . 0.0 109.891 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.545 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 11.4 mt -160.95 64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.82 56.24 3.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -150.28 151.95 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.2 OUTLIER -78.87 146.27 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 109.33 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.1 m-85 54.75 19.65 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.64 128.97 24.52 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 10.5 tttt -52.47 151.35 4.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.124 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 29.0 p -145.96 -167.68 2.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.8 m -157.4 123.56 4.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.297 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -53.35 110.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.485 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.46 -36.33 4.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.97 -133.38 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.462 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 1.3 m -74.52 84.23 2.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -1.164 . . . . 0.0 109.601 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 20.6 ttpt -65.64 163.65 15.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -60.37 120.65 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.471 -0.768 . . . . 0.0 109.582 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 2.1 m -50.06 146.07 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 1.6 mtt180 77.53 3.01 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.704 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.93 99.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.444 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -139.2 155.96 72.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.289 -1.124 . . . . 0.0 109.345 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HD3' ' NE ' ' A' ' 39' ' ' ARG . 2.7 Cg_endo -61.37 144.41 98.33 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.206 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.25 116.07 10.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 148.52 25.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.502 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 36.0 m -119.45 -172.37 2.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -117.25 44.88 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.554 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 61.42 22.35 12.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -124.47 -30.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.73 36.52 47.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -45.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -1.184 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -106.43 72.0 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.893 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 58.3 m -92.85 114.26 26.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.85 . . . . 0.0 109.299 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 125.39 33.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 37' ' ' THR . 16.0 t -81.43 159.47 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.481 ' N ' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -119.71 148.24 45.71 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.638 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.1 176.28 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.229 1.953 . . . . 0.0 110.331 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.48 ' NE ' ' HD3' ' A' ' 24' ' ' PRO . 7.6 mtt180 -149.79 62.55 1.0 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.294 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 22.0 tp 42.97 37.45 1.12 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.349 -0.845 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 40' ' ' LEU . 52.6 mt 43.01 91.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.884 . . . . 0.0 109.548 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 43' ' ' GLU . 6.0 mtp -129.85 121.81 27.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 42' ' ' MET . 10.4 mm-40 -44.34 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.07 63.05 0.84 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -174.23 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -1.177 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.67 -29.2 40.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -50.63 106.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.192 -0.942 . . . . 0.0 109.498 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.924 -1.036 . . . . 0.0 109.456 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 2.2 t0 -133.14 -72.5 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 2.6 t-20 170.5 128.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.3 p -107.33 153.55 22.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 17' ' ' THR . 5.3 mt -81.49 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.512 ' CB ' ' SG ' ' A' ' 20' ' ' CYS . . . -98.99 47.76 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.95 176.82 7.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.1 130.25 36.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 47.2 m-85 58.34 19.54 6.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 133.48 52.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -46.78 144.5 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -1.182 . . . . 0.0 109.491 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.45 -168.42 3.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.569 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 m -154.71 137.49 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -63.36 92.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.35 43.79 1.96 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.28 -116.45 0.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.462 ' O ' HD13 ' A' ' 5' ' ' ILE . 12.2 m -84.48 96.95 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -1.132 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 1.9 ttmt -70.59 167.82 17.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.334 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -65.48 139.22 58.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.797 . . . . 0.0 109.257 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.512 ' SG ' ' CB ' ' A' ' 6' ' ' ALA . 73.9 m -44.17 -62.47 1.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.147 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.66 -73.72 0.05 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.462 -0.774 . . . . 0.0 109.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.29 82.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 39' ' ' ARG . 3.2 mmt-85 -138.38 155.16 74.04 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.133 -1.216 . . . . 0.0 109.546 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.42 -174.82 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.23 1.954 . . . . 0.0 110.195 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -150.11 153.72 36.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.379 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -126.74 164.44 21.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.566 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 m -136.4 -172.01 3.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -85.28 5.06 32.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.688 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER 75.2 17.63 2.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.414 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.411 ' CG1' ' HB3' ' A' ' 28' ' ' SER . 0.3 OUTLIER -141.83 26.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 30' ' ' ILE . . . 43.51 86.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 p -158.28 -41.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.104 . . . . 0.0 109.434 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.92 139.44 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.59 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 26' ' ' ARG . 28.2 m -130.2 168.56 16.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.3 mm-40 -142.44 155.89 45.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 109.717 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 36.4 t -86.91 145.27 26.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.48 123.57 36.95 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.001 . . . . 0.0 109.613 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.07 -169.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.898 1.732 . . . . 0.0 110.106 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 1.2 tmm_? -53.47 124.62 15.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.408 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -177.74 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.83 40.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.86 154.44 17.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.344 -0.848 . . . . 0.0 109.467 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.02 91.6 1.95 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.22 164.93 24.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 51.57 39.01 23.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -1.126 . . . . 0.0 109.402 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -108.66 98.72 8.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 58.19 43.01 21.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.444 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.37 113.72 25.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.529 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -116.66 126.19 52.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.499 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.2 p -126.46 -175.86 3.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.554 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.503 ' CG2' ' HA3' ' A' ' 10' ' ' GLY . 88.2 mt -99.56 73.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.91 -12.39 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.75 146.42 52.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.243 -0.911 . . . . 0.0 109.508 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 7.7 p-10 -65.97 130.19 42.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 52.5 m-85 62.86 12.2 5.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -45.09 121.78 4.74 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -42.78 125.19 3.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -1.069 . . . . 0.0 109.563 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.4 p -115.59 -170.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.09 134.2 7.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.332 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -72.09 100.29 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.47 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.3 -8.52 13.83 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.51 -140.3 8.79 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.58 148.02 35.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.198 -1.178 . . . . 0.0 109.531 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -164.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.816 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.479 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.8 139.21 32.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.553 -0.717 . . . . 0.0 109.57 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -53.51 145.34 15.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.216 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 25.6 mtp180 83.02 -42.59 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.553 -0.717 . . . . 0.0 109.735 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 83.18 0.84 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.479 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 6.9 mmt-85 -124.79 141.45 38.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.234 -1.156 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.518 ' HD3' ' CG2' ' A' ' 41' ' ' ILE . 1.4 Cg_endo -64.01 169.84 9.87 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.094 1.863 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.04 172.3 13.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.3 ttm-85 -140.81 139.0 34.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.342 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 31' ' ' GLY . 64.3 m -133.64 -167.99 2.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 109.743 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.3 m -67.89 -36.27 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 0.0 109.745 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.457 ' O ' HG21 ' A' ' 30' ' ' ILE . 2.5 ptp -43.32 -27.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.457 HG21 ' O ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -156.2 27.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' CYS . . . -169.72 -93.48 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' SER . 1.1 p -160.4 -92.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -1.148 . . . . 0.0 109.332 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 26' ' ' ARG . 30.7 m120 -102.57 162.54 12.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.172 -0.955 . . . . 0.0 108.907 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 72.7 m -79.66 104.09 10.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 3.3 mt-10 -136.26 143.42 44.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 53.9 t -60.57 121.29 11.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.02 120.33 60.2 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.558 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 85.58 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.868 1.712 . . . . 0.0 110.079 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HG2' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -146.07 125.99 13.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.708 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.506 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 4.6 pp -68.13 141.7 55.99 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.271 -0.893 . . . . 0.0 109.669 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.518 ' CG2' ' HD3' ' A' ' 24' ' ' PRO . 3.1 tp -155.67 146.2 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.347 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.432 ' N ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -98.82 92.8 5.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.43 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 56.4 -148.24 0.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.18 -0.95 . . . . 0.0 109.391 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.26 -126.74 6.37 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 54.27 -168.69 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 109.466 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 47' ' ' PHE . 5.7 t -102.99 72.84 1.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.449 ' O ' ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 45.91 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.445 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -113.9 167.21 10.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.63 1.33 23.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.902 . . . . 0.0 109.47 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.8 p -83.02 171.62 13.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.405 ' O ' HG21 ' A' ' 5' ' ' ILE . 26.7 mt -87.6 63.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.12 -11.16 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.531 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -54.99 152.5 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -64.08 127.02 29.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.883 . . . . 0.0 109.411 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 18.6 m-85 53.05 24.55 3.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.66 123.3 10.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -49.36 123.26 7.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 15.9 p -113.87 -171.65 1.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.13 148.94 45.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -77.17 89.26 3.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.14 9.66 19.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.9 -136.92 9.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -84.92 116.38 23.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 109.437 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -166.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -92.62 155.46 17.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -44.17 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.537 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -23.31 1.03 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.29 57.59 1.0 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HD2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 mtt-85 -96.38 152.06 38.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' HG2' ' CD1' ' A' ' 40' ' ' LEU . 2.0 Cg_endo -62.44 173.36 3.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.23 1.953 . . . . 0.0 110.303 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -139.96 86.12 2.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -68.96 163.98 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 32' ' ' THR . 1.2 m -117.94 -171.9 2.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -68.9 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.42 41.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.87 -38.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.364 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.18 45.92 0.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -105.73 -156.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -1.089 . . . . 0.0 109.469 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 32' ' ' THR . 9.2 m-80 -42.4 150.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -118.02 165.33 13.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.435 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -141.33 142.3 33.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 t -68.14 120.75 14.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 121.51 55.58 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 2.0 Cg_endo -64.51 119.32 6.33 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.875 1.716 . . . . 0.0 110.245 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 3.7 ttm180 70.24 154.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.638 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' CD1' ' HG2' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -178.63 105.34 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.307 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.418 HG21 ' N ' ' A' ' 42' ' ' MET . 4.4 mt -87.0 148.44 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.944 . . . . 0.0 109.766 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.418 ' N ' HG21 ' A' ' 41' ' ' ILE . 15.5 mmt 59.57 110.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -114.94 102.92 10.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.9 135.45 13.23 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.54 179.83 5.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -1.115 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -14.75 39.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -48.37 107.53 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.918 . . . . 0.0 109.42 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.506 -179.993 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 3.4 t0 -101.39 168.07 9.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 17.4 m120 61.21 -167.65 0.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -170.17 -162.76 0.32 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 109.15 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 44.7 mt -78.97 83.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.71 -5.02 59.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.66 167.81 14.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 0.0 109.404 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 44.2 p-10 -88.17 128.41 35.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m-85 55.33 21.42 4.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.861 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -53.28 135.99 39.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 24.9 ttmt -42.54 111.69 0.28 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.422 -1.046 . . . . 0.0 109.445 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 36' ' ' CYS . 16.8 p -94.06 -167.58 1.71 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -158.38 156.52 30.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.436 -0.79 . . . . 0.0 109.641 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.522 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -99.16 51.71 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.54 39.7 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.24 -139.75 3.3 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 m -69.91 85.14 0.5 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -1.156 . . . . 0.0 109.307 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 16.8 ttmt -48.03 167.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -158.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -0.762 . . . . 0.0 109.667 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 73.8 m -106.35 141.59 37.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER 71.48 0.58 3.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 110.156 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.478 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 91.88 109.09 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.126 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -150.66 140.06 13.54 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.31 -1.112 . . . . 0.0 109.301 179.906 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.51 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.332 2.021 . . . . 0.0 110.724 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -120.27 99.28 6.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.963 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 36.4 ttt85 -71.15 152.68 43.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.033 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -137.99 -171.85 3.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.428 -0.795 . . . . 0.0 109.367 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.513 ' HB2' ' CG1' ' A' ' 30' ' ' ILE . 0.9 OUTLIER -93.99 28.04 2.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 66.07 25.82 10.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -128.42 -35.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.2 8.73 11.19 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -130.94 165.24 23.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -1.189 . . . . 0.0 108.997 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 32' ' ' THR . 23.2 t-20 45.33 85.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -102.45 107.93 19.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.698 -179.834 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 26' ' ' ARG . 6.2 mm-40 -85.43 156.43 20.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 42.6 t -76.48 157.44 32.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.39 116.16 35.46 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.18 100.23 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.719 1.613 . . . . 0.0 110.183 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 40' ' ' LEU . 5.5 mtt180 65.95 120.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.376 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 41' ' ' ILE . 1.6 tm? -44.59 112.27 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.288 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 2.3 pt -53.12 146.75 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.506 ' HG2' ' CG ' ' A' ' 43' ' ' GLU . 6.0 ttp -158.51 147.92 19.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.0 109.558 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.506 ' CG ' ' HG2' ' A' ' 42' ' ' MET . 1.4 mt-10 73.89 17.13 3.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.627 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' HD12 ' A' ' 45' ' ' LEU . . . 151.66 153.69 6.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -116.27 -59.98 1.91 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -1.151 . . . . 0.0 109.348 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 47' ' ' PHE . 33.5 m -166.46 -158.47 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 61.46 129.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 -179.967 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.458 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.551 HD12 ' HB3' ' A' ' 12' ' ' CYS . 4.2 mt -89.79 82.88 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.415 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -95.53 27.05 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.23 153.75 20.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 2.6 p30 -66.39 124.31 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 72.1 m-85 62.39 13.04 5.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.1 127.88 9.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -60.68 124.98 22.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -1.105 . . . . 0.0 109.364 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.551 ' HB3' HD12 ' A' ' 5' ' ' ILE . 11.8 p -112.48 -175.98 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.699 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . 2.4 m -150.92 101.46 2.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -0.79 . . . . 0.0 109.281 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 13' ' ' THR . 23.2 m0 -43.5 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 175.76 -37.85 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 18' ' ' LYS . . . -167.06 -70.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.61 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.859 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.6 ttpt -103.81 159.93 15.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 108.844 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.18 140.1 58.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.054 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -60.82 -35.46 76.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 109.68 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' GLY . 1.9 mmt-85 -86.93 23.87 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ARG . . . 43.97 77.77 0.08 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.482 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 49.8 mtt180 -120.94 149.57 51.26 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.153 . . . . 0.0 109.67 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.98 108.51 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.384 2.056 . . . . 0.0 110.54 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 150.71 22.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.994 . . . . 0.0 108.949 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.85 168.43 19.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -145.8 -172.37 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.494 ' HB2' HG12 ' A' ' 30' ' ' ILE . 61.1 m -93.35 -164.62 1.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.7 31.3 1.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 28' ' ' SER . 1.8 pt -115.15 -22.75 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.578 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.414 ' C ' HG23 ' A' ' 32' ' ' THR . . . 90.77 18.57 47.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 63.2 p -152.74 161.35 42.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -1.155 . . . . 0.0 109.43 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER 70.87 86.69 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 55.5 m -117.48 156.76 27.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -135.74 130.78 34.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 9.6 t -70.97 123.58 22.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.075 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.19 123.65 46.04 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.664 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.29 141.54 75.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.876 1.717 . . . . 0.0 109.975 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.547 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 11.1 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.314 0.578 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.511 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 49.5 mt -79.87 75.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.63 15.44 18.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.278 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -84.78 149.82 25.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.402 -0.811 . . . . 0.0 109.59 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.9 OUTLIER -65.3 123.68 20.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 30.6 m-85 62.34 20.69 12.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.65 124.58 35.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -48.43 127.7 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.542 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -114.87 -168.32 1.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 109.724 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 14' ' ' TRP . 38.0 m -149.62 105.56 3.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.413 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -44.01 106.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.64 35.33 4.94 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.7 -131.3 1.91 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -84.49 108.36 17.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.436 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.73 -165.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 109.703 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 139.54 40.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -64.58 -50.05 68.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -18.73 8.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 109.35 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 57.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 38' ' ' PRO . 5.4 mtt85 -124.45 145.12 48.0 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.541 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -65.22 -169.76 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.283 1.989 . . . . 0.0 110.379 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -133.6 155.01 50.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.414 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.78 124.09 45.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.895 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' CB ' ' HA2' ' A' ' 31' ' ' GLY . 71.9 m -91.52 -171.2 2.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.1 OUTLIER -98.5 39.96 1.22 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.767 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' SER . 2.3 ttt 83.07 -43.24 0.11 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 32' ' ' THR . 4.3 pt -104.52 32.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.525 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.482 ' HA2' ' CB ' ' A' ' 27' ' ' CYS . . . 47.67 65.96 2.17 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 30' ' ' ILE . 39.3 p -139.13 126.35 21.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.513 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 47.51 64.67 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 3.8 m -79.87 158.79 26.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.184 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -141.52 138.48 32.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.593 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 50.6 t -54.48 130.96 41.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.256 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.97 123.62 32.44 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.025 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -63.57 157.64 50.09 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.608 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 10.4 p . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.281 0.562 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 11' ' ' LYS . 74.8 mt -79.51 84.49 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.08 13.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.09 164.72 24.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.583 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 9.0 m-20 -85.27 121.35 27.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' GLY . 22.9 m-85 60.86 23.31 13.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.572 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -51.78 -175.78 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.52 ' O ' HD13 ' A' ' 5' ' ' ILE . 3.9 ptpp? -99.74 126.44 45.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.112 -1.228 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 26.8 p -119.55 -170.25 1.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.508 HG22 ' N ' ' A' ' 14' ' ' TRP . 17.1 m -147.25 161.22 41.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.508 ' N ' HG22 ' A' ' 13' ' ' THR . 0.1 OUTLIER -80.59 88.56 5.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.45 15.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 -151.58 28.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.473 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 74.7 m -61.81 90.74 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.224 -1.162 . . . . 0.0 109.531 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -165.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.6 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.99 -164.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 85.7 m -116.48 134.53 54.75 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER 77.74 -6.8 1.92 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.958 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . 102.5 95.37 2.29 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.421 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -157.28 154.33 25.56 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.381 -1.07 . . . . 0.0 109.383 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.36 178.54 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.287 1.991 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -139.89 85.16 2.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 23.8 ttp85 -53.2 146.53 11.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 109.955 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -117.88 -170.08 1.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.584 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.11 39.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.7 OUTLIER 74.57 1.87 3.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.72 -81.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.98 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.06 45.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.36 -41.21 2.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.537 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -128.35 84.66 2.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 1.3 m -80.08 173.21 12.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.7 mp0 -141.24 150.45 42.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.789 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -73.77 107.53 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 124.41 59.09 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.474 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' ARG . 2.2 Cg_endo -63.63 159.17 42.21 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.873 1.715 . . . . 0.0 110.135 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' PRO . 1.6 mmm180 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.708 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.0 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 11' ' ' LYS . 6.5 mt -87.14 95.16 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.586 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -92.65 -5.78 50.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.642 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.9 166.65 22.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.548 ' HB3' ' CD1' ' A' ' 9' ' ' TYR . 79.0 m-20 -89.84 136.64 32.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.604 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.548 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 59.9 m-85 64.79 10.67 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.4 126.42 42.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.551 ' O ' HD13 ' A' ' 5' ' ' ILE . 20.5 tttt -45.66 120.33 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.51 ' HA ' ' CD1' ' A' ' 5' ' ' ILE . 28.7 p -100.64 -169.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.623 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -147.48 121.16 9.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.36 -0.838 . . . . 0.0 109.356 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -69.46 94.63 0.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.08 14.02 25.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.04 -113.28 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.9 90.58 8.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -1.147 . . . . 0.0 109.633 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.582 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.85 154.8 38.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.582 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -37.77 147.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.691 -0.63 . . . . 0.0 110.193 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 6' ' ' ALA . 86.3 m -43.64 -92.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -42.89 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 165.91 93.62 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -136.72 147.63 60.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.137 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.75 -171.29 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.266 1.978 . . . . 0.0 110.311 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 153.44 43.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.81 . . . . 0.0 109.339 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.757 ' HD3' HG23 ' A' ' 37' ' ' THR . 1.3 ptm180 -119.68 134.28 55.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.78 -171.45 1.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.535 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 29' ' ' MET . 70.7 m -87.86 20.13 3.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.448 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 71.05 5.54 5.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.31 14.81 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.35 87.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.14 -54.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -142.8 103.83 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.56 132.44 39.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -121.45 127.44 51.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.57 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 29.1 t -54.51 121.99 9.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.144 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.757 HG23 ' HD3' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -80.14 125.4 81.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.636 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 2.4 Cg_endo -62.75 135.89 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.909 1.74 . . . . 0.0 110.068 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 38' ' ' PRO . 7.0 mtt180 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.196 -0.94 . . . . 0.0 109.688 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.496 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 25.7 mt -81.9 119.79 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.29 -19.31 10.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.463 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.44 173.82 0.64 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.22 -0.925 . . . . 0.0 109.581 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 58.3 m-20 -89.88 141.7 28.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 46.9 m-85 61.66 13.45 5.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 109.528 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -50.55 151.53 5.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -72.74 98.15 2.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -1.204 . . . . 0.0 109.568 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 34' ' ' CYS . 6.3 p -102.16 -178.44 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.8 m -160.18 146.25 15.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.406 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -74.11 89.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLY . . . 137.45 -59.57 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 15' ' ' GLY . . . -63.06 -124.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.45 129.46 34.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -99.34 -164.45 1.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.664 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 130.85 34.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.1 m -55.86 -58.71 6.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -44.75 -25.84 0.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.55 20.64 12.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.8 mtp85 -85.94 161.4 50.1 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.49 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 23' ' ' ARG . 1.8 Cg_endo -62.87 -170.76 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.221 1.947 . . . . 0.0 110.215 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 36.5 t -134.11 85.41 2.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.324 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 3.8 ttt180 -43.65 140.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.621 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 93.5 m -153.06 173.6 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -77.84 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtp 177.64 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.1 pt -88.23 -22.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 32' ' ' THR . . . 119.85 57.88 0.25 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.1 p -160.03 169.36 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 109.524 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 49.6 51.6 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 10.8 m -91.82 117.68 30.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.44 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.6 mm-40 -134.01 114.34 13.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.723 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.5 t -60.62 136.43 58.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.226 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 124.68 28.29 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.571 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 1.9 Cg_endo -63.82 142.14 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.963 1.776 . . . . 0.0 110.181 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.7 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 5' ' ' ILE . 3.7 mm -85.88 59.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.37 14.52 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.1 155.29 18.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -64.17 124.45 21.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.302 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.477 ' CA ' ' HB3' ' A' ' 35' ' ' GLU . 11.0 m-85 62.38 22.84 13.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -49.05 107.89 0.35 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HA ' ' HG3' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -44.21 113.64 0.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.625 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -127.1 -169.09 1.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.516 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.563 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 55.7 m -134.93 127.28 30.32 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.286 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.54 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -0.982 . . . . 0.0 109.384 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 105.78 -41.89 2.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.35 -103.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.87 104.12 16.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.657 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 149.14 32.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -0.929 . . . . 0.0 109.017 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.49 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -53.96 140.63 30.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.98 -83.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 20' ' ' CYS . 5.0 mmm180 -43.48 -72.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 109.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.63 81.47 0.04 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 54.9 mtt180 -132.06 150.46 76.15 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.21 -1.171 . . . . 0.0 109.609 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.22 174.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.3 77.66 1.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 154.8 22.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.205 -0.935 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 20.4 m -81.13 161.63 24.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.174 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 30' ' ' ILE . 0.6 OUTLIER -89.45 52.9 2.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.628 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 44.59 26.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.542 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 32' ' ' THR . 4.5 pt -98.19 -10.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.362 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.456 ' C ' ' CG2' ' A' ' 32' ' ' THR . . . 64.9 25.27 70.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 17.7 p -156.36 121.52 4.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -1.153 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' THR . 2.7 m120 58.89 151.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -119.58 154.25 34.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 11' ' ' LYS . 2.6 mp0 -123.71 155.24 38.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 5' ' ' ILE . 49.6 t -72.73 106.8 4.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.92 123.57 77.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.64 155.68 57.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.91 1.74 . . . . 0.0 110.129 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.208 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.66 ' HA ' HG22 ' A' ' 17' ' ' THR . 12.5 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.933 HD13 ' O ' ' A' ' 11' ' ' LYS . 40.5 mt -138.25 67.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.95 4.99 15.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.62 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -84.35 149.67 25.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.7 m-20 -65.17 129.99 41.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 34.9 m-85 60.0 15.13 4.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.847 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -50.0 134.59 27.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.933 ' O ' HD13 ' A' ' 5' ' ' ILE . 31.4 mttm -54.67 155.9 3.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -1.208 . . . . 0.0 109.693 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.401 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 19.1 p -160.29 -166.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' TRP . 4.1 m -150.69 124.5 9.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.707 . . . . 0.0 109.112 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' THR . 5.9 m0 -43.95 108.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.605 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.46 46.47 6.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.46 -111.41 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -89.08 129.32 35.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -1.126 . . . . 0.0 109.429 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -80.51 -166.76 1.14 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.357 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -104.41 19.29 20.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER 68.27 -90.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 0.0 110.127 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.95 -37.62 1.94 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . 124.17 51.1 0.2 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.554 ' CG ' ' HA ' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -103.51 135.27 19.4 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.043 . . . . 0.0 109.488 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 5.7 Cg_exo -58.97 -169.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.079 1.853 . . . . 0.0 110.117 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.2 124.99 9.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.44 ' CZ ' HG21 ' A' ' 37' ' ' THR . 3.2 ttp180 -115.58 136.77 52.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.485 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 84.1 m -84.42 178.64 7.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.525 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -113.22 36.06 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 109.69 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 79.79 6.45 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -90.33 -29.02 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.807 -1.183 . . . . 0.0 109.099 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.46 10.55 81.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -147.5 -73.34 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 0.0 108.667 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.545 ' N ' ' OG1' ' A' ' 32' ' ' THR . 6.7 m120 -69.45 113.96 7.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.829 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 27' ' ' CYS . 4.2 m -129.45 155.03 46.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -111.75 153.2 26.86 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 23' ' ' ARG . 1.9 t -70.73 173.31 7.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.114 -0.991 . . . . 0.0 108.726 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -153.63 124.55 3.53 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.805 -1.185 . . . . 0.0 110.117 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -68.5 135.89 34.92 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.965 1.777 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 6.9 ttt-85 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 12' ' ' CYS . 19.5 mt -87.39 109.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.88 -16.1 14.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.549 ' CG ' ' HA3' ' A' ' 10' ' ' GLY . 6.6 pt-20 -52.26 170.63 0.06 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.34 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.559 ' OD1' ' CE1' ' A' ' 9' ' ' TYR . 2.3 t0 -90.04 129.7 36.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.559 ' CE1' ' OD1' ' A' ' 8' ' ' ASP . 70.8 m-85 66.32 7.65 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 109.932 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -51.2 133.83 33.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -52.92 109.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.392 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 17.8 p -88.39 -167.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.1 151.42 19.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.476 -0.765 . . . . 0.0 109.385 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.596 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -93.75 77.26 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.77 -55.86 0.7 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.26 -143.33 0.14 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.17 98.28 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -1.094 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -164.0 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.432 ' HB3' ' HG3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -95.22 129.27 42.4 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 109.46 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 35.1 m -44.55 157.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 63.54 11.79 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.617 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.78 92.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -117.64 155.43 50.54 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.237 -1.155 . . . . 0.0 109.358 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.73 136.72 68.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.158 1.905 . . . . 0.0 109.9 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.596 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -91.34 87.8 6.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -0.969 . . . . 0.0 108.558 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -57.82 124.0 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.698 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -152.65 -172.5 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 0.0 109.455 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.94 -92.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mmt -135.11 65.02 1.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.97 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -50.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.85 22.91 22.16 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -123.07 -87.2 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -1.109 . . . . 0.0 109.36 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.8 m-80 -59.67 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.226 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 21.4 m -120.95 141.42 50.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -103.41 112.58 25.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.359 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 12' ' ' CYS . 41.2 t -53.16 119.68 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.598 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.96 130.95 30.01 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 2.5 Cg_endo -61.94 -171.65 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.878 1.719 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.457 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.296 0.57 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.584 HD11 ' O ' ' A' ' 17' ' ' THR . 14.0 mt -82.7 129.06 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.385 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.59 -11.94 13.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.09 172.05 3.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -89.48 137.88 31.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.855 . . . . 0.0 109.356 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 61.6 m-85 58.91 14.88 3.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 36' ' ' CYS . . . -53.74 121.55 18.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -43.81 122.0 2.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 109.743 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.67 174.27 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.09 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -149.77 149.79 31.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.161 -0.962 . . . . 0.0 109.594 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -79.96 89.46 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.62 3.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.83 -127.05 1.58 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.584 ' O ' HD11 ' A' ' 5' ' ' ILE . 2.3 m -90.16 87.87 7.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -1.15 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -89.18 155.17 19.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 109.0 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -49.05 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 21' ' ' ARG . 94.5 m -90.55 114.7 26.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.03 -1.044 . . . . 0.0 110.737 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 5.76 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.248 0.547 . . . . 0.0 111.912 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . -165.15 -35.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.558 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -112.88 117.27 46.54 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.193 -1.18 . . . . 0.0 109.655 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.509 ' O ' ' O ' ' A' ' 25' ' ' CYS . 12.2 Cg_endo -79.76 37.25 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.146 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 24' ' ' PRO . 4.7 t 46.33 178.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 109.635 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 0.1 OUTLIER 178.16 142.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.811 -1.18 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -121.75 175.53 6.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.433 ' C ' ' HG3' ' A' ' 29' ' ' MET . 1.2 m -83.32 -93.46 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.722 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.433 ' HG3' ' C ' ' A' ' 28' ' ' SER . 61.5 mtp -143.54 14.34 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.704 HD13 ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -107.22 -14.96 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.311 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.89 83.89 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.92 161.67 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -1.105 . . . . 0.0 109.354 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 m120 63.9 63.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 4.8 m -98.1 135.99 38.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 0.0 109.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 2.1 mt-10 -101.55 166.05 10.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 23' ' ' ARG . 1.9 t -78.6 109.4 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.421 -0.799 . . . . 0.0 109.052 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -88.54 137.06 30.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.912 -1.118 . . . . 0.0 109.408 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 37' ' ' THR . 4.1 Cg_exo -57.26 176.39 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.11 1.873 . . . . 0.0 110.556 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 20.7 mtt180 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.569 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 19' ' ' CYS . 3.2 p . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.828 HG13 HG22 ' A' ' 17' ' ' THR . 16.6 mt -83.31 104.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -0.976 . . . . 0.0 109.585 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.01 -4.47 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.53 142.13 46.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 42.3 m-20 -70.45 127.71 33.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.13 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.471 ' CA ' ' HB3' ' A' ' 35' ' ' GLU . 11.1 m-85 61.94 26.86 16.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -0.943 . . . . 0.0 109.392 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -69.67 125.04 16.22 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -42.74 124.07 2.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -1.115 . . . . 0.0 109.268 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 17' ' ' THR . 22.5 p -111.31 -167.25 1.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.966 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.6 m -144.35 144.18 31.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.408 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 41.1 m0 -68.95 86.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.76 37.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 -110.94 1.83 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.828 HG22 HG13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -80.03 84.59 5.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.154 . . . . 0.0 109.7 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.1 tppp? -83.79 166.08 18.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.823 . . . . 0.0 108.889 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.589 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -56.98 -144.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 109.717 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 69.7 m -133.54 118.84 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 25.0 mmm180 75.89 57.68 0.05 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . . . 78.11 -30.38 1.84 Allowed Glycine 0 N--CA 1.496 2.674 0 O-C-N 121.106 -0.996 . . . . 0.0 113.826 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -41.75 103.57 0.31 Allowed Pre-proline 0 N--CA 1.505 2.308 0 CA-C-N 119.751 1.776 . . . . 0.0 109.146 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 22' ' ' GLY . 6.1 Cg_endo -66.04 -163.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.46 2.107 . . . . 0.0 111.02 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -130.02 154.33 47.52 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.558 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.5 OUTLIER -138.26 122.0 17.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.492 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 -170.54 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 108.768 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 66.96 -175.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.735 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 77.83 -4.3 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -0.85 . . . . 0.0 109.41 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -160.71 -38.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.244 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 76.64 1.32 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -159.99 -61.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -1.223 . . . . 0.0 109.637 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 170.57 173.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.58 132.08 35.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.21 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.471 ' HB3' ' CA ' ' A' ' 9' ' ' TYR . 2.2 mm-40 -113.13 122.57 47.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -51.95 117.86 3.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -0.788 . . . . 0.0 109.259 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.667 HG22 ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -85.0 145.99 44.64 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.626 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.3 Cg_endo -62.85 -170.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.093 1.862 . . . . 0.0 110.092 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 39' ' ' ARG . 2.6 ptm180 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 109.628 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -80.09 90.2 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.29 -13.79 51.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -72.32 147.12 46.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.455 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 57.4 m-20 -78.48 137.32 37.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 40.0 m-85 61.53 13.18 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.05 129.31 49.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 137.27 10.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -1.183 . . . . 0.0 109.411 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -135.43 -169.45 2.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.669 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.55 135.76 21.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.2 87.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.88 40.3 1.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.67 -122.34 1.3 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -62.91 91.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.398 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 148.99 38.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.135 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.47 147.6 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -56.08 141.43 40.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 12.5 mtt-85 72.79 10.51 5.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.843 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . 55.37 90.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 26.2 mmm180 -128.62 149.43 71.9 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.419 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.45 172.84 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.174 1.916 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -137.74 104.09 5.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -52.95 143.87 16.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.2 m -144.18 176.24 9.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 0.0 109.389 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.466 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 5.0 m -82.88 -91.19 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.99 -83.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -80.18 -30.24 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.66 77.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -101.33 -62.7 1.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -1.124 . . . . 0.0 109.327 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.461 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 50.6 t-20 -125.09 84.05 2.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 90.5 m -80.51 146.5 31.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 9' ' ' TYR . 2.1 mp0 -144.03 118.8 9.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.412 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.408 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.0 t -46.46 113.03 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 109.273 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.94 131.87 32.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.518 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.8 Cg_endo -63.95 -169.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.989 1.793 . . . . 0.0 109.977 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 31.8 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.547 HG21 ' CB ' ' A' ' 36' ' ' CYS . 4.2 mm -80.02 75.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.56 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.15 20.31 11.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.24 152.65 32.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 85.5 m-20 -66.04 128.64 36.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 74.9 m-85 62.97 12.25 5.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -52.51 115.76 4.6 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' GLY . 14.4 ttpt -44.04 126.8 5.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.136 . . . . 0.0 109.422 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 16.6 p -118.54 -165.66 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.678 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -145.66 122.22 11.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.446 -0.784 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 98.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.08 46.21 1.92 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.7 -119.92 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 2.4 m -76.05 107.47 8.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 6.7 tttt -94.9 167.73 11.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.563 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.81 125.47 24.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -44.24 -67.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -42.71 -65.79 0.44 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.437 -0.789 . . . . 0.0 109.54 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.26 52.62 0.04 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 21' ' ' ARG . 8.5 mmt180 -108.35 145.0 30.62 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.196 -1.179 . . . . 0.0 109.376 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.22 179.07 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.09 1.86 . . . . 0.0 110.282 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -131.04 155.0 47.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.339 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -111.21 133.05 53.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 m -126.22 -172.48 2.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.504 ' HB2' ' CG1' ' A' ' 30' ' ' ILE . 1.9 m -89.98 19.47 4.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 76.11 -0.18 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.597 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.504 ' CG1' ' HB2' ' A' ' 28' ' ' SER . 2.0 pt -114.26 1.38 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.567 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 38.8 45.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' ASN . 27.8 p -135.68 124.47 23.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' THR . 11.1 t30 59.27 116.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 61.1 m -135.89 171.24 14.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -143.47 120.41 11.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.508 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.547 ' CB ' HG21 ' A' ' 5' ' ' ILE . 25.0 t -60.08 117.25 4.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.74 132.57 29.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.39 -174.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.983 1.789 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.46 ' HG3' ' HD2' ' A' ' 23' ' ' ARG . 26.7 mtp180 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.288 0.566 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 11' ' ' LYS . 6.5 mt -85.55 106.44 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -119.62 -2.04 10.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.561 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 156.93 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 3.6 m-20 -64.61 138.74 58.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.426 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 56.6 m-85 62.03 12.78 5.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -46.09 107.12 0.16 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 5' ' ' ILE . 26.2 mttt -42.85 130.78 4.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -1.098 . . . . 0.0 109.851 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 14.0 p -134.54 -164.39 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.354 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -157.11 137.77 13.18 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.537 -0.727 . . . . 0.0 109.319 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.6 107.97 2.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.615 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.79 12.99 33.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.55 -127.71 2.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -90.2 111.83 23.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -1.147 . . . . 0.0 109.72 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -92.69 170.5 9.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 108.684 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -47.34 88.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 109.918 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 18' ' ' LYS . 2.0 m 34.63 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.342 0.591 . . . . 0.0 110.251 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -169.55 58.46 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.046 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.5 -35.06 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -119.17 137.58 25.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.969 -1.312 . . . . 0.0 109.876 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 2.5 Cg_endo -68.7 -166.04 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.053 1.835 . . . . 0.0 109.896 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.82 40.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -146.26 144.62 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' N ' ' HG2' ' A' ' 26' ' ' ARG . 1.2 m -116.28 167.15 11.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' MET . 0.7 OUTLIER -89.5 66.4 7.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 mtp 43.79 28.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.96 -74.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 32' ' ' THR . . . 122.5 29.36 1.31 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 31' ' ' GLY . 3.0 p -153.63 -66.27 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.78 114.31 19.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -120.88 156.43 32.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -135.65 113.9 11.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.385 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 22.9 t -43.88 117.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 122.13 52.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.705 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.38 -166.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.985 1.79 . . . . 0.0 110.104 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.802 . . . . 0.0 109.45 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 17.0 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.803 HD13 ' O ' ' A' ' 11' ' ' LYS . 7.1 mt -113.3 91.11 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.06 35.62 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.05 166.43 11.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.56 123.31 15.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.202 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 0.0 OUTLIER 43.64 31.9 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.775 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.54 129.69 7.4 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.803 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -36.7 133.16 0.59 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.589 -0.948 . . . . 0.0 110.316 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 1.6 p -122.4 -176.22 3.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.19 136.61 8.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -76.85 85.27 3.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.27 -17.93 7.43 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.32 -128.22 3.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.1 m -89.78 106.34 18.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -1.148 . . . . 0.0 109.408 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -166.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.691 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -97.44 175.97 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.091 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 1.1 m -104.78 149.38 25.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.988 . . . . 0.0 109.885 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER 77.61 -7.41 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.246 -0.909 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.52 46.76 2.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -93.06 124.48 58.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.165 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 4.6 Cg_exo -59.89 168.26 5.99 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.997 1.798 . . . . 0.0 110.584 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.5 t -120.98 106.4 11.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.485 -0.759 . . . . 0.0 109.087 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 35' ' ' GLU . 3.4 ttm180 -111.21 177.52 4.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -110.79 -177.85 3.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.95 28.73 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.469 ' CB ' ' O ' ' A' ' 28' ' ' SER . 12.5 ttm 72.73 29.54 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.656 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -51.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 109.539 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.43 10.7 9.3 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -123.96 -99.25 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -1.186 . . . . 0.0 109.322 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 18.6 m-20 -55.19 128.91 36.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.983 -1.073 . . . . 0.0 108.75 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -120.64 124.7 45.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.2 OUTLIER -110.37 167.44 10.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.498 ' C ' ' HA ' ' A' ' 9' ' ' TYR . 3.6 t -69.81 -173.93 0.68 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.77 127.41 0.47 Allowed Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 120.686 -1.258 . . . . 0.0 109.956 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.92 159.55 45.55 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.792 1.662 . . . . 0.0 109.228 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.247 -0.908 . . . . 0.0 109.751 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.294 0.569 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.633 HD12 ' HB3' ' A' ' 12' ' ' CYS . 20.4 mt -120.07 82.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.21 69.48 0.74 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 0.0 109.68 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 -178.7 6.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.282 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 9' ' ' TYR . 2.0 m-20 -61.1 89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.951 . . . . 0.0 109.196 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 62.52 46.32 5.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.84 146.17 1.94 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 105.17 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 109.787 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.633 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.6 p -115.08 176.1 5.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 109.02 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.678 ' O ' HG22 ' A' ' 13' ' ' THR . 22.8 m -159.81 73.76 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.964 -1.085 . . . . 0.0 110.382 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.553 ' O ' ' N ' ' A' ' 16' ' ' GLY . 4.1 m-90 40.64 -147.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.428 -0.795 . . . . 0.0 110.451 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 14' ' ' TRP . . . -22.95 -42.39 0.01 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 14' ' ' TRP . . . -54.36 -165.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.631 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -43.61 100.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.054 -1.262 . . . . 0.0 109.353 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.0 tttt -70.94 -164.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.957 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -96.18 134.47 39.22 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.32 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.165 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -44.34 -26.74 0.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' ARG . . . 105.18 95.84 2.41 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.511 ' NH1' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -157.75 154.5 25.0 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.246 -1.149 . . . . 0.0 109.696 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -167.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.467 2.111 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 6.3 t -142.08 78.62 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 156.75 17.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.58 179.64 3.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.356 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.527 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.3 OUTLIER -58.73 171.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.48 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.422 ' HG3' HG23 ' A' ' 30' ' ' ILE . 5.3 ptp -78.34 -2.84 40.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 HG23 ' HG3' ' A' ' 29' ' ' MET . 9.6 pt -117.25 -26.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.988 . . . . 0.0 109.435 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.92 67.02 0.29 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -127.82 -158.56 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' C ' ' OE2' ' A' ' 35' ' ' GLU . 2.9 m-80 -42.97 150.12 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.789 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -107.58 127.35 53.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.295 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 9' ' ' TYR . 8.6 mp0 -119.77 163.32 17.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.032 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.8 t -86.11 116.53 24.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 108.991 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.27 112.78 58.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 110.034 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -66.72 -167.17 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.857 1.705 . . . . 0.0 110.006 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 108.981 179.922 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.288 0.566 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.636 HD11 ' HB ' ' A' ' 17' ' ' THR . 3.8 mt -95.03 80.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.354 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.12 5.22 52.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.697 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.05 170.8 10.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.161 -0.962 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 1.4 p30 -79.98 123.33 27.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.835 . . . . 0.0 109.365 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 61.5 m-85 61.16 13.39 4.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' TYR . . . -44.32 132.33 7.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.611 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -52.08 151.56 3.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -1.137 . . . . 0.0 109.176 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -150.12 -167.87 2.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.79 134.97 10.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.44 84.24 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 109.372 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.88 -4.48 4.28 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.44 -125.95 3.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.636 ' HB ' HD11 ' A' ' 5' ' ' ILE . 11.9 m -65.01 118.35 8.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.145 . . . . 0.0 109.735 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.565 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.3 tppt? -93.49 160.69 14.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.161 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.565 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -66.74 156.93 34.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 110.324 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -82.9 158.16 22.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.485 ' HB2' ' NH2' ' A' ' 23' ' ' ARG . 2.6 mmp_? 65.34 8.3 4.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.828 . . . . 0.0 109.849 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . 74.6 98.29 0.1 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -150.94 131.03 6.9 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 108.724 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.15 -174.83 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.052 1.835 . . . . 0.0 110.62 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -145.33 111.67 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.085 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.589 HH11 HG21 ' A' ' 37' ' ' THR . 28.6 mtt180 -84.89 163.21 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.9 m -138.54 -168.56 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 30' ' ' ILE . 89.6 p -73.5 -2.22 21.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 28' ' ' SER . 2.1 mtt 67.59 7.18 5.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 109.689 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 28' ' ' SER . 1.4 pp -131.44 -29.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 110.001 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 32' ' ' THR . . . 123.21 90.29 0.95 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 31' ' ' GLY . 6.8 p -159.74 -74.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -144.56 151.63 39.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.456 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.31 132.74 54.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -126.48 138.74 53.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.413 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 34.6 t -73.16 144.15 46.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.887 . . . . 0.0 109.413 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.589 HG21 HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -96.87 136.94 21.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.003 -1.061 . . . . 0.0 109.488 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.5 Cg_endo -65.16 117.22 4.36 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 21.4 mtm-85 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 110.359 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 9.2 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.423 0.63 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 5' ' ' ILE . 11.4 mt -160.95 64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.82 56.24 3.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -150.28 151.95 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.2 OUTLIER -78.87 146.27 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 109.33 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.1 m-85 54.75 19.65 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.64 128.97 24.52 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 10.5 tttt -52.47 151.35 4.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.124 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 29.0 p -145.96 -167.68 2.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.8 m -157.4 123.56 4.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.297 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -53.35 110.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.485 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.46 -36.33 4.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.97 -133.38 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.585 ' O ' HD11 ' A' ' 5' ' ' ILE . 1.3 m -74.52 84.23 2.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -1.164 . . . . 0.0 109.601 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 20.6 ttpt -65.64 163.65 15.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -60.37 120.65 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.471 -0.768 . . . . 0.0 109.582 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 2.1 m -50.06 146.07 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 1.6 mtt180 77.53 3.01 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.704 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.93 99.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -139.2 155.96 72.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.289 -1.124 . . . . 0.0 109.345 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.503 ' HD3' ' NE ' ' A' ' 39' ' ' ARG . 2.7 Cg_endo -61.37 144.41 98.33 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.206 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.25 116.07 10.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 148.52 25.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.502 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 36.0 m -119.45 -172.37 2.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.486 ' O ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -117.25 44.88 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.554 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 61.42 22.35 12.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -124.47 -30.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.73 36.52 47.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -45.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -1.184 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -106.43 72.0 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.893 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 58.3 m -92.85 114.26 26.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.85 . . . . 0.0 109.299 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 125.39 33.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 37' ' ' THR . 16.0 t -81.43 159.47 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.702 HG22 ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -119.71 148.24 45.71 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.638 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.702 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.9 Cg_endo -61.1 176.28 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.229 1.953 . . . . 0.0 110.331 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.503 ' NE ' ' HD3' ' A' ' 24' ' ' PRO . 7.6 mtt180 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.294 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 11' ' ' LYS . 5.3 mt -81.49 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.918 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -98.99 47.76 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.95 176.82 7.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.1 130.25 36.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 47.2 m-85 58.34 19.54 6.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 133.48 52.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.593 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -46.78 144.5 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -1.182 . . . . 0.0 109.491 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.45 -168.42 3.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.569 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 m -154.71 137.49 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -63.36 92.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.35 43.79 1.96 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.28 -116.45 0.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 m -84.48 96.95 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -1.132 . . . . 0.0 109.459 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 1.9 ttmt -70.59 167.82 17.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.334 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -65.48 139.22 58.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.797 . . . . 0.0 109.257 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.918 ' SG ' ' HB2' ' A' ' 6' ' ' ALA . 73.9 m -44.17 -62.47 1.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.147 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.66 -73.72 0.05 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.462 -0.774 . . . . 0.0 109.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.29 82.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' CZ ' ' HA ' ' A' ' 39' ' ' ARG . 3.2 mmt-85 -138.38 155.16 74.04 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.133 -1.216 . . . . 0.0 109.546 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HD2' ' HD2' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -62.42 -174.82 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.23 1.954 . . . . 0.0 110.195 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.11 153.72 36.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.379 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -126.74 164.44 21.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.566 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 m -136.4 -172.01 3.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -85.28 5.06 32.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.688 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER 75.2 17.63 2.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.414 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.427 ' CG1' ' HB3' ' A' ' 28' ' ' SER . 0.3 OUTLIER -141.83 26.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 32' ' ' THR . . . 43.51 86.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.9 p -158.28 -41.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.104 . . . . 0.0 109.434 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.92 139.44 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.59 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 26' ' ' ARG . 28.2 m -130.2 168.56 16.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.3 mm-40 -142.44 155.89 45.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 109.717 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 36.4 t -86.91 145.27 26.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.48 123.57 36.95 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.001 . . . . 0.0 109.613 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.07 -169.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.898 1.732 . . . . 0.0 110.106 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.52 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 1.2 tmm_? . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.408 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.521 HG23 ' HA3' ' A' ' 10' ' ' GLY . 88.2 mt -99.56 73.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.91 -12.39 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.75 146.42 52.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.243 -0.911 . . . . 0.0 109.508 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 7.7 p-10 -65.97 130.19 42.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 52.5 m-85 62.86 12.2 5.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -45.09 121.78 4.74 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -42.78 125.19 3.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -1.069 . . . . 0.0 109.563 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.4 p -115.59 -170.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.09 134.2 7.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.332 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -72.09 100.29 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.47 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.3 -8.52 13.83 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.51 -140.3 8.79 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.58 148.02 35.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.198 -1.178 . . . . 0.0 109.531 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -164.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.816 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.483 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.8 139.21 32.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.553 -0.717 . . . . 0.0 109.57 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -53.51 145.34 15.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.216 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 25.6 mtp180 83.02 -42.59 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.553 -0.717 . . . . 0.0 109.735 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 83.18 0.84 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 6.9 mmt-85 -124.79 141.45 38.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.234 -1.156 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.467 ' HG2' ' HD3' ' A' ' 39' ' ' ARG . 1.4 Cg_endo -64.01 169.84 9.87 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.094 1.863 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.04 172.3 13.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.3 ttm-85 -140.81 139.0 34.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.342 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 31' ' ' GLY . 64.3 m -133.64 -167.99 2.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 109.743 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.3 m -67.89 -36.27 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 0.0 109.745 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 30' ' ' ILE . 2.5 ptp -43.32 -27.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -156.2 27.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.629 ' O ' HG23 ' A' ' 32' ' ' THR . . . -169.72 -93.48 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.1 p -160.4 -92.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -1.148 . . . . 0.0 109.332 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 26' ' ' ARG . 30.7 m120 -102.57 162.54 12.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.172 -0.955 . . . . 0.0 108.907 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 72.7 m -79.66 104.09 10.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 3.3 mt-10 -136.26 143.42 44.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 53.9 t -60.57 121.29 11.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.02 120.33 60.2 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.558 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 85.58 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.868 1.712 . . . . 0.0 110.079 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.468 ' HG2' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.708 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 5' ' ' ILE . 26.7 mt -87.6 63.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.12 -11.16 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.531 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -54.99 152.5 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -64.08 127.02 29.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.883 . . . . 0.0 109.411 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 18.6 m-85 53.05 24.55 3.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.66 123.3 10.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -49.36 123.26 7.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 15.9 p -113.87 -171.65 1.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.13 148.94 45.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -77.17 89.26 3.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.14 9.66 19.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.9 -136.92 9.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -84.92 116.38 23.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 109.437 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -166.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -92.62 155.46 17.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -44.17 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.537 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -23.31 1.03 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.29 57.59 1.0 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 mtt-85 -96.38 152.06 38.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.44 173.36 3.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.23 1.953 . . . . 0.0 110.303 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -139.96 86.12 2.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -68.96 163.98 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 32' ' ' THR . 1.2 m -117.94 -171.9 2.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -68.9 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.42 41.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.87 -38.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.364 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.18 45.92 0.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -105.73 -156.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -1.089 . . . . 0.0 109.469 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 32' ' ' THR . 7.4 m120 -42.4 150.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -118.02 165.33 13.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.435 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -141.33 142.3 33.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 t -68.14 120.75 14.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 121.51 55.58 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 2.0 Cg_endo -64.51 119.32 6.33 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.875 1.716 . . . . 0.0 110.245 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 3.7 ttm180 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.638 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 44.7 mt -78.97 83.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.71 -5.02 59.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.66 167.81 14.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 0.0 109.404 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 44.2 p-10 -88.17 128.41 35.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m-85 55.33 21.42 4.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.861 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -53.28 135.99 39.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 24.9 ttmt -42.54 111.69 0.28 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.422 -1.046 . . . . 0.0 109.445 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 36' ' ' CYS . 16.8 p -94.06 -167.58 1.71 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -158.38 156.52 30.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.436 -0.79 . . . . 0.0 109.641 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -99.16 51.71 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.54 39.7 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.24 -139.75 3.3 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 m -69.91 85.14 0.5 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -1.156 . . . . 0.0 109.307 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 16.8 ttmt -48.03 167.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -158.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -0.762 . . . . 0.0 109.667 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 73.8 m -106.35 141.59 37.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER 71.48 0.58 3.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 110.156 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.512 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 91.88 109.09 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.126 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -150.66 140.06 13.54 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.31 -1.112 . . . . 0.0 109.301 179.906 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.51 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.332 2.021 . . . . 0.0 110.724 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.541 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -120.27 99.28 6.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.963 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.499 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 36.4 ttt85 -71.15 152.68 43.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.033 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -137.99 -171.85 3.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.428 -0.795 . . . . 0.0 109.367 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.585 ' HB2' HD11 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -93.99 28.04 2.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 66.07 25.82 10.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -128.42 -35.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.2 8.73 11.19 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -130.94 165.24 23.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -1.189 . . . . 0.0 108.997 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 32' ' ' THR . 23.2 t-20 45.33 85.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -102.45 107.93 19.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.698 -179.834 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 26' ' ' ARG . 6.2 mm-40 -85.43 156.43 20.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 42.6 t -76.48 157.44 32.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.39 116.16 35.46 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.18 100.23 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.719 1.613 . . . . 0.0 110.183 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.376 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.287 0.565 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 3' ' ' ASN . 9.8 p30 -175.0 29.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.64 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 2' ' ' ASP . 2.4 p30 -55.95 -164.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.4 p -113.41 156.19 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.551 HD12 ' HB3' ' A' ' 12' ' ' CYS . 4.2 mt -89.79 82.88 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.415 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -95.53 27.05 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.23 153.75 20.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 2.6 p30 -66.39 124.31 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 72.1 m-85 62.39 13.04 5.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.1 127.88 9.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -60.68 124.98 22.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -1.105 . . . . 0.0 109.364 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.551 ' HB3' HD12 ' A' ' 5' ' ' ILE . 11.8 p -112.48 -175.98 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.699 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . 2.4 m -150.92 101.46 2.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -0.79 . . . . 0.0 109.281 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 13' ' ' THR . 23.2 m0 -43.5 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 175.76 -37.85 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 18' ' ' LYS . . . -167.06 -70.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.61 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.859 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.6 ttpt -103.81 159.93 15.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 108.844 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.18 140.1 58.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.054 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -60.82 -35.46 76.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 109.68 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' GLY . 1.9 mmt-85 -86.93 23.87 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ARG . . . 43.97 77.77 0.08 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.482 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 49.8 mtt180 -120.94 149.57 51.26 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.153 . . . . 0.0 109.67 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.98 108.51 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.384 2.056 . . . . 0.0 110.54 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 150.71 22.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.994 . . . . 0.0 108.949 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.85 168.43 19.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -145.8 -172.37 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.494 ' HB2' HG12 ' A' ' 30' ' ' ILE . 61.1 m -93.35 -164.62 1.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.7 31.3 1.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 28' ' ' SER . 1.8 pt -115.15 -22.75 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.578 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.414 ' C ' HG23 ' A' ' 32' ' ' THR . . . 90.77 18.57 47.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 63.2 p -152.74 161.35 42.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -1.155 . . . . 0.0 109.43 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER 70.87 86.69 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 55.5 m -117.48 156.76 27.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -135.74 130.78 34.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 9.6 t -70.97 123.58 22.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.075 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.19 123.65 46.04 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.664 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.29 141.54 75.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.876 1.717 . . . . 0.0 109.975 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.453 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -159.75 66.33 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.547 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -165.01 -76.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.378 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.615 HG22 ' N ' ' A' ' 42' ' ' MET . 12.5 mt 54.71 166.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 109.644 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.615 ' N ' HG22 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -95.71 170.64 9.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.49 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.72 151.98 21.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.449 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.36 -125.62 8.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.3 mp -140.73 -159.73 0.99 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -1.17 . . . . 0.0 109.493 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 47' ' ' PHE . 5.4 p -92.75 -149.66 0.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 48' ' ' ALA . 22.8 p90 -67.5 -164.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 109.523 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.452 ' N ' ' CD2' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -117.74 127.99 54.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.77 -54.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.733 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 11.1 p -67.18 -150.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.511 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 49.5 mt -79.87 75.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.63 15.44 18.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.278 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -84.78 149.82 25.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.402 -0.811 . . . . 0.0 109.59 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.9 OUTLIER -65.3 123.68 20.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 30.6 m-85 62.34 20.69 12.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.65 124.58 35.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -48.43 127.7 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.542 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -114.87 -168.32 1.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 109.724 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 14' ' ' TRP . 38.0 m -149.62 105.56 3.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.413 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -44.01 106.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.64 35.33 4.94 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.7 -131.3 1.91 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -84.49 108.36 17.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.436 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.73 -165.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 109.703 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 139.54 40.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -64.58 -50.05 68.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -18.73 8.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 109.35 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 57.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 38' ' ' PRO . 5.4 mtt85 -124.45 145.12 48.0 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.541 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -65.22 -169.76 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.283 1.989 . . . . 0.0 110.379 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -133.6 155.01 50.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.414 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.78 124.09 45.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.895 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' CB ' ' HA2' ' A' ' 31' ' ' GLY . 71.9 m -91.52 -171.2 2.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.1 OUTLIER -98.5 39.96 1.22 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.767 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' SER . 2.3 ttt 83.07 -43.24 0.11 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 32' ' ' THR . 4.3 pt -104.52 32.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.525 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' HA2' ' CB ' ' A' ' 27' ' ' CYS . . . 47.67 65.96 2.17 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 30' ' ' ILE . 39.3 p -139.13 126.35 21.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.513 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 47.51 64.67 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 3.8 m -79.87 158.79 26.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.184 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -141.52 138.48 32.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.593 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 50.6 t -54.48 130.96 41.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.256 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.97 123.62 32.44 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.025 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -63.57 157.64 50.09 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.29 144.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.608 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.5 39.53 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.54 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 42' ' ' MET . 1.9 mt -118.77 -151.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 0.0 109.458 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.514 ' H ' HG22 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -163.83 136.1 5.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 109.508 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 42' ' ' MET . 4.0 pt-20 164.75 -35.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 109.074 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -133.13 114.01 1.32 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER 74.43 135.8 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -1.129 . . . . 0.0 109.159 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 92.2 p -145.0 -172.04 3.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.0 109.779 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 19.6 p90 -164.16 147.44 9.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.436 -0.79 . . . . 0.0 109.275 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.593 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 18.9 t70 -131.09 -47.4 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.901 -1.124 . . . . 0.0 109.968 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 40.5 t-20 178.73 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.955 . . . . 0.0 110.574 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 10.4 p -44.09 169.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.939 -1.101 . . . . 0.0 109.872 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 11' ' ' LYS . 74.8 mt -79.51 84.49 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.08 13.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.09 164.72 24.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.583 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 9.0 m-20 -85.27 121.35 27.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' GLY . 22.9 m-85 60.86 23.31 13.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.572 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -51.78 -175.78 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.52 ' O ' HD13 ' A' ' 5' ' ' ILE . 3.9 ptpp? -99.74 126.44 45.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.112 -1.228 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 26.8 p -119.55 -170.25 1.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.508 HG22 ' N ' ' A' ' 14' ' ' TRP . 17.1 m -147.25 161.22 41.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.508 ' N ' HG22 ' A' ' 13' ' ' THR . 0.1 OUTLIER -80.59 88.56 5.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.45 15.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 -151.58 28.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.473 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 74.7 m -61.81 90.74 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.224 -1.162 . . . . 0.0 109.531 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -165.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.6 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.99 -164.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 85.7 m -116.48 134.53 54.75 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER 77.74 -6.8 1.92 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.958 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . 102.5 95.37 2.29 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.421 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -157.28 154.33 25.56 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.381 -1.07 . . . . 0.0 109.383 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.36 178.54 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.287 1.991 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -139.89 85.16 2.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 23.8 ttp85 -53.2 146.53 11.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 109.955 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -117.88 -170.08 1.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.584 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.11 39.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.7 OUTLIER 74.57 1.87 3.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.72 -81.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.98 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.06 45.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.36 -41.21 2.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.537 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -128.35 84.66 2.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 1.3 m -80.08 173.21 12.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.7 mp0 -141.24 150.45 42.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.789 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -73.77 107.53 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 124.41 59.09 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.474 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' ARG . 2.2 Cg_endo -63.63 159.17 42.21 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.873 1.715 . . . . 0.0 110.135 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' PRO . 1.6 mmm180 52.92 172.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.708 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.924 HD13 ' N ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.12 168.68 11.69 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.328 -0.857 . . . . 0.0 109.54 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -157.04 73.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.532 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.46 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 3.9 ttt -143.24 120.04 11.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 42' ' ' MET . 36.6 tt0 66.96 159.69 0.14 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.907 . . . . 0.0 109.455 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.0 -85.49 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.409 HD23 ' H ' ' A' ' 46' ' ' SER . 0.2 OUTLIER -98.07 164.22 12.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 109.405 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.409 ' H ' HD23 ' A' ' 45' ' ' LEU . 57.4 p -129.82 133.39 46.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.953 . . . . 0.0 109.454 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -61.61 126.98 29.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.246 -0.909 . . . . 0.0 109.452 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.481 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 2' ' ' ASP . 7.7 pt-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 1' ' ' GLU . 0.1 OUTLIER 39.18 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.737 . . . . 0.0 109.932 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 2' ' ' ASP . 1.8 t-20 -43.65 -57.8 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.513 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.0 p -87.45 164.54 16.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 11' ' ' LYS . 6.5 mt -87.14 95.16 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.586 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -92.65 -5.78 50.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.642 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.9 166.65 22.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.548 ' HB3' ' CD1' ' A' ' 9' ' ' TYR . 79.0 m-20 -89.84 136.64 32.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.604 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.548 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 59.9 m-85 64.79 10.67 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.4 126.42 42.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.551 ' O ' HD13 ' A' ' 5' ' ' ILE . 20.5 tttt -45.66 120.33 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.51 ' HA ' ' CD1' ' A' ' 5' ' ' ILE . 28.7 p -100.64 -169.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.623 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -147.48 121.16 9.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.36 -0.838 . . . . 0.0 109.356 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -69.46 94.63 0.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.08 14.02 25.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.04 -113.28 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.9 90.58 8.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -1.147 . . . . 0.0 109.633 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.582 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.85 154.8 38.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.582 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -37.77 147.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.691 -0.63 . . . . 0.0 110.193 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 6' ' ' ALA . 86.3 m -43.64 -92.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -42.89 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 165.91 93.62 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -136.72 147.63 60.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.137 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HG2' HD21 ' A' ' 40' ' ' LEU . 1.9 Cg_endo -62.75 -171.29 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.266 1.978 . . . . 0.0 110.311 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 153.44 43.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.81 . . . . 0.0 109.339 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.757 ' HD3' HG23 ' A' ' 37' ' ' THR . 1.3 ptm180 -119.68 134.28 55.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.78 -171.45 1.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.535 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 29' ' ' MET . 70.7 m -87.86 20.13 3.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.448 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 71.05 5.54 5.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.31 14.81 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.35 87.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.14 -54.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -142.8 103.83 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.56 132.44 39.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -121.45 127.44 51.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.57 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 29.1 t -54.51 121.99 9.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.144 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.757 HG23 ' HD3' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -80.14 125.4 81.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.636 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 2.4 Cg_endo -62.75 135.89 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.909 1.74 . . . . 0.0 110.068 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 38' ' ' PRO . 7.0 mtt180 52.15 173.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.196 -0.94 . . . . 0.0 109.688 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -140.01 75.98 1.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.369 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.01 72.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.1 mtt 55.27 90.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.346 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' OE1' HG21 ' A' ' 37' ' ' THR . 15.3 tp10 -64.52 130.98 45.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.45 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -137.62 161.61 25.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 46' ' ' SER . 1.2 mm? -119.85 -35.08 3.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -1.105 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.527 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 3.6 p 168.41 -28.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 109.469 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 59.47 14.81 4.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.358 -0.839 . . . . 0.0 109.461 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.395 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.66 ' OE1' ' HB3' ' A' ' 6' ' ' ALA . 2.1 mt-10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.337 0.589 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 1' ' ' GLU . 0.7 OUTLIER 62.97 46.6 4.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.371 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.47 -59.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -129.52 174.94 9.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 108.944 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.496 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 25.7 mt -81.9 119.79 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.66 ' HB3' ' OE1' ' A' ' 1' ' ' GLU . . . -116.29 -19.31 10.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.463 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.44 173.82 0.64 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.22 -0.925 . . . . 0.0 109.581 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 58.3 m-20 -89.88 141.7 28.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 46.9 m-85 61.66 13.45 5.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 109.528 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -50.55 151.53 5.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -72.74 98.15 2.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -1.204 . . . . 0.0 109.568 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 34' ' ' CYS . 6.3 p -102.16 -178.44 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.8 m -160.18 146.25 15.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.406 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -74.11 89.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLY . . . 137.45 -59.57 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 15' ' ' GLY . . . -63.06 -124.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.45 129.46 34.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -99.34 -164.45 1.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.664 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 130.85 34.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.1 m -55.86 -58.71 6.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -44.75 -25.84 0.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.55 20.64 12.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.8 mtp85 -85.94 161.4 50.1 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.49 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 23' ' ' ARG . 1.8 Cg_endo -62.87 -170.76 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.221 1.947 . . . . 0.0 110.215 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 36.5 t -134.11 85.41 2.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.324 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 3.8 ttt180 -43.65 140.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.621 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 93.5 m -153.06 173.6 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -77.84 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtp 177.64 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.1 pt -88.23 -22.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 32' ' ' THR . . . 119.85 57.88 0.25 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.1 p -160.03 169.36 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 109.524 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 49.6 51.6 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 10.8 m -91.82 117.68 30.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.44 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.6 mm-40 -134.01 114.34 13.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.723 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.5 t -60.62 136.43 58.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.226 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 124.68 28.29 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.571 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 1.9 Cg_endo -63.82 142.14 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.963 1.776 . . . . 0.0 110.181 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.74 138.61 48.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 39' ' ' ARG . 6.8 tp -44.16 144.57 0.93 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.525 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 mt -63.62 139.0 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.403 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.51 98.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.423 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -86.95 -23.53 25.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.92 -175.05 27.98 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.444 ' HA ' HD13 ' A' ' 45' ' ' LEU . 3.8 mm? 59.82 15.29 4.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.475 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.5 m -77.51 -67.1 0.75 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.463 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.8 t80 -75.82 138.74 41.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.535 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.988 -1.005 . . . . 0.0 109.461 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.12 -95.19 0.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.105 -0.997 . . . . 0.0 109.612 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 4' ' ' CYS . 8.2 t30 -133.2 -148.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.037 -1.039 . . . . 0.0 109.479 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' ASN . 28.7 p -52.16 -174.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.408 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 5' ' ' ILE . 3.7 mm -85.88 59.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.37 14.52 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.1 155.29 18.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -64.17 124.45 21.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.302 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.477 ' CA ' ' HB3' ' A' ' 35' ' ' GLU . 11.0 m-85 62.38 22.84 13.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -49.05 107.89 0.35 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HA ' ' HG3' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -44.21 113.64 0.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.625 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -127.1 -169.09 1.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.516 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.563 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 55.7 m -134.93 127.28 30.32 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.286 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.54 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -0.982 . . . . 0.0 109.384 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 105.78 -41.89 2.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.35 -103.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.87 104.12 16.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.657 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 149.14 32.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -0.929 . . . . 0.0 109.017 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.49 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -53.96 140.63 30.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.98 -83.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 20' ' ' CYS . 5.0 mmm180 -43.48 -72.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 109.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.63 81.47 0.04 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 54.9 mtt180 -132.06 150.46 76.15 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.21 -1.171 . . . . 0.0 109.609 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.22 174.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.3 77.66 1.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 154.8 22.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.205 -0.935 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 20.4 m -81.13 161.63 24.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.174 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 30' ' ' ILE . 0.6 OUTLIER -89.45 52.9 2.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.628 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 44.59 26.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.542 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 32' ' ' THR . 4.5 pt -98.19 -10.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.362 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' C ' ' CG2' ' A' ' 32' ' ' THR . . . 64.9 25.27 70.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 17.7 p -156.36 121.52 4.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -1.153 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' THR . 2.7 m120 58.89 151.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -119.58 154.25 34.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 11' ' ' LYS . 2.6 mp0 -123.71 155.24 38.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 5' ' ' ILE . 49.6 t -72.73 106.8 4.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.92 123.57 77.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 40' ' ' LEU . 2.4 Cg_endo -62.64 155.68 57.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.91 1.74 . . . . 0.0 110.129 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -59.64 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.208 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 38' ' ' PRO . 5.8 tp -147.82 -71.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.068 -1.02 . . . . 0.0 109.889 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.78 -168.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.206 -0.933 . . . . 0.0 109.918 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.532 ' N ' ' SD ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -165.67 29.09 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.281 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -41.67 164.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.805 . . . . 0.0 109.815 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.4 87.21 0.07 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.66 49.31 2.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -1.207 . . . . 0.0 109.687 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 m -99.13 -11.82 21.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.395 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 t80 69.12 20.11 7.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.207 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.493 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.441 ' O ' ' CG ' ' A' ' 2' ' ' ASP . 1.6 pm0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 1' ' ' GLU . 1.4 p30 40.18 57.48 2.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 0.0 109.892 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' O ' ' CG2' ' A' ' 17' ' ' THR . 13.8 p-10 -142.19 8.72 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 109.839 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.66 ' HA ' HG22 ' A' ' 17' ' ' THR . 12.5 p -110.09 -151.93 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.497 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.933 HD13 ' O ' ' A' ' 11' ' ' LYS . 40.5 mt -138.25 67.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.95 4.99 15.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.62 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -84.35 149.67 25.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.7 m-20 -65.17 129.99 41.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 34.9 m-85 60.0 15.13 4.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.847 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -50.0 134.59 27.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.933 ' O ' HD13 ' A' ' 5' ' ' ILE . 31.4 mttm -54.67 155.9 3.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -1.208 . . . . 0.0 109.693 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.401 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 19.1 p -160.29 -166.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' TRP . 4.1 m -150.69 124.5 9.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.707 . . . . 0.0 109.112 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' THR . 5.9 m0 -43.95 108.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.605 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.46 46.47 6.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.46 -111.41 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -89.08 129.32 35.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -1.126 . . . . 0.0 109.429 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -80.51 -166.76 1.14 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.357 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -104.41 19.29 20.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER 68.27 -90.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 0.0 110.127 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.95 -37.62 1.94 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . 124.17 51.1 0.2 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.554 ' CG ' ' HA ' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -103.51 135.27 19.4 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.043 . . . . 0.0 109.488 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 5.7 Cg_exo -58.97 -169.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.079 1.853 . . . . 0.0 110.117 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.2 124.99 9.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.44 ' CZ ' HG21 ' A' ' 37' ' ' THR . 3.2 ttp180 -115.58 136.77 52.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.485 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 84.1 m -84.42 178.64 7.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.525 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -113.22 36.06 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 109.69 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 79.79 6.45 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -90.33 -29.02 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.807 -1.183 . . . . 0.0 109.099 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.46 10.55 81.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -147.5 -73.34 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 0.0 108.667 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.545 ' N ' ' OG1' ' A' ' 32' ' ' THR . 6.7 m120 -69.45 113.96 7.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.829 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 27' ' ' CYS . 4.2 m -129.45 155.03 46.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -111.75 153.2 26.86 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 23' ' ' ARG . 1.9 t -70.73 173.31 7.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.114 -0.991 . . . . 0.0 108.726 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -153.63 124.55 3.53 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.805 -1.185 . . . . 0.0 110.117 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -68.5 135.89 34.92 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.965 1.777 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 6.9 ttt-85 71.39 158.11 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.737 HD12 ' CG ' ' A' ' 42' ' ' MET . 0.1 OUTLIER -105.51 -171.83 1.98 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.798 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -116.2 84.78 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.142 -0.974 . . . . 0.0 109.357 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.737 ' CG ' HD12 ' A' ' 40' ' ' LEU . 9.0 ptm 171.04 -179.33 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.583 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -52.14 120.61 5.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -120.03 -121.17 2.88 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.927 ' O ' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.99 11.96 0.49 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -1.173 . . . . 0.0 110.249 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.503 ' N ' HD13 ' A' ' 45' ' ' LEU . 8.7 m -75.63 -72.2 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.997 -1.065 . . . . 0.0 109.555 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -79.76 169.05 18.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.681 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.554 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -48.14 116.03 1.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.467 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -154.53 44.21 0.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.457 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 p 179.96 178.49 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 12' ' ' CYS . 19.5 mt -87.39 109.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.88 -16.1 14.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.549 ' CG ' ' HA3' ' A' ' 10' ' ' GLY . 6.6 pt-20 -52.26 170.63 0.06 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.34 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.559 ' OD1' ' CE1' ' A' ' 9' ' ' TYR . 2.3 t0 -90.04 129.7 36.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.559 ' CE1' ' OD1' ' A' ' 8' ' ' ASP . 70.8 m-85 66.32 7.65 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 109.932 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -51.2 133.83 33.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -52.92 109.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.392 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 17.8 p -88.39 -167.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.1 151.42 19.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.476 -0.765 . . . . 0.0 109.385 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.596 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -93.75 77.26 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.77 -55.86 0.7 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.26 -143.33 0.14 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.17 98.28 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -1.094 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -164.0 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.432 ' HB3' ' HG3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -95.22 129.27 42.4 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 109.46 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 35.1 m -44.55 157.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 63.54 11.79 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.617 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.78 92.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -117.64 155.43 50.54 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.237 -1.155 . . . . 0.0 109.358 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.73 136.72 68.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.158 1.905 . . . . 0.0 109.9 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.596 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -91.34 87.8 6.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -0.969 . . . . 0.0 108.558 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -57.82 124.0 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.698 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -152.65 -172.5 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 0.0 109.455 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.94 -92.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mmt -135.11 65.02 1.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.97 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -50.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.85 22.91 22.16 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -123.07 -87.2 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -1.109 . . . . 0.0 109.36 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.8 m-80 -59.67 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.226 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 21.4 m -120.95 141.42 50.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -103.41 112.58 25.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.359 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 12' ' ' CYS . 41.2 t -53.16 119.68 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.598 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.96 130.95 30.01 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 2.5 Cg_endo -61.94 -171.65 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.878 1.719 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.457 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 166.76 152.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.2 106.78 19.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.576 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 41' ' ' ILE . 42.3 mm -106.42 -34.46 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.489 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -80.12 -10.12 59.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -0.88 . . . . 0.0 109.417 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 42' ' ' MET . 0.3 OUTLIER 51.98 172.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.672 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.72 116.09 4.38 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.15 87.94 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -1.143 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -162.71 174.71 12.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.354 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -56.02 12.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.216 -0.927 . . . . 0.0 109.493 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.405 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.95 10.08 25.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -91.66 132.1 36.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.432 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -153.13 170.86 19.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 109.583 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.584 HD11 ' O ' ' A' ' 17' ' ' THR . 14.0 mt -82.7 129.06 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.385 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.59 -11.94 13.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.09 172.05 3.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -89.48 137.88 31.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.855 . . . . 0.0 109.356 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 61.6 m-85 58.91 14.88 3.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 36' ' ' CYS . . . -53.74 121.55 18.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -43.81 122.0 2.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 109.743 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.67 174.27 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.09 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -149.77 149.79 31.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.161 -0.962 . . . . 0.0 109.594 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -79.96 89.46 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.62 3.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.83 -127.05 1.58 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.584 ' O ' HD11 ' A' ' 5' ' ' ILE . 2.3 m -90.16 87.87 7.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -1.15 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -89.18 155.17 19.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 109.0 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -49.05 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 21' ' ' ARG . 94.5 m -90.55 114.7 26.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.03 -1.044 . . . . 0.0 110.737 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 5.76 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.248 0.547 . . . . 0.0 111.912 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . -165.15 -35.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.558 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -112.88 117.27 46.54 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.193 -1.18 . . . . 0.0 109.655 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.686 ' HG3' HD11 ' A' ' 40' ' ' LEU . 12.2 Cg_endo -79.76 37.25 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.146 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 24' ' ' PRO . 4.7 t 46.33 178.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 109.635 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 0.1 OUTLIER 178.16 142.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.811 -1.18 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -121.75 175.53 6.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.433 ' C ' ' HG3' ' A' ' 29' ' ' MET . 1.2 m -83.32 -93.46 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.722 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.433 ' HG3' ' C ' ' A' ' 28' ' ' SER . 61.5 mtp -143.54 14.34 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.704 HD13 ' N ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -107.22 -14.96 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.311 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.89 83.89 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.92 161.67 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -1.105 . . . . 0.0 109.354 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 m120 63.9 63.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 4.8 m -98.1 135.99 38.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 0.0 109.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 2.1 mt-10 -101.55 166.05 10.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 23' ' ' ARG . 1.9 t -78.6 109.4 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.421 -0.799 . . . . 0.0 109.052 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -88.54 137.06 30.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.912 -1.118 . . . . 0.0 109.408 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 37' ' ' THR . 4.1 Cg_exo -57.26 176.39 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.11 1.873 . . . . 0.0 110.556 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 20.7 mtt180 -43.46 145.46 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.686 HD11 ' HG3' ' A' ' 24' ' ' PRO . 5.1 mt -73.59 126.22 29.78 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.281 -0.887 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.546 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -69.01 -142.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.191 -0.943 . . . . 0.0 109.096 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.79 152.22 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.942 -1.099 . . . . 0.0 109.655 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -79.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 0.0 109.576 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.51 -130.96 38.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -139.15 131.8 28.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -1.147 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t -111.81 15.59 20.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.318 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.558 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -142.66 74.44 1.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.374 -0.829 . . . . 0.0 109.536 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.524 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.275 0.559 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.04 94.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.862 . . . . 0.0 109.65 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 8.1 t30 -177.94 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.885 . . . . 0.0 109.405 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 19' ' ' CYS . 3.2 p 167.23 -169.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 109.358 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.828 HG13 HG22 ' A' ' 17' ' ' THR . 16.6 mt -83.31 104.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -0.976 . . . . 0.0 109.585 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.01 -4.47 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.53 142.13 46.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 42.3 m-20 -70.45 127.71 33.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.13 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.471 ' CA ' ' HB3' ' A' ' 35' ' ' GLU . 11.1 m-85 61.94 26.86 16.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -0.943 . . . . 0.0 109.392 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -69.67 125.04 16.22 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -42.74 124.07 2.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -1.115 . . . . 0.0 109.268 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 17' ' ' THR . 22.5 p -111.31 -167.25 1.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.966 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.6 m -144.35 144.18 31.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.408 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 41.1 m0 -68.95 86.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.76 37.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 -110.94 1.83 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.828 HG22 HG13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -80.03 84.59 5.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.154 . . . . 0.0 109.7 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.1 tppp? -83.79 166.08 18.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.823 . . . . 0.0 108.889 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.589 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -56.98 -144.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 109.717 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 69.7 m -133.54 118.84 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 25.0 mmm180 75.89 57.68 0.05 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . . . 78.11 -30.38 1.84 Allowed Glycine 0 N--CA 1.496 2.674 0 O-C-N 121.106 -0.996 . . . . 0.0 113.826 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -41.75 103.57 0.31 Allowed Pre-proline 0 N--CA 1.505 2.308 0 CA-C-N 119.751 1.776 . . . . 0.0 109.146 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 22' ' ' GLY . 6.1 Cg_endo -66.04 -163.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.46 2.107 . . . . 0.0 111.02 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -130.02 154.33 47.52 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.558 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.5 OUTLIER -138.26 122.0 17.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.492 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 -170.54 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 108.768 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 66.96 -175.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.735 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 77.83 -4.3 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -0.85 . . . . 0.0 109.41 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -160.71 -38.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.244 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 76.64 1.32 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -159.99 -61.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -1.223 . . . . 0.0 109.637 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 170.57 173.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.58 132.08 35.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.21 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.471 ' HB3' ' CA ' ' A' ' 9' ' ' TYR . 2.2 mm-40 -113.13 122.57 47.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -51.95 117.86 3.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -0.788 . . . . 0.0 109.259 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.667 HG22 ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -85.0 145.99 44.64 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.626 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.3 Cg_endo -62.85 -170.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.093 1.862 . . . . 0.0 110.092 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 39' ' ' ARG . 2.6 ptm180 -85.89 103.4 14.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 109.628 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.09 140.34 49.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.251 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 41' ' ' ILE . 8.8 tt -151.28 77.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 109.526 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.521 ' CG ' ' O ' ' A' ' 41' ' ' ILE . 18.1 ptt? 41.06 -162.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.413 -0.804 . . . . 0.0 109.769 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 116.29 19.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.96 -64.72 0.66 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 58.21 27.94 15.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.169 -1.195 . . . . 0.0 109.472 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 p -94.64 -41.78 9.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.535 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -151.96 99.08 2.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.355 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.406 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.281 0.563 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.77 144.2 2.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -0.933 . . . . 0.0 109.445 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -114.83 19.66 15.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 p -74.77 157.61 34.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -80.09 90.2 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.29 -13.79 51.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -72.32 147.12 46.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.455 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 57.4 m-20 -78.48 137.32 37.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 40.0 m-85 61.53 13.18 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.05 129.31 49.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 137.27 10.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -1.183 . . . . 0.0 109.411 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -135.43 -169.45 2.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.669 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.55 135.76 21.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.2 87.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.88 40.3 1.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.67 -122.34 1.3 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -62.91 91.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.398 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 148.99 38.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.135 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.47 147.6 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -56.08 141.43 40.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 12.5 mtt-85 72.79 10.51 5.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.843 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . 55.37 90.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 26.2 mmm180 -128.62 149.43 71.9 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.419 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.45 172.84 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.174 1.916 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -137.74 104.09 5.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -52.95 143.87 16.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.2 m -144.18 176.24 9.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 0.0 109.389 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.466 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 5.0 m -82.88 -91.19 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.99 -83.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -80.18 -30.24 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.66 77.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -101.33 -62.7 1.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -1.124 . . . . 0.0 109.327 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.461 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 50.6 t-20 -125.09 84.05 2.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 90.5 m -80.51 146.5 31.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 2.1 mp0 -144.03 118.8 9.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.412 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.408 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.0 t -46.46 113.03 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 109.273 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.94 131.87 32.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.518 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.8 Cg_endo -63.95 -169.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.989 1.793 . . . . 0.0 109.977 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -44.87 113.52 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' A' ' 43' ' ' GLU . 1.6 tt -151.65 102.68 2.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 20.03 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.209 -0.932 . . . . 0.0 109.516 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.5 tpt -127.79 -4.26 5.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.652 ' HB2' HD21 ' A' ' 40' ' ' LEU . 2.8 mt-10 -94.14 -88.91 0.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.484 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -165.33 -63.65 0.03 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.659 ' C ' HD13 ' A' ' 45' ' ' LEU . 2.1 tm? 79.37 -73.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.516 -0.991 . . . . 0.0 109.601 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.462 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 31.4 t -73.98 -16.55 61.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.121 -0.987 . . . . 0.0 109.455 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 46' ' ' SER . 2.0 m-85 -173.83 138.29 0.63 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.445 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.41 32.55 3.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.43 161.96 37.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.474 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 31.8 p -110.16 176.08 5.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.433 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.547 HG21 ' CB ' ' A' ' 36' ' ' CYS . 4.2 mm -80.02 75.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.56 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.15 20.31 11.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.24 152.65 32.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 85.5 m-20 -66.04 128.64 36.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 74.9 m-85 62.97 12.25 5.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -52.51 115.76 4.6 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' GLY . 14.4 ttpt -44.04 126.8 5.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.136 . . . . 0.0 109.422 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 16.6 p -118.54 -165.66 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.678 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -145.66 122.22 11.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.446 -0.784 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 98.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.08 46.21 1.92 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.7 -119.92 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 2.4 m -76.05 107.47 8.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 6.7 tttt -94.9 167.73 11.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.563 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.81 125.47 24.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -44.24 -67.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -42.71 -65.79 0.44 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.437 -0.789 . . . . 0.0 109.54 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.26 52.62 0.04 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 21' ' ' ARG . 8.5 mmt180 -108.35 145.0 30.62 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.196 -1.179 . . . . 0.0 109.376 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.22 179.07 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.09 1.86 . . . . 0.0 110.282 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -131.04 155.0 47.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.339 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -111.21 133.05 53.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 m -126.22 -172.48 2.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.504 ' HB2' ' CG1' ' A' ' 30' ' ' ILE . 1.9 m -89.98 19.47 4.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 76.11 -0.18 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.597 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.504 ' CG1' ' HB2' ' A' ' 28' ' ' SER . 2.0 pt -114.26 1.38 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.567 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 38.8 45.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' ASN . 27.8 p -135.68 124.47 23.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' THR . 11.1 t30 59.27 116.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 61.1 m -135.89 171.24 14.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -143.47 120.41 11.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.508 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.547 ' CB ' HG21 ' A' ' 5' ' ' ILE . 25.0 t -60.08 117.25 4.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.74 132.57 29.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.39 -174.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.983 1.789 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.46 ' HG3' ' HD2' ' A' ' 23' ' ' ARG . 26.7 mtp180 -83.08 118.92 23.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.47 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -174.96 -66.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.958 . . . . 0.0 109.537 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 2.5 mp 61.36 109.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.351 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.446 ' O ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -170.47 -159.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.405 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 42' ' ' MET . 1.8 pt-20 -43.97 166.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.62 -30.44 2.83 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.89 -155.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -1.128 . . . . 0.0 109.398 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 m -109.88 91.55 3.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.454 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -117.72 48.85 1.3 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.444 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.52 114.83 10.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -136.12 61.16 1.65 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 109.516 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p -162.98 -170.19 2.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 109.569 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 11' ' ' LYS . 6.5 mt -85.55 106.44 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -119.62 -2.04 10.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.561 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 156.93 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 3.6 m-20 -64.61 138.74 58.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.426 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 56.6 m-85 62.03 12.78 5.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -46.09 107.12 0.16 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 5' ' ' ILE . 26.2 mttt -42.85 130.78 4.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -1.098 . . . . 0.0 109.851 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 14.0 p -134.54 -164.39 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.354 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -157.11 137.77 13.18 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.537 -0.727 . . . . 0.0 109.319 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.6 107.97 2.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.615 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.79 12.99 33.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.55 -127.71 2.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -90.2 111.83 23.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -1.147 . . . . 0.0 109.72 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -92.69 170.5 9.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 108.684 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -47.34 88.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 109.918 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 18' ' ' LYS . 2.0 m 34.63 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.342 0.591 . . . . 0.0 110.251 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -169.55 58.46 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.046 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.5 -35.06 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -119.17 137.58 25.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.969 -1.312 . . . . 0.0 109.876 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 2.5 Cg_endo -68.7 -166.04 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.053 1.835 . . . . 0.0 109.896 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.82 40.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -146.26 144.62 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' N ' ' HG2' ' A' ' 26' ' ' ARG . 1.2 m -116.28 167.15 11.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' MET . 0.7 OUTLIER -89.5 66.4 7.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 mtp 43.79 28.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.96 -74.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 32' ' ' THR . . . 122.5 29.36 1.31 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 31' ' ' GLY . 3.0 p -153.63 -66.27 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.78 114.31 19.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -120.88 156.43 32.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -135.65 113.9 11.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.385 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 22.9 t -43.88 117.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 122.13 52.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.705 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.38 -166.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.985 1.79 . . . . 0.0 110.104 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.01 118.52 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.802 . . . . 0.0 109.45 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.8 mt -46.15 110.6 0.28 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.254 -0.904 . . . . 0.0 109.428 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.744 HG23 ' O ' ' A' ' 41' ' ' ILE . 4.8 tt -51.1 103.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.298 -0.877 . . . . 0.0 109.615 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.415 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 2.4 ttm 174.13 -175.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 42' ' ' MET . 1.6 tm-20 62.31 13.74 6.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.499 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.52 57.47 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -88.84 174.1 8.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -1.185 . . . . 0.0 109.412 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER 73.84 131.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.873 . . . . 0.0 109.499 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.6 m-85 54.42 -176.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 109.488 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.43 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER -97.95 -63.74 1.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.88 . . . . 0.0 109.501 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 2' ' ' ASP . 0.7 OUTLIER -45.42 163.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.942 . . . . 0.0 109.374 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 17.0 p -68.41 -146.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.181 -0.95 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.803 HD13 ' O ' ' A' ' 11' ' ' LYS . 7.1 mt -113.3 91.11 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.06 35.62 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.05 166.43 11.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.56 123.31 15.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.202 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 0.0 OUTLIER 43.64 31.9 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.775 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.54 129.69 7.4 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.803 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -36.7 133.16 0.59 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.589 -0.948 . . . . 0.0 110.316 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.417 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 1.6 p -122.4 -176.22 3.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.19 136.61 8.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -76.85 85.27 3.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.27 -17.93 7.43 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.32 -128.22 3.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.1 m -89.78 106.34 18.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -1.148 . . . . 0.0 109.408 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -166.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.691 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -97.44 175.97 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.091 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 1.1 m -104.78 149.38 25.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.988 . . . . 0.0 109.885 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER 77.61 -7.41 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.246 -0.909 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.52 46.76 2.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -93.06 124.48 58.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.165 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 4.6 Cg_exo -59.89 168.26 5.99 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.997 1.798 . . . . 0.0 110.584 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.5 t -120.98 106.4 11.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.485 -0.759 . . . . 0.0 109.087 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 35' ' ' GLU . 3.4 ttm180 -111.21 177.52 4.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -110.79 -177.85 3.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.95 28.73 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.469 ' CB ' ' O ' ' A' ' 28' ' ' SER . 12.5 ttm 72.73 29.54 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.656 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -51.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 109.539 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.43 10.7 9.3 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -123.96 -99.25 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -1.186 . . . . 0.0 109.322 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 18.6 m-20 -55.19 128.91 36.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.983 -1.073 . . . . 0.0 108.75 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -120.64 124.7 45.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.2 OUTLIER -110.37 167.44 10.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.498 ' C ' ' HA ' ' A' ' 9' ' ' TYR . 3.6 t -69.81 -173.93 0.68 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.77 127.41 0.47 Allowed Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 120.686 -1.258 . . . . 0.0 109.956 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.92 159.55 45.55 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.792 1.662 . . . . 0.0 109.228 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -40.65 143.67 0.32 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.247 -0.908 . . . . 0.0 109.751 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.831 HD23 ' N ' ' A' ' 41' ' ' ILE . 9.8 tt 177.96 150.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 109.547 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.831 ' N ' HD23 ' A' ' 40' ' ' LEU . 97.6 mt -150.58 137.41 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.945 . . . . 0.0 109.384 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.1 ptm -160.97 140.87 10.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 53.46 96.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.499 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.99 164.72 43.19 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.499 ' O ' ' CB ' ' A' ' 46' ' ' SER . 27.4 mt -96.72 133.65 41.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -1.099 . . . . 0.0 109.418 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 1.6 t 164.23 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.697 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 61.2 t80 -133.92 104.21 6.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.468 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.247 0.546 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.37 -10.65 14.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.525 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -172.02 -48.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.643 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.2 p -93.84 -155.1 0.43 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -0.993 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.633 HD12 ' HB3' ' A' ' 12' ' ' CYS . 20.4 mt -120.07 82.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.21 69.48 0.74 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 0.0 109.68 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 -178.7 6.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.282 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 9' ' ' TYR . 2.0 m-20 -61.1 89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.951 . . . . 0.0 109.196 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 62.52 46.32 5.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.84 146.17 1.94 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 105.17 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 109.787 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.633 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.6 p -115.08 176.1 5.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 109.02 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.678 ' O ' HG22 ' A' ' 13' ' ' THR . 22.8 m -159.81 73.76 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.964 -1.085 . . . . 0.0 110.382 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.553 ' O ' ' N ' ' A' ' 16' ' ' GLY . 4.1 m-90 40.64 -147.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.428 -0.795 . . . . 0.0 110.451 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 14' ' ' TRP . . . -22.95 -42.39 0.01 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 14' ' ' TRP . . . -54.36 -165.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.631 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -43.61 100.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.054 -1.262 . . . . 0.0 109.353 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.0 tttt -70.94 -164.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.957 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -96.18 134.47 39.22 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.32 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.165 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -44.34 -26.74 0.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' ARG . . . 105.18 95.84 2.41 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.511 ' NH1' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -157.75 154.5 25.0 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.246 -1.149 . . . . 0.0 109.696 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -167.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.467 2.111 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 6.3 t -142.08 78.62 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 156.75 17.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.58 179.64 3.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.356 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.527 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.3 OUTLIER -58.73 171.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.48 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.422 ' HG3' HG23 ' A' ' 30' ' ' ILE . 5.3 ptp -78.34 -2.84 40.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 HG23 ' HG3' ' A' ' 29' ' ' MET . 9.6 pt -117.25 -26.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.988 . . . . 0.0 109.435 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.92 67.02 0.29 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -127.82 -158.56 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' C ' ' OE2' ' A' ' 35' ' ' GLU . 2.9 m-80 -42.97 150.12 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.789 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -107.58 127.35 53.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.295 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 9' ' ' TYR . 8.6 mp0 -119.77 163.32 17.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.032 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.8 t -86.11 116.53 24.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 108.991 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.27 112.78 58.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 110.034 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -66.72 -167.17 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.857 1.705 . . . . 0.0 110.006 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -104.8 -174.18 2.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 108.981 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 40' ' ' LEU . 8.5 tp -47.08 114.02 0.78 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.005 . . . . 0.0 109.444 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.0 tt -110.74 172.16 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.965 . . . . 0.0 109.561 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.9 mtm -116.34 -27.77 6.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -85.56 162.94 18.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . 160.18 -90.97 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.694 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.8 mm? 61.09 161.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -1.136 . . . . 0.0 109.542 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.561 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 177.94 50.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 109.431 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.706 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 0.1 OUTLIER 39.77 92.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.542 -0.724 . . . . 0.0 109.814 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.506 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.294 0.568 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.56 -82.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 1.4 m120 -171.95 -92.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 3' ' ' ASN . 31.4 p 177.88 -175.88 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.613 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.636 HD11 ' HB ' ' A' ' 17' ' ' THR . 3.8 mt -95.03 80.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.354 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.12 5.22 52.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.697 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.05 170.8 10.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.161 -0.962 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 1.4 p30 -79.98 123.33 27.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.835 . . . . 0.0 109.365 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 61.5 m-85 61.16 13.39 4.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' TYR . . . -44.32 132.33 7.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.611 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -52.08 151.56 3.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -1.137 . . . . 0.0 109.176 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -150.12 -167.87 2.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.79 134.97 10.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.44 84.24 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 109.372 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.88 -4.48 4.28 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.44 -125.95 3.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.636 ' HB ' HD11 ' A' ' 5' ' ' ILE . 11.9 m -65.01 118.35 8.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.145 . . . . 0.0 109.735 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.565 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.3 tppt? -93.49 160.69 14.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.161 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.565 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -66.74 156.93 34.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 110.324 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -82.9 158.16 22.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.485 ' HB2' ' NH2' ' A' ' 23' ' ' ARG . 2.6 mmp_? 65.34 8.3 4.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.828 . . . . 0.0 109.849 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . 74.6 98.29 0.1 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -150.94 131.03 6.9 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 108.724 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HG2' ' HG ' ' A' ' 40' ' ' LEU . 1.2 Cg_endo -66.15 -174.83 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.052 1.835 . . . . 0.0 110.62 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -145.33 111.67 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.085 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.589 HH11 HG21 ' A' ' 37' ' ' THR . 28.6 mtt180 -84.89 163.21 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.9 m -138.54 -168.56 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 30' ' ' ILE . 89.6 p -73.5 -2.22 21.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 28' ' ' SER . 2.1 mtt 67.59 7.18 5.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 109.689 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 28' ' ' SER . 1.4 pp -131.44 -29.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 110.001 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 32' ' ' THR . . . 123.21 90.29 0.95 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 31' ' ' GLY . 6.8 p -159.74 -74.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -144.56 151.63 39.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.456 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.31 132.74 54.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -126.48 138.74 53.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.413 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 34.6 t -73.16 144.15 46.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.887 . . . . 0.0 109.413 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.589 HG21 HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -96.87 136.94 21.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.003 -1.061 . . . . 0.0 109.488 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.5 Cg_endo -65.16 117.22 4.36 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 21.4 mtm-85 40.06 51.21 2.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 110.359 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.808 ' C ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -51.94 151.32 3.65 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.111 -0.993 . . . . 0.0 109.884 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -137.61 22.91 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.936 -1.102 . . . . 0.0 109.611 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER 44.59 -145.48 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.991 . . . . 0.0 109.415 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' MET . 2.0 tt0 76.3 72.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 0.0 109.35 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 45' ' ' LEU . . . -62.46 154.04 42.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' GLY . 26.4 mt 59.55 154.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.135 . . . . 0.0 109.358 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.9 123.83 20.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.35 -149.27 0.28 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.395 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.437 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 2' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.328 0.585 . . . . 0.0 109.637 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.496 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -58.67 -155.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.182 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -145.43 8.44 1.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.904 -1.123 . . . . 0.0 110.492 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 9.2 p -114.69 -47.71 2.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.804 -1.185 . . . . 0.0 109.891 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 5' ' ' ILE . 11.4 mt -160.95 64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.82 56.24 3.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -150.28 151.95 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.2 OUTLIER -78.87 146.27 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 109.33 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.1 m-85 54.75 19.65 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.64 128.97 24.52 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 10.5 tttt -52.47 151.35 4.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.124 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 29.0 p -145.96 -167.68 2.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.8 m -157.4 123.56 4.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.297 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -53.35 110.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.485 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.46 -36.33 4.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.97 -133.38 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.585 ' O ' HD11 ' A' ' 5' ' ' ILE . 1.3 m -74.52 84.23 2.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -1.164 . . . . 0.0 109.601 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 20.6 ttpt -65.64 163.65 15.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -60.37 120.65 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.471 -0.768 . . . . 0.0 109.582 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 2.1 m -50.06 146.07 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 1.6 mtt180 77.53 3.01 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.704 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.93 99.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -139.2 155.96 72.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.289 -1.124 . . . . 0.0 109.345 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.503 ' HD3' ' NE ' ' A' ' 39' ' ' ARG . 2.7 Cg_endo -61.37 144.41 98.33 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.206 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.25 116.07 10.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 148.52 25.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.502 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 36.0 m -119.45 -172.37 2.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.486 ' O ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -117.25 44.88 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.554 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 61.42 22.35 12.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -124.47 -30.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.73 36.52 47.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -45.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -1.184 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -106.43 72.0 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.893 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 58.3 m -92.85 114.26 26.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.85 . . . . 0.0 109.299 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 125.39 33.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 37' ' ' THR . 16.0 t -81.43 159.47 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.702 HG22 ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -119.71 148.24 45.71 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.638 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.702 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.9 Cg_endo -61.1 176.28 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.229 1.953 . . . . 0.0 110.331 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.503 ' NE ' ' HD3' ' A' ' 24' ' ' PRO . 7.6 mtt180 -149.79 62.55 1.0 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.294 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 22.0 tp 42.97 37.45 1.12 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.349 -0.845 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 40' ' ' LEU . 52.6 mt 43.01 91.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.884 . . . . 0.0 109.548 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 43' ' ' GLU . 6.0 mtp -129.85 121.81 27.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 42' ' ' MET . 10.4 mm-40 -44.34 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.07 63.05 0.84 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -174.23 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -1.177 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.67 -29.2 40.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -50.63 106.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.192 -0.942 . . . . 0.0 109.498 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.924 -1.036 . . . . 0.0 109.456 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 2.2 t0 -133.14 -72.5 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 11.3 t30 170.5 128.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.3 p -107.33 153.55 22.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 11' ' ' LYS . 5.3 mt -81.49 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.918 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -98.99 47.76 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.95 176.82 7.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.1 130.25 36.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 47.2 m-85 58.34 19.54 6.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 133.48 52.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.593 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -46.78 144.5 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -1.182 . . . . 0.0 109.491 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.45 -168.42 3.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.569 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 m -154.71 137.49 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -63.36 92.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.35 43.79 1.96 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.28 -116.45 0.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 3' ' ' ASN . 12.2 m -84.48 96.95 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -1.132 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 1.9 ttmt -70.59 167.82 17.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.334 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -65.48 139.22 58.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.797 . . . . 0.0 109.257 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.918 ' SG ' ' HB2' ' A' ' 6' ' ' ALA . 73.9 m -44.17 -62.47 1.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.147 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.66 -73.72 0.05 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.462 -0.774 . . . . 0.0 109.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.29 82.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' CZ ' ' HA ' ' A' ' 39' ' ' ARG . 3.2 mmt-85 -138.38 155.16 74.04 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.133 -1.216 . . . . 0.0 109.546 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HD2' ' HD2' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -62.42 -174.82 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.23 1.954 . . . . 0.0 110.195 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.11 153.72 36.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.379 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -126.74 164.44 21.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.566 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 m -136.4 -172.01 3.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -85.28 5.06 32.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.688 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER 75.2 17.63 2.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.414 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.427 ' CG1' ' HB3' ' A' ' 28' ' ' SER . 0.3 OUTLIER -141.83 26.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 32' ' ' THR . . . 43.51 86.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.9 p -158.28 -41.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.104 . . . . 0.0 109.434 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.92 139.44 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.59 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 26' ' ' ARG . 28.2 m -130.2 168.56 16.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.3 mm-40 -142.44 155.89 45.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 109.717 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 36.4 t -86.91 145.27 26.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.48 123.57 36.95 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.001 . . . . 0.0 109.613 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.07 -169.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.898 1.732 . . . . 0.0 110.106 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.52 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 1.2 tmm_? -53.47 124.62 15.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.408 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -177.74 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 41' ' ' ILE . 1.0 OUTLIER -137.83 40.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.86 154.44 17.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.344 -0.848 . . . . 0.0 109.467 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.02 91.6 1.95 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.22 164.93 24.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 51.57 39.01 23.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -1.126 . . . . 0.0 109.402 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -108.66 98.72 8.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 58.19 43.01 21.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.444 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.37 113.72 25.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.529 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -116.66 126.19 52.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.499 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.2 p -126.46 -175.86 3.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.554 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.521 HG23 ' HA3' ' A' ' 10' ' ' GLY . 88.2 mt -99.56 73.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.91 -12.39 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.75 146.42 52.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.243 -0.911 . . . . 0.0 109.508 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 7.7 p-10 -65.97 130.19 42.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 52.5 m-85 62.86 12.2 5.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -45.09 121.78 4.74 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -42.78 125.19 3.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -1.069 . . . . 0.0 109.563 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.4 p -115.59 -170.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.09 134.2 7.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.332 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -72.09 100.29 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.47 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.3 -8.52 13.83 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.51 -140.3 8.79 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.58 148.02 35.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.198 -1.178 . . . . 0.0 109.531 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -164.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.816 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.483 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.8 139.21 32.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.553 -0.717 . . . . 0.0 109.57 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -53.51 145.34 15.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.216 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 25.6 mtp180 83.02 -42.59 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.553 -0.717 . . . . 0.0 109.735 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 83.18 0.84 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 6.9 mmt-85 -124.79 141.45 38.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.234 -1.156 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.517 ' HD3' ' CG2' ' A' ' 41' ' ' ILE . 1.4 Cg_endo -64.01 169.84 9.87 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.094 1.863 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.04 172.3 13.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.3 ttm-85 -140.81 139.0 34.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.342 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 31' ' ' GLY . 64.3 m -133.64 -167.99 2.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 109.743 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.3 m -67.89 -36.27 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 0.0 109.745 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 30' ' ' ILE . 2.5 ptp -43.32 -27.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -156.2 27.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.629 ' O ' HG23 ' A' ' 32' ' ' THR . . . -169.72 -93.48 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.1 p -160.4 -92.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -1.148 . . . . 0.0 109.332 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 26' ' ' ARG . 30.7 m120 -102.57 162.54 12.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.172 -0.955 . . . . 0.0 108.907 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 72.7 m -79.66 104.09 10.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 3.3 mt-10 -136.26 143.42 44.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 53.9 t -60.57 121.29 11.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.02 120.33 60.2 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.558 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 85.58 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.868 1.712 . . . . 0.0 110.079 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.468 ' HG2' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -146.07 125.99 13.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.708 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.919 ' O ' HD12 ' A' ' 40' ' ' LEU . 4.6 pp -68.13 141.7 55.99 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.271 -0.893 . . . . 0.0 109.669 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.517 ' CG2' ' HD3' ' A' ' 24' ' ' PRO . 3.1 tp -155.67 146.2 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.347 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.419 ' N ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -98.82 92.8 5.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.43 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 56.4 -148.24 0.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.18 -0.95 . . . . 0.0 109.391 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.26 -126.74 6.37 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 54.27 -168.69 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 109.466 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 47' ' ' PHE . 5.7 t -102.99 72.84 1.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.449 ' O ' ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 45.91 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.445 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -113.9 167.21 10.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.63 1.33 23.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.902 . . . . 0.0 109.47 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.8 p -83.02 171.62 13.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.534 ' O ' HG22 ' A' ' 5' ' ' ILE . 26.7 mt -87.6 63.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.12 -11.16 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.531 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -54.99 152.5 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -64.08 127.02 29.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.883 . . . . 0.0 109.411 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 18.6 m-85 53.05 24.55 3.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.66 123.3 10.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -49.36 123.26 7.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 15.9 p -113.87 -171.65 1.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.13 148.94 45.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -77.17 89.26 3.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.14 9.66 19.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.9 -136.92 9.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -84.92 116.38 23.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 109.437 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -166.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -92.62 155.46 17.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -44.17 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.537 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -23.31 1.03 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.29 57.59 1.0 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 mtt-85 -96.38 152.06 38.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.665 ' HG2' HD12 ' A' ' 40' ' ' LEU . 2.0 Cg_endo -62.44 173.36 3.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.23 1.953 . . . . 0.0 110.303 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -139.96 86.12 2.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -68.96 163.98 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 32' ' ' THR . 1.2 m -117.94 -171.9 2.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -68.9 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.42 41.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.87 -38.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.364 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.18 45.92 0.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -105.73 -156.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -1.089 . . . . 0.0 109.469 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 32' ' ' THR . 7.4 m120 -42.4 150.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -118.02 165.33 13.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.435 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -141.33 142.3 33.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 t -68.14 120.75 14.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 121.51 55.58 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 2.0 Cg_endo -64.51 119.32 6.33 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.875 1.716 . . . . 0.0 110.245 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 3.7 ttm180 70.24 154.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.638 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.665 HD12 ' HG2' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -178.63 105.34 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.307 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.0 148.44 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.944 . . . . 0.0 109.766 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.5 mmt 59.57 110.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -114.94 102.92 10.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.9 135.45 13.23 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.54 179.83 5.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -1.115 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -14.75 39.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -48.37 107.53 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.918 . . . . 0.0 109.42 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.506 -179.993 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 3.4 t0 -101.39 168.07 9.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 78.7 m-20 61.21 -167.65 0.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -170.17 -162.76 0.32 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 109.15 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 44.7 mt -78.97 83.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.71 -5.02 59.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.66 167.81 14.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 0.0 109.404 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 44.2 p-10 -88.17 128.41 35.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m-85 55.33 21.42 4.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.861 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -53.28 135.99 39.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 24.9 ttmt -42.54 111.69 0.28 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.422 -1.046 . . . . 0.0 109.445 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 36' ' ' CYS . 16.8 p -94.06 -167.58 1.71 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -158.38 156.52 30.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.436 -0.79 . . . . 0.0 109.641 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -99.16 51.71 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.54 39.7 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.24 -139.75 3.3 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 m -69.91 85.14 0.5 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -1.156 . . . . 0.0 109.307 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 16.8 ttmt -48.03 167.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -158.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -0.762 . . . . 0.0 109.667 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 73.8 m -106.35 141.59 37.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER 71.48 0.58 3.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 110.156 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.512 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 91.88 109.09 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.126 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -150.66 140.06 13.54 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.31 -1.112 . . . . 0.0 109.301 179.906 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.51 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.332 2.021 . . . . 0.0 110.724 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.541 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -120.27 99.28 6.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.963 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.499 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 36.4 ttt85 -71.15 152.68 43.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.033 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -137.99 -171.85 3.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.428 -0.795 . . . . 0.0 109.367 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.585 ' HB2' HD11 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -93.99 28.04 2.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 66.07 25.82 10.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -128.42 -35.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.2 8.73 11.19 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -130.94 165.24 23.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -1.189 . . . . 0.0 108.997 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 32' ' ' THR . 23.2 t-20 45.33 85.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -102.45 107.93 19.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.698 -179.834 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 26' ' ' ARG . 6.2 mm-40 -85.43 156.43 20.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 42.6 t -76.48 157.44 32.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.39 116.16 35.46 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.18 100.23 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.719 1.613 . . . . 0.0 110.183 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 40' ' ' LEU . 5.5 mtt180 65.95 120.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.376 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.638 ' C ' HD13 ' A' ' 40' ' ' LEU . 1.6 tm? -44.59 112.27 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.288 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.577 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.3 pt -53.12 146.75 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.528 ' HG2' ' CG ' ' A' ' 43' ' ' GLU . 6.0 ttp -158.51 147.92 19.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.0 109.558 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.528 ' CG ' ' HG2' ' A' ' 42' ' ' MET . 1.4 mt-10 73.89 17.13 3.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.627 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.891 ' C ' HD13 ' A' ' 45' ' ' LEU . . . 151.66 153.69 6.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.891 HD13 ' C ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -116.27 -59.98 1.91 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -1.151 . . . . 0.0 109.348 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 47' ' ' PHE . 33.5 m -166.46 -158.47 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 61.46 129.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 -179.967 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.458 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.551 HD12 ' HB3' ' A' ' 12' ' ' CYS . 4.2 mt -89.79 82.88 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.415 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -95.53 27.05 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.23 153.75 20.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 2.6 p30 -66.39 124.31 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 72.1 m-85 62.39 13.04 5.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.1 127.88 9.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -60.68 124.98 22.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -1.105 . . . . 0.0 109.364 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.551 ' HB3' HD12 ' A' ' 5' ' ' ILE . 11.8 p -112.48 -175.98 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.699 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . 2.4 m -150.92 101.46 2.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -0.79 . . . . 0.0 109.281 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 13' ' ' THR . 23.2 m0 -43.5 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 175.76 -37.85 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 18' ' ' LYS . . . -167.06 -70.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.61 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.859 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.6 ttpt -103.81 159.93 15.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 108.844 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.18 140.1 58.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.054 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -60.82 -35.46 76.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 109.68 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' GLY . 1.9 mmt-85 -86.93 23.87 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ARG . . . 43.97 77.77 0.08 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.482 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 49.8 mtt180 -120.94 149.57 51.26 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.153 . . . . 0.0 109.67 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.98 108.51 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.384 2.056 . . . . 0.0 110.54 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 150.71 22.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.994 . . . . 0.0 108.949 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.85 168.43 19.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -145.8 -172.37 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.494 ' HB2' HG12 ' A' ' 30' ' ' ILE . 61.1 m -93.35 -164.62 1.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.7 31.3 1.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 28' ' ' SER . 1.8 pt -115.15 -22.75 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.578 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.414 ' C ' HG23 ' A' ' 32' ' ' THR . . . 90.77 18.57 47.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 63.2 p -152.74 161.35 42.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -1.155 . . . . 0.0 109.43 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER 70.87 86.69 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 55.5 m -117.48 156.76 27.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -135.74 130.78 34.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 9.6 t -70.97 123.58 22.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.075 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.19 123.65 46.04 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.664 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.29 141.54 75.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.876 1.717 . . . . 0.0 109.975 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.547 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 11.1 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.314 0.578 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.511 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 49.5 mt -79.87 75.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.63 15.44 18.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.278 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -84.78 149.82 25.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.402 -0.811 . . . . 0.0 109.59 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.9 OUTLIER -65.3 123.68 20.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 30.6 m-85 62.34 20.69 12.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.65 124.58 35.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -48.43 127.7 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.542 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -114.87 -168.32 1.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 109.724 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 14' ' ' TRP . 38.0 m -149.62 105.56 3.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.413 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -44.01 106.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.64 35.33 4.94 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.7 -131.3 1.91 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -84.49 108.36 17.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.436 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.73 -165.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 109.703 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 139.54 40.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -64.58 -50.05 68.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -18.73 8.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 109.35 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 57.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 38' ' ' PRO . 5.4 mtt85 -124.45 145.12 48.0 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.541 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -65.22 -169.76 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.283 1.989 . . . . 0.0 110.379 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -133.6 155.01 50.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.414 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.78 124.09 45.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.895 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' CB ' ' HA2' ' A' ' 31' ' ' GLY . 71.9 m -91.52 -171.2 2.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.1 OUTLIER -98.5 39.96 1.22 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.767 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' SER . 2.3 ttt 83.07 -43.24 0.11 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 32' ' ' THR . 4.3 pt -104.52 32.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.525 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.482 ' HA2' ' CB ' ' A' ' 27' ' ' CYS . . . 47.67 65.96 2.17 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 30' ' ' ILE . 39.3 p -139.13 126.35 21.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.513 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 47.51 64.67 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 3.8 m -79.87 158.79 26.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.184 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -141.52 138.48 32.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.593 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 50.6 t -54.48 130.96 41.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.256 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.97 123.62 32.44 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.025 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -63.57 157.64 50.09 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.608 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 10.4 p . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.281 0.562 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 11' ' ' LYS . 74.8 mt -79.51 84.49 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.08 13.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.09 164.72 24.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.583 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 9.0 m-20 -85.27 121.35 27.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' GLY . 22.9 m-85 60.86 23.31 13.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.572 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -51.78 -175.78 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.52 ' O ' HD13 ' A' ' 5' ' ' ILE . 3.9 ptpp? -99.74 126.44 45.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.112 -1.228 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 26.8 p -119.55 -170.25 1.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.508 HG22 ' N ' ' A' ' 14' ' ' TRP . 17.1 m -147.25 161.22 41.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.508 ' N ' HG22 ' A' ' 13' ' ' THR . 0.1 OUTLIER -80.59 88.56 5.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.45 15.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 -151.58 28.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.473 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 74.7 m -61.81 90.74 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.224 -1.162 . . . . 0.0 109.531 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -165.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.6 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.99 -164.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 85.7 m -116.48 134.53 54.75 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER 77.74 -6.8 1.92 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.958 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . 102.5 95.37 2.29 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.421 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -157.28 154.33 25.56 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.381 -1.07 . . . . 0.0 109.383 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.36 178.54 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.287 1.991 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -139.89 85.16 2.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 23.8 ttp85 -53.2 146.53 11.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 109.955 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -117.88 -170.08 1.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.584 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.11 39.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.7 OUTLIER 74.57 1.87 3.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.72 -81.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.98 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.06 45.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.36 -41.21 2.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.537 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -128.35 84.66 2.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 1.3 m -80.08 173.21 12.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.7 mp0 -141.24 150.45 42.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.789 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -73.77 107.53 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 124.41 59.09 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.474 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' ARG . 2.2 Cg_endo -63.63 159.17 42.21 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.873 1.715 . . . . 0.0 110.135 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' PRO . 1.6 mmm180 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.708 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.0 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 11' ' ' LYS . 6.5 mt -87.14 95.16 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.586 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -92.65 -5.78 50.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.642 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.9 166.65 22.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.548 ' HB3' ' CD1' ' A' ' 9' ' ' TYR . 79.0 m-20 -89.84 136.64 32.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.604 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.548 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 59.9 m-85 64.79 10.67 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.4 126.42 42.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.551 ' O ' HD13 ' A' ' 5' ' ' ILE . 20.5 tttt -45.66 120.33 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.51 ' HA ' ' CD1' ' A' ' 5' ' ' ILE . 28.7 p -100.64 -169.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.623 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -147.48 121.16 9.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.36 -0.838 . . . . 0.0 109.356 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -69.46 94.63 0.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.08 14.02 25.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.04 -113.28 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.9 90.58 8.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -1.147 . . . . 0.0 109.633 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.582 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.85 154.8 38.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.582 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -37.77 147.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.691 -0.63 . . . . 0.0 110.193 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 6' ' ' ALA . 86.3 m -43.64 -92.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -42.89 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 165.91 93.62 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -136.72 147.63 60.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.137 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.75 -171.29 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.266 1.978 . . . . 0.0 110.311 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 153.44 43.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.81 . . . . 0.0 109.339 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.757 ' HD3' HG23 ' A' ' 37' ' ' THR . 1.3 ptm180 -119.68 134.28 55.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.78 -171.45 1.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.535 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 29' ' ' MET . 70.7 m -87.86 20.13 3.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.448 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 71.05 5.54 5.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.31 14.81 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.35 87.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.14 -54.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -142.8 103.83 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.56 132.44 39.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -121.45 127.44 51.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.57 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 29.1 t -54.51 121.99 9.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.144 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.757 HG23 ' HD3' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -80.14 125.4 81.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.636 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 2.4 Cg_endo -62.75 135.89 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.909 1.74 . . . . 0.0 110.068 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 38' ' ' PRO . 7.0 mtt180 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.196 -0.94 . . . . 0.0 109.688 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.496 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 25.7 mt -81.9 119.79 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.29 -19.31 10.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.463 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.44 173.82 0.64 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.22 -0.925 . . . . 0.0 109.581 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 58.3 m-20 -89.88 141.7 28.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 46.9 m-85 61.66 13.45 5.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 109.528 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -50.55 151.53 5.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -72.74 98.15 2.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -1.204 . . . . 0.0 109.568 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 34' ' ' CYS . 6.3 p -102.16 -178.44 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.8 m -160.18 146.25 15.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.406 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -74.11 89.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLY . . . 137.45 -59.57 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 15' ' ' GLY . . . -63.06 -124.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.45 129.46 34.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -99.34 -164.45 1.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.664 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 130.85 34.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.1 m -55.86 -58.71 6.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -44.75 -25.84 0.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.55 20.64 12.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.8 mtp85 -85.94 161.4 50.1 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.49 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 23' ' ' ARG . 1.8 Cg_endo -62.87 -170.76 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.221 1.947 . . . . 0.0 110.215 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 36.5 t -134.11 85.41 2.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.324 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 3.8 ttt180 -43.65 140.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.621 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 93.5 m -153.06 173.6 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -77.84 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtp 177.64 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.1 pt -88.23 -22.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 32' ' ' THR . . . 119.85 57.88 0.25 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.1 p -160.03 169.36 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 109.524 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 49.6 51.6 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 10.8 m -91.82 117.68 30.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.44 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.6 mm-40 -134.01 114.34 13.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.723 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.5 t -60.62 136.43 58.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.226 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 124.68 28.29 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.571 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 1.9 Cg_endo -63.82 142.14 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.963 1.776 . . . . 0.0 110.181 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.7 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 5' ' ' ILE . 3.7 mm -85.88 59.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.37 14.52 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.1 155.29 18.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -64.17 124.45 21.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.302 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.477 ' CA ' ' HB3' ' A' ' 35' ' ' GLU . 11.0 m-85 62.38 22.84 13.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -49.05 107.89 0.35 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HA ' ' HG3' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -44.21 113.64 0.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.625 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -127.1 -169.09 1.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.516 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.563 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 55.7 m -134.93 127.28 30.32 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.286 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.54 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -0.982 . . . . 0.0 109.384 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 105.78 -41.89 2.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.35 -103.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.87 104.12 16.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.657 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 149.14 32.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -0.929 . . . . 0.0 109.017 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.49 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -53.96 140.63 30.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.98 -83.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 20' ' ' CYS . 5.0 mmm180 -43.48 -72.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 109.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.63 81.47 0.04 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 54.9 mtt180 -132.06 150.46 76.15 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.21 -1.171 . . . . 0.0 109.609 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.22 174.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.3 77.66 1.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 154.8 22.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.205 -0.935 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 20.4 m -81.13 161.63 24.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.174 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 30' ' ' ILE . 0.6 OUTLIER -89.45 52.9 2.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.628 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 44.59 26.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.542 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 32' ' ' THR . 4.5 pt -98.19 -10.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.362 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.456 ' C ' ' CG2' ' A' ' 32' ' ' THR . . . 64.9 25.27 70.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 17.7 p -156.36 121.52 4.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -1.153 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' THR . 1.4 m-80 58.89 151.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -119.58 154.25 34.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 11' ' ' LYS . 2.6 mp0 -123.71 155.24 38.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 5' ' ' ILE . 49.6 t -72.73 106.8 4.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.92 123.57 77.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.64 155.68 57.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.91 1.74 . . . . 0.0 110.129 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.208 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.66 ' HA ' HG22 ' A' ' 17' ' ' THR . 12.5 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.933 HD13 ' O ' ' A' ' 11' ' ' LYS . 40.5 mt -138.25 67.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.95 4.99 15.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.62 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -84.35 149.67 25.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.7 m-20 -65.17 129.99 41.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 34.9 m-85 60.0 15.13 4.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.847 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -50.0 134.59 27.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.933 ' O ' HD13 ' A' ' 5' ' ' ILE . 31.4 mttm -54.67 155.9 3.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -1.208 . . . . 0.0 109.693 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.401 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 19.1 p -160.29 -166.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' TRP . 4.1 m -150.69 124.5 9.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.707 . . . . 0.0 109.112 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' THR . 5.9 m0 -43.95 108.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.605 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.46 46.47 6.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.46 -111.41 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -89.08 129.32 35.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -1.126 . . . . 0.0 109.429 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -80.51 -166.76 1.14 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.357 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -104.41 19.29 20.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER 68.27 -90.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 0.0 110.127 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.95 -37.62 1.94 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . 124.17 51.1 0.2 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.554 ' CG ' ' HA ' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -103.51 135.27 19.4 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.043 . . . . 0.0 109.488 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 5.7 Cg_exo -58.97 -169.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.079 1.853 . . . . 0.0 110.117 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.2 124.99 9.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.44 ' CZ ' HG21 ' A' ' 37' ' ' THR . 3.2 ttp180 -115.58 136.77 52.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.485 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 84.1 m -84.42 178.64 7.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.525 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -113.22 36.06 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 109.69 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 79.79 6.45 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -90.33 -29.02 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.807 -1.183 . . . . 0.0 109.099 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.46 10.55 81.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -147.5 -73.34 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 0.0 108.667 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.545 ' N ' ' OG1' ' A' ' 32' ' ' THR . 6.7 m120 -69.45 113.96 7.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.829 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 27' ' ' CYS . 4.2 m -129.45 155.03 46.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -111.75 153.2 26.86 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 23' ' ' ARG . 1.9 t -70.73 173.31 7.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.114 -0.991 . . . . 0.0 108.726 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -153.63 124.55 3.53 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.805 -1.185 . . . . 0.0 110.117 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -68.5 135.89 34.92 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.965 1.777 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 6.9 ttt-85 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 12' ' ' CYS . 19.5 mt -87.39 109.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.88 -16.1 14.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.549 ' CG ' ' HA3' ' A' ' 10' ' ' GLY . 6.6 pt-20 -52.26 170.63 0.06 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.34 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.559 ' OD1' ' CE1' ' A' ' 9' ' ' TYR . 2.3 t0 -90.04 129.7 36.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.559 ' CE1' ' OD1' ' A' ' 8' ' ' ASP . 70.8 m-85 66.32 7.65 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 109.932 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -51.2 133.83 33.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -52.92 109.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.392 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 17.8 p -88.39 -167.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.1 151.42 19.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.476 -0.765 . . . . 0.0 109.385 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.596 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -93.75 77.26 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.77 -55.86 0.7 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.26 -143.33 0.14 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.17 98.28 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -1.094 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -164.0 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.432 ' HB3' ' HG3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -95.22 129.27 42.4 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 109.46 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 35.1 m -44.55 157.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 63.54 11.79 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.617 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.78 92.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -117.64 155.43 50.54 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.237 -1.155 . . . . 0.0 109.358 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.73 136.72 68.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.158 1.905 . . . . 0.0 109.9 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.596 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -91.34 87.8 6.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -0.969 . . . . 0.0 108.558 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -57.82 124.0 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.698 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -152.65 -172.5 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 0.0 109.455 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.94 -92.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mmt -135.11 65.02 1.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.97 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -50.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.85 22.91 22.16 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -123.07 -87.2 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -1.109 . . . . 0.0 109.36 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.8 m-80 -59.67 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.226 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 21.4 m -120.95 141.42 50.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -103.41 112.58 25.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.359 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 12' ' ' CYS . 41.2 t -53.16 119.68 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.598 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.96 130.95 30.01 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 2.5 Cg_endo -61.94 -171.65 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.878 1.719 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.457 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.296 0.57 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.584 HD11 ' O ' ' A' ' 17' ' ' THR . 14.0 mt -82.7 129.06 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.385 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.59 -11.94 13.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.09 172.05 3.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -89.48 137.88 31.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.855 . . . . 0.0 109.356 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 61.6 m-85 58.91 14.88 3.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 36' ' ' CYS . . . -53.74 121.55 18.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -43.81 122.0 2.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 109.743 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.67 174.27 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.09 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -149.77 149.79 31.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.161 -0.962 . . . . 0.0 109.594 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -79.96 89.46 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.62 3.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.83 -127.05 1.58 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.584 ' O ' HD11 ' A' ' 5' ' ' ILE . 2.3 m -90.16 87.87 7.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -1.15 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -89.18 155.17 19.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 109.0 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -49.05 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 21' ' ' ARG . 94.5 m -90.55 114.7 26.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.03 -1.044 . . . . 0.0 110.737 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 5.76 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.248 0.547 . . . . 0.0 111.912 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . -165.15 -35.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.558 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -112.88 117.27 46.54 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.193 -1.18 . . . . 0.0 109.655 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.509 ' O ' ' O ' ' A' ' 25' ' ' CYS . 12.2 Cg_endo -79.76 37.25 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.146 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 24' ' ' PRO . 4.7 t 46.33 178.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 109.635 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 0.1 OUTLIER 178.16 142.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.811 -1.18 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -121.75 175.53 6.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.433 ' C ' ' HG3' ' A' ' 29' ' ' MET . 1.2 m -83.32 -93.46 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.722 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.433 ' HG3' ' C ' ' A' ' 28' ' ' SER . 61.5 mtp -143.54 14.34 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.704 ' N ' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -107.22 -14.96 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.311 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.89 83.89 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.92 161.67 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -1.105 . . . . 0.0 109.354 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 m120 63.9 63.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 4.8 m -98.1 135.99 38.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 0.0 109.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 2.1 mt-10 -101.55 166.05 10.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 23' ' ' ARG . 1.9 t -78.6 109.4 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.421 -0.799 . . . . 0.0 109.052 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -88.54 137.06 30.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.912 -1.118 . . . . 0.0 109.408 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 37' ' ' THR . 4.1 Cg_exo -57.26 176.39 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.11 1.873 . . . . 0.0 110.556 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 20.7 mtt180 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.569 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 19' ' ' CYS . 3.2 p . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.828 HG13 HG22 ' A' ' 17' ' ' THR . 16.6 mt -83.31 104.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -0.976 . . . . 0.0 109.585 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.01 -4.47 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.53 142.13 46.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 42.3 m-20 -70.45 127.71 33.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.13 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.471 ' CA ' ' HB3' ' A' ' 35' ' ' GLU . 11.1 m-85 61.94 26.86 16.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -0.943 . . . . 0.0 109.392 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -69.67 125.04 16.22 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -42.74 124.07 2.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -1.115 . . . . 0.0 109.268 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 17' ' ' THR . 22.5 p -111.31 -167.25 1.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.966 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.6 m -144.35 144.18 31.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.408 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 41.1 m0 -68.95 86.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.76 37.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 -110.94 1.83 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.828 HG22 HG13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -80.03 84.59 5.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.154 . . . . 0.0 109.7 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.1 tppp? -83.79 166.08 18.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.823 . . . . 0.0 108.889 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.589 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -56.98 -144.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 109.717 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 69.7 m -133.54 118.84 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 25.0 mmm180 75.89 57.68 0.05 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . . . 78.11 -30.38 1.84 Allowed Glycine 0 N--CA 1.496 2.674 0 O-C-N 121.106 -0.996 . . . . 0.0 113.826 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -41.75 103.57 0.31 Allowed Pre-proline 0 N--CA 1.505 2.308 0 CA-C-N 119.751 1.776 . . . . 0.0 109.146 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 22' ' ' GLY . 6.1 Cg_endo -66.04 -163.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.46 2.107 . . . . 0.0 111.02 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -130.02 154.33 47.52 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.558 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.5 OUTLIER -138.26 122.0 17.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.492 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 -170.54 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 108.768 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 66.96 -175.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.735 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 77.83 -4.3 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -0.85 . . . . 0.0 109.41 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -160.71 -38.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.244 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 76.64 1.32 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -159.99 -61.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -1.223 . . . . 0.0 109.637 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 170.57 173.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.58 132.08 35.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.21 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.471 ' HB3' ' CA ' ' A' ' 9' ' ' TYR . 2.2 mm-40 -113.13 122.57 47.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -51.95 117.86 3.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -0.788 . . . . 0.0 109.259 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.667 HG22 ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -85.0 145.99 44.64 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.626 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.3 Cg_endo -62.85 -170.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.093 1.862 . . . . 0.0 110.092 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 39' ' ' ARG . 2.6 ptm180 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 109.628 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -80.09 90.2 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.29 -13.79 51.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -72.32 147.12 46.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.455 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 57.4 m-20 -78.48 137.32 37.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 40.0 m-85 61.53 13.18 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.05 129.31 49.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 137.27 10.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -1.183 . . . . 0.0 109.411 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -135.43 -169.45 2.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.669 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.55 135.76 21.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.2 87.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.88 40.3 1.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.67 -122.34 1.3 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -62.91 91.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.398 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 148.99 38.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.135 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.47 147.6 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -56.08 141.43 40.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 12.5 mtt-85 72.79 10.51 5.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.843 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . 55.37 90.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 26.2 mmm180 -128.62 149.43 71.9 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.419 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.45 172.84 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.174 1.916 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -137.74 104.09 5.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -52.95 143.87 16.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.2 m -144.18 176.24 9.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 0.0 109.389 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.466 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 5.0 m -82.88 -91.19 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.99 -83.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -80.18 -30.24 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.66 77.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -101.33 -62.7 1.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -1.124 . . . . 0.0 109.327 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.461 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 50.6 t-20 -125.09 84.05 2.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 90.5 m -80.51 146.5 31.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 9' ' ' TYR . 2.1 mp0 -144.03 118.8 9.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.412 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.408 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.0 t -46.46 113.03 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 109.273 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.94 131.87 32.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.518 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.8 Cg_endo -63.95 -169.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.989 1.793 . . . . 0.0 109.977 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 31.8 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.547 HG21 ' CB ' ' A' ' 36' ' ' CYS . 4.2 mm -80.02 75.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.56 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.15 20.31 11.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.24 152.65 32.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 85.5 m-20 -66.04 128.64 36.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 74.9 m-85 62.97 12.25 5.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -52.51 115.76 4.6 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' GLY . 14.4 ttpt -44.04 126.8 5.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.136 . . . . 0.0 109.422 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 16.6 p -118.54 -165.66 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.678 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -145.66 122.22 11.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.446 -0.784 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 98.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.08 46.21 1.92 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.7 -119.92 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 2.4 m -76.05 107.47 8.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 6.7 tttt -94.9 167.73 11.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.563 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.81 125.47 24.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -44.24 -67.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -42.71 -65.79 0.44 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.437 -0.789 . . . . 0.0 109.54 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.26 52.62 0.04 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 21' ' ' ARG . 8.5 mmt180 -108.35 145.0 30.62 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.196 -1.179 . . . . 0.0 109.376 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.22 179.07 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.09 1.86 . . . . 0.0 110.282 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -131.04 155.0 47.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.339 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -111.21 133.05 53.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 m -126.22 -172.48 2.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.504 ' HB2' ' CG1' ' A' ' 30' ' ' ILE . 1.9 m -89.98 19.47 4.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 76.11 -0.18 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.597 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.504 ' CG1' ' HB2' ' A' ' 28' ' ' SER . 2.0 pt -114.26 1.38 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.567 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 38.8 45.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' ASN . 27.8 p -135.68 124.47 23.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' THR . 11.1 t30 59.27 116.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 61.1 m -135.89 171.24 14.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -143.47 120.41 11.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.508 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.547 ' CB ' HG21 ' A' ' 5' ' ' ILE . 25.0 t -60.08 117.25 4.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.74 132.57 29.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.39 -174.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.983 1.789 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.46 ' HG3' ' HD2' ' A' ' 23' ' ' ARG . 26.7 mtp180 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.288 0.566 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 11' ' ' LYS . 6.5 mt -85.55 106.44 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -119.62 -2.04 10.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.561 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 156.93 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 3.6 m-20 -64.61 138.74 58.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.426 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 56.6 m-85 62.03 12.78 5.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -46.09 107.12 0.16 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 5' ' ' ILE . 26.2 mttt -42.85 130.78 4.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -1.098 . . . . 0.0 109.851 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 14.0 p -134.54 -164.39 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.354 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -157.11 137.77 13.18 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.537 -0.727 . . . . 0.0 109.319 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.6 107.97 2.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.615 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.79 12.99 33.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.55 -127.71 2.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -90.2 111.83 23.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -1.147 . . . . 0.0 109.72 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -92.69 170.5 9.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 108.684 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -47.34 88.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 109.918 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 18' ' ' LYS . 2.0 m 34.63 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.342 0.591 . . . . 0.0 110.251 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -169.55 58.46 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.046 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.5 -35.06 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -119.17 137.58 25.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.969 -1.312 . . . . 0.0 109.876 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 2.5 Cg_endo -68.7 -166.04 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.053 1.835 . . . . 0.0 109.896 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.82 40.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -146.26 144.62 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' N ' ' HG2' ' A' ' 26' ' ' ARG . 1.2 m -116.28 167.15 11.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' MET . 0.7 OUTLIER -89.5 66.4 7.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 mtp 43.79 28.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.96 -74.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 32' ' ' THR . . . 122.5 29.36 1.31 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 31' ' ' GLY . 3.0 p -153.63 -66.27 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.78 114.31 19.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -120.88 156.43 32.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -135.65 113.9 11.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.385 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 22.9 t -43.88 117.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 122.13 52.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.705 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.38 -166.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.985 1.79 . . . . 0.0 110.104 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.802 . . . . 0.0 109.45 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 17.0 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.803 HD13 ' O ' ' A' ' 11' ' ' LYS . 7.1 mt -113.3 91.11 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.06 35.62 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.05 166.43 11.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.56 123.31 15.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.202 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER 43.64 31.9 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.775 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.54 129.69 7.4 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.803 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -36.7 133.16 0.59 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.589 -0.948 . . . . 0.0 110.316 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 1.6 p -122.4 -176.22 3.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.19 136.61 8.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -76.85 85.27 3.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.27 -17.93 7.43 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.32 -128.22 3.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.1 m -89.78 106.34 18.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -1.148 . . . . 0.0 109.408 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -166.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.691 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -97.44 175.97 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.091 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 1.1 m -104.78 149.38 25.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.988 . . . . 0.0 109.885 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER 77.61 -7.41 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.246 -0.909 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.52 46.76 2.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -93.06 124.48 58.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.165 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 4.6 Cg_exo -59.89 168.26 5.99 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.997 1.798 . . . . 0.0 110.584 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.5 t -120.98 106.4 11.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.485 -0.759 . . . . 0.0 109.087 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 35' ' ' GLU . 3.4 ttm180 -111.21 177.52 4.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -110.79 -177.85 3.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.95 28.73 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.469 ' CB ' ' O ' ' A' ' 28' ' ' SER . 12.5 ttm 72.73 29.54 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.656 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -51.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 109.539 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.43 10.7 9.3 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -123.96 -99.25 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -1.186 . . . . 0.0 109.322 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 2.2 m120 -55.19 128.91 36.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.983 -1.073 . . . . 0.0 108.75 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -120.64 124.7 45.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.2 OUTLIER -110.37 167.44 10.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.498 ' C ' ' HA ' ' A' ' 9' ' ' TYR . 3.6 t -69.81 -173.93 0.68 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.77 127.41 0.47 Allowed Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 120.686 -1.258 . . . . 0.0 109.956 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.92 159.55 45.55 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.792 1.662 . . . . 0.0 109.228 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.247 -0.908 . . . . 0.0 109.751 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.294 0.569 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.633 HD12 ' HB3' ' A' ' 12' ' ' CYS . 20.4 mt -120.07 82.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.21 69.48 0.74 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 0.0 109.68 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 -178.7 6.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.282 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 9' ' ' TYR . 2.0 m-20 -61.1 89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.951 . . . . 0.0 109.196 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 62.52 46.32 5.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.84 146.17 1.94 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 105.17 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 109.787 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.633 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.6 p -115.08 176.1 5.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 109.02 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 13' ' ' THR . 22.8 m -159.81 73.76 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.964 -1.085 . . . . 0.0 110.382 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.553 ' O ' ' N ' ' A' ' 16' ' ' GLY . 4.1 m-90 40.64 -147.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.428 -0.795 . . . . 0.0 110.451 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 14' ' ' TRP . . . -22.95 -42.39 0.01 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 14' ' ' TRP . . . -54.36 -165.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.631 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -43.61 100.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.054 -1.262 . . . . 0.0 109.353 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.0 tttt -70.94 -164.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.957 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -96.18 134.47 39.22 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.32 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.165 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -44.34 -26.74 0.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' ARG . . . 105.18 95.84 2.41 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.511 ' HB3' ' NH1' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -157.75 154.5 25.0 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.246 -1.149 . . . . 0.0 109.696 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -167.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.467 2.111 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 6.3 t -142.08 78.62 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 156.75 17.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.58 179.64 3.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.356 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.527 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.3 OUTLIER -58.73 171.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.48 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.422 ' HG3' HG23 ' A' ' 30' ' ' ILE . 5.3 ptp -78.34 -2.84 40.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 HG23 ' HG3' ' A' ' 29' ' ' MET . 9.6 pt -117.25 -26.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.988 . . . . 0.0 109.435 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.92 67.02 0.29 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -127.82 -158.56 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' C ' ' OE2' ' A' ' 35' ' ' GLU . 2.9 m-80 -42.97 150.12 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.789 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -107.58 127.35 53.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.295 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 9' ' ' TYR . 8.6 mp0 -119.77 163.32 17.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.032 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.8 t -86.11 116.53 24.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 108.991 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.27 112.78 58.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 110.034 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -66.72 -167.17 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.857 1.705 . . . . 0.0 110.006 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 108.981 179.922 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.288 0.566 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.636 HD11 ' HB ' ' A' ' 17' ' ' THR . 3.8 mt -95.03 80.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.354 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.12 5.22 52.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.697 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.05 170.8 10.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.161 -0.962 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 1.4 p30 -79.98 123.33 27.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.835 . . . . 0.0 109.365 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 61.5 m-85 61.16 13.39 4.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' TYR . . . -44.32 132.33 7.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.611 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -52.08 151.56 3.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -1.137 . . . . 0.0 109.176 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -150.12 -167.87 2.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.79 134.97 10.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.44 84.24 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 109.372 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.88 -4.48 4.28 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.44 -125.95 3.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.636 ' HB ' HD11 ' A' ' 5' ' ' ILE . 11.9 m -65.01 118.35 8.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.145 . . . . 0.0 109.735 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.565 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.3 tppt? -93.49 160.69 14.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.161 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.565 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -66.74 156.93 34.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 110.324 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -82.9 158.16 22.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.485 ' HB2' ' NH2' ' A' ' 23' ' ' ARG . 2.6 mmp_? 65.34 8.3 4.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.828 . . . . 0.0 109.849 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . 74.6 98.29 0.1 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -150.94 131.03 6.9 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 108.724 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.15 -174.83 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.052 1.835 . . . . 0.0 110.62 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -145.33 111.67 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.085 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.589 HH11 HG21 ' A' ' 37' ' ' THR . 28.6 mtt180 -84.89 163.21 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.9 m -138.54 -168.56 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 30' ' ' ILE . 89.6 p -73.5 -2.22 21.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 28' ' ' SER . 2.1 mtt 67.59 7.18 5.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 109.689 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 28' ' ' SER . 1.4 pp -131.44 -29.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 110.001 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 32' ' ' THR . . . 123.21 90.29 0.95 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 31' ' ' GLY . 6.8 p -159.74 -74.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -144.56 151.63 39.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.456 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.31 132.74 54.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -126.48 138.74 53.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.413 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 34.6 t -73.16 144.15 46.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.887 . . . . 0.0 109.413 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.589 HG21 HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -96.87 136.94 21.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.003 -1.061 . . . . 0.0 109.488 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.5 Cg_endo -65.16 117.22 4.36 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 21.4 mtm-85 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 110.359 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 9.2 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.423 0.63 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 5' ' ' ILE . 11.4 mt -160.95 64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.82 56.24 3.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -150.28 151.95 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.2 OUTLIER -78.87 146.27 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 109.33 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.1 m-85 54.75 19.65 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.64 128.97 24.52 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 10.5 tttt -52.47 151.35 4.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.124 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 29.0 p -145.96 -167.68 2.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.8 m -157.4 123.56 4.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.297 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -53.35 110.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.485 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.46 -36.33 4.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.97 -133.38 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.585 ' O ' HD11 ' A' ' 5' ' ' ILE . 1.3 m -74.52 84.23 2.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -1.164 . . . . 0.0 109.601 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 20.6 ttpt -65.64 163.65 15.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -60.37 120.65 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.471 -0.768 . . . . 0.0 109.582 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 2.1 m -50.06 146.07 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 1.6 mtt180 77.53 3.01 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.704 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.93 99.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -139.2 155.96 72.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.289 -1.124 . . . . 0.0 109.345 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.503 ' HD3' ' NE ' ' A' ' 39' ' ' ARG . 2.7 Cg_endo -61.37 144.41 98.33 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.206 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.25 116.07 10.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 148.52 25.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.502 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 36.0 m -119.45 -172.37 2.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.486 ' O ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -117.25 44.88 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.554 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 61.42 22.35 12.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -124.47 -30.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.73 36.52 47.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -45.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -1.184 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -106.43 72.0 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.893 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 58.3 m -92.85 114.26 26.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.85 . . . . 0.0 109.299 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 125.39 33.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 37' ' ' THR . 16.0 t -81.43 159.47 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.702 HG22 ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -119.71 148.24 45.71 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.638 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.702 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.9 Cg_endo -61.1 176.28 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.229 1.953 . . . . 0.0 110.331 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.503 ' NE ' ' HD3' ' A' ' 24' ' ' PRO . 7.6 mtt180 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.294 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 11' ' ' LYS . 5.3 mt -81.49 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.918 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -98.99 47.76 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.95 176.82 7.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.1 130.25 36.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 47.2 m-85 58.34 19.54 6.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 133.48 52.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.593 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -46.78 144.5 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -1.182 . . . . 0.0 109.491 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.45 -168.42 3.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.569 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 m -154.71 137.49 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -63.36 92.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.35 43.79 1.96 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.28 -116.45 0.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 m -84.48 96.95 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -1.132 . . . . 0.0 109.459 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 1.9 ttmt -70.59 167.82 17.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.334 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -65.48 139.22 58.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.797 . . . . 0.0 109.257 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.918 ' SG ' ' HB2' ' A' ' 6' ' ' ALA . 73.9 m -44.17 -62.47 1.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.147 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.66 -73.72 0.05 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.462 -0.774 . . . . 0.0 109.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.29 82.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' CZ ' ' HA ' ' A' ' 39' ' ' ARG . 3.2 mmt-85 -138.38 155.16 74.04 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.133 -1.216 . . . . 0.0 109.546 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HD2' ' HD2' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -62.42 -174.82 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.23 1.954 . . . . 0.0 110.195 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.11 153.72 36.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.379 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -126.74 164.44 21.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.566 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 m -136.4 -172.01 3.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -85.28 5.06 32.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.688 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER 75.2 17.63 2.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.414 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.427 ' CG1' ' HB3' ' A' ' 28' ' ' SER . 0.3 OUTLIER -141.83 26.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 32' ' ' THR . . . 43.51 86.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.9 p -158.28 -41.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.104 . . . . 0.0 109.434 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.92 139.44 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.59 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 26' ' ' ARG . 28.2 m -130.2 168.56 16.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.3 mm-40 -142.44 155.89 45.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 109.717 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 36.4 t -86.91 145.27 26.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.48 123.57 36.95 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.001 . . . . 0.0 109.613 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.07 -169.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.898 1.732 . . . . 0.0 110.106 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.52 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 1.2 tmm_? . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.408 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.521 HG23 ' HA3' ' A' ' 10' ' ' GLY . 88.2 mt -99.56 73.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.91 -12.39 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.75 146.42 52.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.243 -0.911 . . . . 0.0 109.508 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 7.7 p-10 -65.97 130.19 42.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 52.5 m-85 62.86 12.2 5.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -45.09 121.78 4.74 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -42.78 125.19 3.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -1.069 . . . . 0.0 109.563 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.4 p -115.59 -170.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.09 134.2 7.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.332 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -72.09 100.29 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.47 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.3 -8.52 13.83 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.51 -140.3 8.79 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.58 148.02 35.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.198 -1.178 . . . . 0.0 109.531 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -164.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.816 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.483 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.8 139.21 32.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.553 -0.717 . . . . 0.0 109.57 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -53.51 145.34 15.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.216 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 25.6 mtp180 83.02 -42.59 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.553 -0.717 . . . . 0.0 109.735 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 83.18 0.84 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 6.9 mmt-85 -124.79 141.45 38.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.234 -1.156 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.467 ' HG2' ' HD3' ' A' ' 39' ' ' ARG . 1.4 Cg_endo -64.01 169.84 9.87 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.094 1.863 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.04 172.3 13.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.3 ttm-85 -140.81 139.0 34.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.342 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 31' ' ' GLY . 64.3 m -133.64 -167.99 2.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 109.743 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.3 m -67.89 -36.27 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 0.0 109.745 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 30' ' ' ILE . 2.5 ptp -43.32 -27.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -156.2 27.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.629 ' O ' HG23 ' A' ' 32' ' ' THR . . . -169.72 -93.48 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.1 p -160.4 -92.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -1.148 . . . . 0.0 109.332 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 26' ' ' ARG . 30.7 m120 -102.57 162.54 12.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.172 -0.955 . . . . 0.0 108.907 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 72.7 m -79.66 104.09 10.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 3.3 mt-10 -136.26 143.42 44.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 53.9 t -60.57 121.29 11.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.02 120.33 60.2 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.558 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 85.58 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.868 1.712 . . . . 0.0 110.079 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.468 ' HG2' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.708 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 5' ' ' ILE . 26.7 mt -87.6 63.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.12 -11.16 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.531 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -54.99 152.5 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -64.08 127.02 29.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.883 . . . . 0.0 109.411 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 18.6 m-85 53.05 24.55 3.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.66 123.3 10.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -49.36 123.26 7.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 15.9 p -113.87 -171.65 1.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.13 148.94 45.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -77.17 89.26 3.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.14 9.66 19.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.9 -136.92 9.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -84.92 116.38 23.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 109.437 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -166.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -92.62 155.46 17.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -44.17 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.537 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -23.31 1.03 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.29 57.59 1.0 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 mtt-85 -96.38 152.06 38.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.44 173.36 3.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.23 1.953 . . . . 0.0 110.303 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -139.96 86.12 2.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -68.96 163.98 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 32' ' ' THR . 1.2 m -117.94 -171.9 2.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -68.9 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.42 41.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.87 -38.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.364 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.18 45.92 0.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -105.73 -156.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -1.089 . . . . 0.0 109.469 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.416 ' ND2' ' H ' ' A' ' 33' ' ' ASN . 9.2 m-80 -42.4 150.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -118.02 165.33 13.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.435 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -141.33 142.3 33.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 t -68.14 120.75 14.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 121.51 55.58 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 2.0 Cg_endo -64.51 119.32 6.33 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.875 1.716 . . . . 0.0 110.245 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 3.7 ttm180 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.638 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 44.7 mt -78.97 83.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.71 -5.02 59.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.66 167.81 14.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 0.0 109.404 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 44.2 p-10 -88.17 128.41 35.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m-85 55.33 21.42 4.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.861 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -53.28 135.99 39.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 24.9 ttmt -42.54 111.69 0.28 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.422 -1.046 . . . . 0.0 109.445 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 36' ' ' CYS . 16.8 p -94.06 -167.58 1.71 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -158.38 156.52 30.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.436 -0.79 . . . . 0.0 109.641 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -99.16 51.71 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.54 39.7 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.24 -139.75 3.3 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 m -69.91 85.14 0.5 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -1.156 . . . . 0.0 109.307 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 16.8 ttmt -48.03 167.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -158.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -0.762 . . . . 0.0 109.667 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 73.8 m -106.35 141.59 37.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER 71.48 0.58 3.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 110.156 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.512 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 91.88 109.09 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.126 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -150.66 140.06 13.54 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.31 -1.112 . . . . 0.0 109.301 179.906 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.51 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.332 2.021 . . . . 0.0 110.724 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.541 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -120.27 99.28 6.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.499 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 36.4 ttt85 -71.15 152.68 43.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.033 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -137.99 -171.85 3.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.428 -0.795 . . . . 0.0 109.367 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.585 ' HB2' HD11 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -93.99 28.04 2.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 66.07 25.82 10.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -128.42 -35.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.2 8.73 11.19 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -130.94 165.24 23.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -1.189 . . . . 0.0 108.997 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 32' ' ' THR . 23.2 t-20 45.33 85.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -102.45 107.93 19.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.698 -179.834 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 26' ' ' ARG . 6.2 mm-40 -85.43 156.43 20.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 42.6 t -76.48 157.44 32.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.39 116.16 35.46 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.18 100.23 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.719 1.613 . . . . 0.0 110.183 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.376 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.287 0.565 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 3' ' ' ASN . 9.8 p30 -175.0 29.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.64 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 2' ' ' ASP . 2.4 p30 -55.95 -164.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.4 p -113.41 156.19 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.551 HD12 ' HB3' ' A' ' 12' ' ' CYS . 4.2 mt -89.79 82.88 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.339 -0.851 . . . . 0.0 109.415 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -95.53 27.05 3.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.23 153.75 20.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 2.6 p30 -66.39 124.31 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 72.1 m-85 62.39 13.04 5.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.414 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.1 127.88 9.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -60.68 124.98 22.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -1.105 . . . . 0.0 109.364 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.551 ' HB3' HD12 ' A' ' 5' ' ' ILE . 11.8 p -112.48 -175.98 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.699 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 15' ' ' GLY . 2.4 m -150.92 101.46 2.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -0.79 . . . . 0.0 109.281 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.429 ' C ' ' O ' ' A' ' 13' ' ' THR . 23.2 m0 -43.5 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 175.76 -37.85 0.1 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 18' ' ' LYS . . . -167.06 -70.01 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.61 92.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.859 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.6 ttpt -103.81 159.93 15.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.208 -0.933 . . . . 0.0 108.844 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.18 140.1 58.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.054 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -60.82 -35.46 76.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 109.68 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 22' ' ' GLY . 1.9 mmt-85 -86.93 23.87 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.266 -0.896 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' ARG . . . 43.97 77.77 0.08 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.482 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 49.8 mtt180 -120.94 149.57 51.26 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.153 . . . . 0.0 109.67 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.98 108.51 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.384 2.056 . . . . 0.0 110.54 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 150.71 22.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.109 -0.994 . . . . 0.0 108.949 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.85 168.43 19.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.812 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.2 m -145.8 -172.37 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.337 -0.852 . . . . 0.0 109.181 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.494 ' HB2' HG12 ' A' ' 30' ' ' ILE . 61.1 m -93.35 -164.62 1.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.97 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.7 31.3 1.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 28' ' ' SER . 1.8 pt -115.15 -22.75 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.578 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.414 ' C ' HG23 ' A' ' 32' ' ' THR . . . 90.77 18.57 47.31 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 63.2 p -152.74 161.35 42.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -1.155 . . . . 0.0 109.43 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER 70.87 86.69 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 55.5 m -117.48 156.76 27.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.317 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -135.74 130.78 34.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 9.6 t -70.97 123.58 22.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.075 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.19 123.65 46.04 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.664 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.29 141.54 75.61 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.876 1.717 . . . . 0.0 109.975 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.453 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -159.75 66.33 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.547 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -165.01 -76.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.378 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.615 HG22 ' N ' ' A' ' 42' ' ' MET . 12.5 mt 54.71 166.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 109.644 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.615 ' N ' HG22 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -95.71 170.64 9.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.49 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.72 151.98 21.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.449 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.36 -125.62 8.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.3 mp -140.73 -159.73 0.99 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -1.17 . . . . 0.0 109.493 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 47' ' ' PHE . 5.4 p -92.75 -149.66 0.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 48' ' ' ALA . 22.8 p90 -67.5 -164.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.295 -0.878 . . . . 0.0 109.523 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.452 ' N ' ' CD2' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -117.74 127.99 54.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.77 -54.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.733 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 11.1 p -67.18 -150.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.511 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 49.5 mt -79.87 75.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.63 15.44 18.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.278 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -84.78 149.82 25.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.402 -0.811 . . . . 0.0 109.59 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.9 OUTLIER -65.3 123.68 20.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 30.6 m-85 62.34 20.69 12.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.65 124.58 35.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -48.43 127.7 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.542 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.9 p -114.87 -168.32 1.36 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 109.724 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 14' ' ' TRP . 38.0 m -149.62 105.56 3.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.538 -0.726 . . . . 0.0 109.413 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -44.01 106.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.64 35.33 4.94 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.7 -131.3 1.91 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -84.49 108.36 17.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 109.436 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.73 -165.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 109.703 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 139.54 40.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 m -64.58 -50.05 68.74 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.22 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -18.73 8.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.386 -0.821 . . . . 0.0 109.35 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.85 57.62 1.23 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 38' ' ' PRO . 5.4 mtt85 -124.45 145.12 48.0 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.541 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -65.22 -169.76 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.283 1.989 . . . . 0.0 110.379 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -133.6 155.01 50.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.414 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.78 124.09 45.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.895 . . . . 0.0 109.526 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' CB ' ' HA2' ' A' ' 31' ' ' GLY . 71.9 m -91.52 -171.2 2.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.587 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.1 OUTLIER -98.5 39.96 1.22 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 109.767 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.552 ' CB ' ' O ' ' A' ' 28' ' ' SER . 2.3 ttt 83.07 -43.24 0.11 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 32' ' ' THR . 4.3 pt -104.52 32.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.525 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' HA2' ' CB ' ' A' ' 27' ' ' CYS . . . 47.67 65.96 2.17 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 30' ' ' ILE . 39.3 p -139.13 126.35 21.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -1.087 . . . . 0.0 109.513 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 47.51 64.67 1.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 3.8 m -79.87 158.79 26.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.184 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -141.52 138.48 32.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.593 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 50.6 t -54.48 130.96 41.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.256 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.97 123.62 32.44 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.059 -1.025 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -63.57 157.64 50.09 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.29 144.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.608 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.5 39.53 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.54 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 42' ' ' MET . 1.9 mt -118.77 -151.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 0.0 109.458 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.514 ' H ' HG22 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -163.83 136.1 5.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 109.508 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 42' ' ' MET . 4.0 pt-20 164.75 -35.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 109.074 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -133.13 114.01 1.32 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER 74.43 135.8 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -1.129 . . . . 0.0 109.159 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 92.2 p -145.0 -172.04 3.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.0 109.779 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 19.6 p90 -164.16 147.44 9.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.436 -0.79 . . . . 0.0 109.275 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.593 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 18.9 t70 -131.09 -47.4 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.901 -1.124 . . . . 0.0 109.968 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 40.5 t-20 178.73 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.955 . . . . 0.0 110.574 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 10.4 p -44.09 169.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.939 -1.101 . . . . 0.0 109.872 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 11' ' ' LYS . 74.8 mt -79.51 84.49 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.08 13.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.09 164.72 24.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.583 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 9.0 m-20 -85.27 121.35 27.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' GLY . 22.9 m-85 60.86 23.31 13.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.572 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -51.78 -175.78 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.52 ' O ' HD13 ' A' ' 5' ' ' ILE . 3.9 ptpp? -99.74 126.44 45.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.112 -1.228 . . . . 0.0 109.477 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 26.8 p -119.55 -170.25 1.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.508 HG22 ' N ' ' A' ' 14' ' ' TRP . 17.1 m -147.25 161.22 41.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.508 ' N ' HG22 ' A' ' 13' ' ' THR . 0.1 OUTLIER -80.59 88.56 5.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.45 15.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 -151.58 28.35 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.473 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 74.7 m -61.81 90.74 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.224 -1.162 . . . . 0.0 109.531 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -165.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.6 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.99 -164.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 85.7 m -116.48 134.53 54.75 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER 77.74 -6.8 1.92 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.958 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . 102.5 95.37 2.29 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.421 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -157.28 154.33 25.56 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.381 -1.07 . . . . 0.0 109.383 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.36 178.54 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.287 1.991 . . . . 0.0 110.62 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -139.89 85.16 2.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.436 -0.79 . . . . 0.0 108.947 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 23.8 ttp85 -53.2 146.53 11.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 109.955 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -117.88 -170.08 1.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.584 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.11 39.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.7 OUTLIER 74.57 1.87 3.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.72 -81.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.98 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.06 45.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.36 -41.21 2.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.537 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -128.35 84.66 2.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.599 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 1.3 m -80.08 173.21 12.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.7 mp0 -141.24 150.45 42.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.789 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -73.77 107.53 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.59 124.41 59.09 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.474 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' ARG . 2.2 Cg_endo -63.63 159.17 42.21 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.873 1.715 . . . . 0.0 110.135 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' PRO . 1.6 mmm180 52.92 172.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.708 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.924 ' N ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -122.12 168.68 11.69 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.328 -0.857 . . . . 0.0 109.54 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -157.04 73.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.532 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.46 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 3.9 ttt -143.24 120.04 11.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 42' ' ' MET . 36.6 tt0 66.96 159.69 0.14 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.907 . . . . 0.0 109.455 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.0 -85.49 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.409 HD23 ' H ' ' A' ' 46' ' ' SER . 0.2 OUTLIER -98.07 164.22 12.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 109.405 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.409 ' H ' HD23 ' A' ' 45' ' ' LEU . 57.4 p -129.82 133.39 46.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.953 . . . . 0.0 109.454 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -61.61 126.98 29.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.246 -0.909 . . . . 0.0 109.452 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.481 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 2' ' ' ASP . 7.7 pt-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 1' ' ' GLU . 0.1 OUTLIER 39.18 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.737 . . . . 0.0 109.932 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 2' ' ' ASP . 1.8 t-20 -43.65 -57.8 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.513 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 28.0 p -87.45 164.54 16.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 11' ' ' LYS . 6.5 mt -87.14 95.16 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.586 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -92.65 -5.78 50.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.642 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.9 166.65 22.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 109.46 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.548 ' HB3' ' CD1' ' A' ' 9' ' ' TYR . 79.0 m-20 -89.84 136.64 32.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.604 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.548 ' CD1' ' HB3' ' A' ' 8' ' ' ASP . 59.9 m-85 64.79 10.67 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.4 126.42 42.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.551 ' O ' HD13 ' A' ' 5' ' ' ILE . 20.5 tttt -45.66 120.33 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.51 ' HA ' ' CD1' ' A' ' 5' ' ' ILE . 28.7 p -100.64 -169.26 1.69 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -0.908 . . . . 0.0 109.623 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.0 m -147.48 121.16 9.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.36 -0.838 . . . . 0.0 109.356 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -69.46 94.63 0.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.08 14.02 25.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.04 -113.28 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.9 90.58 8.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -1.147 . . . . 0.0 109.633 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.582 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -74.85 154.8 38.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.582 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -37.77 147.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.691 -0.63 . . . . 0.0 110.193 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 6' ' ' ALA . 86.3 m -43.64 -92.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.4 OUTLIER -42.89 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 165.91 93.62 0.09 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -136.72 147.63 60.22 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.137 . . . . 0.0 109.544 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HG2' HD21 ' A' ' 40' ' ' LEU . 1.9 Cg_endo -62.75 -171.29 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.266 1.978 . . . . 0.0 110.311 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 153.44 43.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.403 -0.81 . . . . 0.0 109.339 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.757 ' HD3' HG23 ' A' ' 37' ' ' THR . 1.3 ptm180 -119.68 134.28 55.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.78 -171.45 1.9 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 109.535 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 29' ' ' MET . 70.7 m -87.86 20.13 3.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.448 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 71.05 5.54 5.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.31 14.81 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.35 87.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.14 -54.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -142.8 103.83 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.56 132.44 39.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -121.45 127.44 51.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.57 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 29.1 t -54.51 121.99 9.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.144 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.757 HG23 ' HD3' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -80.14 125.4 81.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.636 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 2.4 Cg_endo -62.75 135.89 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.909 1.74 . . . . 0.0 110.068 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 38' ' ' PRO . 7.0 mtt180 52.15 173.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.196 -0.94 . . . . 0.0 109.688 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -140.01 75.98 1.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 0.0 109.369 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.01 72.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.1 mtt 55.27 90.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.346 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' OE1' HG21 ' A' ' 37' ' ' THR . 15.3 tp10 -64.52 130.98 45.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.45 ' O ' HD22 ' A' ' 45' ' ' LEU . . . -137.62 161.61 25.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 46' ' ' SER . 1.2 mm? -119.85 -35.08 3.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -1.105 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.527 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 3.6 p 168.41 -28.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 109.469 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 59.47 14.81 4.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.358 -0.839 . . . . 0.0 109.461 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.395 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.66 ' OE1' ' HB3' ' A' ' 6' ' ' ALA . 2.1 mt-10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.337 0.589 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 1' ' ' GLU . 0.7 OUTLIER 62.97 46.6 4.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.371 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.47 -59.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -0.882 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -129.52 174.94 9.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 108.944 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.496 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 25.7 mt -81.9 119.79 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.66 ' HB3' ' OE1' ' A' ' 1' ' ' GLU . . . -116.29 -19.31 10.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.463 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.44 173.82 0.64 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.22 -0.925 . . . . 0.0 109.581 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 58.3 m-20 -89.88 141.7 28.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 46.9 m-85 61.66 13.45 5.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.0 109.528 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -50.55 151.53 5.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -72.74 98.15 2.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -1.204 . . . . 0.0 109.568 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 34' ' ' CYS . 6.3 p -102.16 -178.44 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.8 m -160.18 146.25 15.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.406 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -74.11 89.05 1.95 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 16' ' ' GLY . . . 137.45 -59.57 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 15' ' ' GLY . . . -63.06 -124.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.45 129.46 34.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -1.136 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -99.34 -164.45 1.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.664 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 130.85 34.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.1 m -55.86 -58.71 6.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -44.75 -25.84 0.33 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.55 20.64 12.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.8 mtp85 -85.94 161.4 50.1 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.342 -1.093 . . . . 0.0 109.49 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 23' ' ' ARG . 1.8 Cg_endo -62.87 -170.76 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.221 1.947 . . . . 0.0 110.215 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 36.5 t -134.11 85.41 2.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.324 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 3.8 ttt180 -43.65 140.03 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.621 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 93.5 m -153.06 173.6 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.3 -77.84 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.8 mtp 177.64 -31.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.1 pt -88.23 -22.42 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 32' ' ' THR . . . 119.85 57.88 0.25 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.1 p -160.03 169.36 23.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 109.524 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 49.6 51.6 16.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 10.8 m -91.82 117.68 30.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 109.44 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.6 mm-40 -134.01 114.34 13.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.723 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 48.5 t -60.62 136.43 58.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.226 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 124.68 28.29 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.571 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 1.9 Cg_endo -63.82 142.14 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.963 1.776 . . . . 0.0 110.181 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.74 138.61 48.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 39' ' ' ARG . 6.8 tp -44.16 144.57 0.93 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.525 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 mt -63.62 139.0 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.403 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.51 98.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.423 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -86.95 -23.53 25.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.92 -175.05 27.98 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 45' ' ' LEU . 3.8 mm? 59.82 15.29 4.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.475 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.5 m -77.51 -67.1 0.75 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.463 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.8 t80 -75.82 138.74 41.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.535 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.988 -1.005 . . . . 0.0 109.461 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.12 -95.19 0.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.105 -0.997 . . . . 0.0 109.612 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 4' ' ' CYS . 8.2 t30 -133.2 -148.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.037 -1.039 . . . . 0.0 109.479 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' ASN . 28.7 p -52.16 -174.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.408 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 5' ' ' ILE . 3.7 mm -85.88 59.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.37 14.52 6.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.1 155.29 18.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.7 OUTLIER -64.17 124.45 21.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.302 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.477 ' CA ' ' HB3' ' A' ' 35' ' ' GLU . 11.0 m-85 62.38 22.84 13.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -49.05 107.89 0.35 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HA ' ' HG3' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -44.21 113.64 0.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.625 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -127.1 -169.09 1.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.516 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.563 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 55.7 m -134.93 127.28 30.32 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.286 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -47.54 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -0.982 . . . . 0.0 109.384 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 13' ' ' THR . . . 105.78 -41.89 2.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.35 -103.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.87 104.12 16.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.657 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 149.14 32.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -0.929 . . . . 0.0 109.017 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.49 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -53.96 140.63 30.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.98 -83.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.641 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 20' ' ' CYS . 5.0 mmm180 -43.48 -72.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 109.375 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.63 81.47 0.04 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 54.9 mtt180 -132.06 150.46 76.15 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.21 -1.171 . . . . 0.0 109.609 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.22 174.98 1.19 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.123 1.882 . . . . 0.0 110.223 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.3 77.66 1.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.353 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 154.8 22.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.205 -0.935 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 20.4 m -81.13 161.63 24.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.174 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 30' ' ' ILE . 0.6 OUTLIER -89.45 52.9 2.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.628 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 44.59 26.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.542 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 32' ' ' THR . 4.5 pt -98.19 -10.54 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 0.0 109.362 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' C ' ' CG2' ' A' ' 32' ' ' THR . . . 64.9 25.27 70.59 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' ILE . 17.7 p -156.36 121.52 4.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -1.153 . . . . 0.0 109.687 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 32' ' ' THR . 1.4 m-80 58.89 151.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -119.58 154.25 34.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 11' ' ' LYS . 2.6 mp0 -123.71 155.24 38.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.736 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 5' ' ' ILE . 49.6 t -72.73 106.8 4.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.92 123.57 77.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 40' ' ' LEU . 2.4 Cg_endo -62.64 155.68 57.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.91 1.74 . . . . 0.0 110.129 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -59.64 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.208 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 38' ' ' PRO . 5.8 tp -147.82 -71.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.068 -1.02 . . . . 0.0 109.889 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.78 -168.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.206 -0.933 . . . . 0.0 109.918 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.532 ' N ' ' SD ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -165.67 29.09 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.281 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -41.67 164.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.411 -0.805 . . . . 0.0 109.815 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.4 87.21 0.07 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.66 49.31 2.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -1.207 . . . . 0.0 109.687 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 m -99.13 -11.82 21.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.395 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 t80 69.12 20.11 7.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.207 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.493 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.441 ' O ' ' CG ' ' A' ' 2' ' ' ASP . 1.6 pm0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 1' ' ' GLU . 1.4 p30 40.18 57.48 2.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.57 -0.706 . . . . 0.0 109.892 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' O ' ' CG2' ' A' ' 17' ' ' THR . 13.8 p-10 -142.19 8.72 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 109.839 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.66 ' HA ' HG22 ' A' ' 17' ' ' THR . 12.5 p -110.09 -151.93 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.497 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.933 HD13 ' O ' ' A' ' 11' ' ' LYS . 40.5 mt -138.25 67.95 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 109.233 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.95 4.99 15.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.62 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -84.35 149.67 25.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.438 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.7 m-20 -65.17 129.99 41.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 34.9 m-85 60.0 15.13 4.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.847 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -50.0 134.59 27.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.933 ' O ' HD13 ' A' ' 5' ' ' ILE . 31.4 mttm -54.67 155.9 3.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -1.208 . . . . 0.0 109.693 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.401 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 19.1 p -160.29 -166.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' TRP . 4.1 m -150.69 124.5 9.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.707 . . . . 0.0 109.112 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 13' ' ' THR . 5.9 m0 -43.95 108.67 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.605 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.46 46.47 6.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.46 -111.41 0.8 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -89.08 129.32 35.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.285 -1.126 . . . . 0.0 109.429 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -80.51 -166.76 1.14 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.357 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -104.41 19.29 20.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.402 -0.811 . . . . 0.0 109.092 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER 68.27 -90.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 0.0 110.127 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.95 -37.62 1.94 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' N ' ' HG3' ' A' ' 21' ' ' ARG . . . 124.17 51.1 0.2 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.554 ' CG ' ' HA ' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -103.51 135.27 19.4 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.426 -1.043 . . . . 0.0 109.488 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 5.7 Cg_exo -58.97 -169.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.079 1.853 . . . . 0.0 110.117 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.2 124.99 9.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.44 ' CZ ' HG21 ' A' ' 37' ' ' THR . 3.2 ttp180 -115.58 136.77 52.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.485 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 84.1 m -84.42 178.64 7.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 0.0 109.525 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -113.22 36.06 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 109.69 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.544 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 79.79 6.45 1.85 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.42 -0.8 . . . . 0.0 110.486 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -90.33 -29.02 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.807 -1.183 . . . . 0.0 109.099 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.46 10.55 81.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -147.5 -73.34 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 0.0 108.667 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.545 ' N ' ' OG1' ' A' ' 32' ' ' THR . 6.7 m120 -69.45 113.96 7.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 108.829 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.485 ' CB ' ' HA ' ' A' ' 27' ' ' CYS . 4.2 m -129.45 155.03 46.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -111.75 153.2 26.86 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 23' ' ' ARG . 1.9 t -70.73 173.31 7.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.114 -0.991 . . . . 0.0 108.726 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -153.63 124.55 3.53 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.805 -1.185 . . . . 0.0 110.117 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -68.5 135.89 34.92 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.965 1.777 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 6.9 ttt-85 71.39 158.11 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.737 HD12 ' CG ' ' A' ' 42' ' ' MET . 0.1 OUTLIER -105.51 -171.83 1.98 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.798 HD13 ' N ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -116.2 84.78 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.142 -0.974 . . . . 0.0 109.357 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.737 ' CG ' HD12 ' A' ' 40' ' ' LEU . 9.0 ptm 171.04 -179.33 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.583 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -52.14 120.61 5.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -120.03 -121.17 2.88 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.927 HD22 ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -152.99 11.96 0.49 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -1.173 . . . . 0.0 110.249 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.503 ' N ' HD13 ' A' ' 45' ' ' LEU . 8.7 m -75.63 -72.2 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.997 -1.065 . . . . 0.0 109.555 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -79.76 169.05 18.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.681 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.554 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -48.14 116.03 1.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.467 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -154.53 44.21 0.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.457 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.6 p 179.96 178.49 0.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 12' ' ' CYS . 19.5 mt -87.39 109.18 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.88 -16.1 14.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.549 ' CG ' ' HA3' ' A' ' 10' ' ' GLY . 6.6 pt-20 -52.26 170.63 0.06 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.34 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.559 ' OD1' ' CE1' ' A' ' 9' ' ' TYR . 2.3 t0 -90.04 129.7 36.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.559 ' CE1' ' OD1' ' A' ' 8' ' ' ASP . 70.8 m-85 66.32 7.65 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 109.932 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -51.2 133.83 33.1 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -52.92 109.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -1.153 . . . . 0.0 109.392 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 17.8 p -88.39 -167.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.1 151.42 19.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.476 -0.765 . . . . 0.0 109.385 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.596 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -93.75 77.26 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.444 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.77 -55.86 0.7 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.26 -143.33 0.14 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.17 98.28 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.34 -1.094 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.61 -164.0 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.432 ' HB3' ' HG3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -95.22 129.27 42.4 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.588 -0.695 . . . . 0.0 109.46 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 35.1 m -44.55 157.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER 63.54 11.79 5.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.617 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.78 92.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' HB3' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -117.64 155.43 50.54 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.237 -1.155 . . . . 0.0 109.358 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.73 136.72 68.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.158 1.905 . . . . 0.0 109.9 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.596 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -91.34 87.8 6.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.15 -0.969 . . . . 0.0 108.558 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -57.82 124.0 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.236 -0.915 . . . . 0.0 110.698 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -152.65 -172.5 4.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 0.0 109.455 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.94 -92.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.649 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.9 mmt -135.11 65.02 1.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.97 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.15 -50.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 109.416 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.85 22.91 22.16 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -123.07 -87.2 0.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -1.109 . . . . 0.0 109.36 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.8 m-80 -59.67 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.226 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 21.4 m -120.95 141.42 50.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.336 -0.852 . . . . 0.0 109.522 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -103.41 112.58 25.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.359 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 12' ' ' CYS . 41.2 t -53.16 119.68 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.598 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.96 130.95 30.01 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 2.5 Cg_endo -61.94 -171.65 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.878 1.719 . . . . 0.0 110.313 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.457 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 166.76 152.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.2 106.78 19.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.576 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 41' ' ' ILE . 42.3 mm -106.42 -34.46 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.375 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.489 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -80.12 -10.12 59.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -0.88 . . . . 0.0 109.417 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 42' ' ' MET . 0.3 OUTLIER 51.98 172.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.734 . . . . 0.0 109.672 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.72 116.09 4.38 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.15 87.94 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -1.143 . . . . 0.0 109.458 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -162.71 174.71 12.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.876 . . . . 0.0 109.354 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.9 -56.02 12.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.216 -0.927 . . . . 0.0 109.493 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.405 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.95 10.08 25.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -91.66 132.1 36.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.432 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -153.13 170.86 19.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 109.583 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.584 HD11 ' O ' ' A' ' 17' ' ' THR . 14.0 mt -82.7 129.06 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.385 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.59 -11.94 13.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.09 172.05 3.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -89.48 137.88 31.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.855 . . . . 0.0 109.356 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 61.6 m-85 58.91 14.88 3.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 36' ' ' CYS . . . -53.74 121.55 18.61 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -43.81 122.0 2.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 109.743 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.67 174.27 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.09 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.4 m -149.77 149.79 31.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.161 -0.962 . . . . 0.0 109.594 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -79.96 89.46 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 30.62 3.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.83 -127.05 1.58 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.584 ' O ' HD11 ' A' ' 5' ' ' ILE . 2.3 m -90.16 87.87 7.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -1.15 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' HG2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -89.18 155.17 19.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.346 -0.846 . . . . 0.0 109.0 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -49.05 -177.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.552 ' O ' ' C ' ' A' ' 21' ' ' ARG . 94.5 m -90.55 114.7 26.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.03 -1.044 . . . . 0.0 110.737 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.552 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER 5.76 64.11 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.248 0.547 . . . . 0.0 111.912 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . -165.15 -35.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.558 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -112.88 117.27 46.54 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.193 -1.18 . . . . 0.0 109.655 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.686 ' HG3' HD11 ' A' ' 40' ' ' LEU . 12.2 Cg_endo -79.76 37.25 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.456 2.104 . . . . 0.0 111.146 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 24' ' ' PRO . 4.7 t 46.33 178.98 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.437 -0.789 . . . . 0.0 109.635 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.491 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 0.1 OUTLIER 178.16 142.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.811 -1.18 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -121.75 175.53 6.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.433 ' C ' ' HG3' ' A' ' 29' ' ' MET . 1.2 m -83.32 -93.46 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.722 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.433 ' HG3' ' C ' ' A' ' 28' ' ' SER . 61.5 mtp -143.54 14.34 1.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.704 ' N ' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -107.22 -14.96 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.311 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.89 83.89 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.92 161.67 35.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -1.105 . . . . 0.0 109.354 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 m120 63.9 63.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 4.8 m -98.1 135.99 38.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.264 -0.897 . . . . 0.0 109.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 2.1 mt-10 -101.55 166.05 10.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 109.617 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 23' ' ' ARG . 1.9 t -78.6 109.4 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.421 -0.799 . . . . 0.0 109.052 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.542 ' O ' ' CG ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -88.54 137.06 30.65 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.912 -1.118 . . . . 0.0 109.408 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 37' ' ' THR . 4.1 Cg_exo -57.26 176.39 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.11 1.873 . . . . 0.0 110.556 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 20.7 mtt180 -43.46 145.46 0.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.686 HD11 ' HG3' ' A' ' 24' ' ' PRO . 5.1 mt -73.59 126.22 29.78 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.281 -0.887 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.546 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -69.01 -142.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.191 -0.943 . . . . 0.0 109.096 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.79 152.22 28.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.942 -1.099 . . . . 0.0 109.655 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -79.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 0.0 109.576 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 52.51 -130.96 38.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -139.15 131.8 28.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -1.147 . . . . 0.0 109.467 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t -111.81 15.59 20.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.318 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.558 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -142.66 74.44 1.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.374 -0.829 . . . . 0.0 109.536 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.524 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.275 0.559 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.04 94.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.862 . . . . 0.0 109.65 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 8.1 t30 -177.94 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.885 . . . . 0.0 109.405 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 19' ' ' CYS . 3.2 p 167.23 -169.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 109.358 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.828 HG13 HG22 ' A' ' 17' ' ' THR . 16.6 mt -83.31 104.24 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -0.976 . . . . 0.0 109.585 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.01 -4.47 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.473 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -73.53 142.13 46.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 42.3 m-20 -70.45 127.71 33.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.13 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.471 ' CA ' ' HB3' ' A' ' 35' ' ' GLU . 11.1 m-85 61.94 26.86 16.27 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.191 -0.943 . . . . 0.0 109.392 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -69.67 125.04 16.22 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -42.74 124.07 2.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -1.115 . . . . 0.0 109.268 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 17' ' ' THR . 22.5 p -111.31 -167.25 1.16 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.966 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.6 m -144.35 144.18 31.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.408 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 41.1 m0 -68.95 86.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.76 37.42 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.16 -110.94 1.83 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.828 HG22 HG13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -80.03 84.59 5.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.154 . . . . 0.0 109.7 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.1 tppp? -83.79 166.08 18.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.823 . . . . 0.0 108.889 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.589 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -56.98 -144.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.429 -0.794 . . . . 0.0 109.717 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 69.7 m -133.54 118.84 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 25.0 mmm180 75.89 57.68 0.05 Allowed 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . . . 78.11 -30.38 1.84 Allowed Glycine 0 N--CA 1.496 2.674 0 O-C-N 121.106 -0.996 . . . . 0.0 113.826 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -41.75 103.57 0.31 Allowed Pre-proline 0 N--CA 1.505 2.308 0 CA-C-N 119.751 1.776 . . . . 0.0 109.146 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 22' ' ' GLY . 6.1 Cg_endo -66.04 -163.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.46 2.107 . . . . 0.0 111.02 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -130.02 154.33 47.52 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.558 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.5 OUTLIER -138.26 122.0 17.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.492 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 -170.54 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 108.768 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 66.96 -175.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.735 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 77.83 -4.3 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -0.85 . . . . 0.0 109.41 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -160.71 -38.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.244 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.23 76.64 1.32 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.429 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -159.99 -61.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -1.223 . . . . 0.0 109.637 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 170.57 173.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 m -80.58 132.08 35.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.21 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.471 ' HB3' ' CA ' ' A' ' 9' ' ' TYR . 2.2 mm-40 -113.13 122.57 47.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 110.241 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.501 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -51.95 117.86 3.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -0.788 . . . . 0.0 109.259 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.667 HG22 ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -85.0 145.99 44.64 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.626 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.667 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.3 Cg_endo -62.85 -170.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.093 1.862 . . . . 0.0 110.092 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.504 ' CG ' ' O ' ' A' ' 39' ' ' ARG . 2.6 ptm180 -85.89 103.4 14.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 109.628 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.09 140.34 49.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.251 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 41' ' ' ILE . 8.8 tt -151.28 77.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 109.526 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.521 ' CG ' ' O ' ' A' ' 41' ' ' ILE . 18.1 ptt? 41.06 -162.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.413 -0.804 . . . . 0.0 109.769 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 116.29 19.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.96 -64.72 0.66 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 58.21 27.94 15.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.169 -1.195 . . . . 0.0 109.472 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 p -94.64 -41.78 9.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.535 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -151.96 99.08 2.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.355 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.406 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.281 0.563 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.77 144.2 2.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -0.933 . . . . 0.0 109.445 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -114.83 19.66 15.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 p -74.77 157.61 34.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -80.09 90.2 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.29 -13.79 51.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -72.32 147.12 46.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.455 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 57.4 m-20 -78.48 137.32 37.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 35' ' ' GLU . 40.0 m-85 61.53 13.18 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.539 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.05 129.31 49.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.0 137.27 10.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -1.183 . . . . 0.0 109.411 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 27.6 p -135.43 -169.45 2.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.669 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.55 135.76 21.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.2 87.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.88 40.3 1.45 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.67 -122.34 1.3 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -62.91 91.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.398 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 148.99 38.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.895 . . . . 0.0 109.135 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.47 147.6 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -56.08 141.43 40.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 12.5 mtt-85 72.79 10.51 5.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.843 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . 55.37 90.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 26.2 mmm180 -128.62 149.43 71.9 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.419 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.45 172.84 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.174 1.916 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -137.74 104.09 5.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.445 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -52.95 143.87 16.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.2 m -144.18 176.24 9.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 0.0 109.389 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.466 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 5.0 m -82.88 -91.19 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.99 -83.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -80.18 -30.24 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.66 77.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -101.33 -62.7 1.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -1.124 . . . . 0.0 109.327 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.461 ' O ' ' OE1' ' A' ' 35' ' ' GLU . 50.6 t-20 -125.09 84.05 2.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 90.5 m -80.51 146.5 31.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.485 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 2.1 mp0 -144.03 118.8 9.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.412 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.408 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 49.0 t -46.46 113.03 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 109.273 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.94 131.87 32.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.518 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.8 Cg_endo -63.95 -169.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.989 1.793 . . . . 0.0 109.977 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -44.87 113.52 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' A' ' 43' ' ' GLU . 1.6 tt -151.65 102.68 2.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.7 20.03 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.209 -0.932 . . . . 0.0 109.516 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.5 tpt -127.79 -4.26 5.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.652 ' HB2' HD21 ' A' ' 40' ' ' LEU . 2.8 mt-10 -94.14 -88.91 0.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.484 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 45' ' ' LEU . . . -165.33 -63.65 0.03 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.659 HD13 ' C ' ' A' ' 45' ' ' LEU . 2.1 tm? 79.37 -73.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.516 -0.991 . . . . 0.0 109.601 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.462 ' O ' ' CD2' ' A' ' 47' ' ' PHE . 31.4 t -73.98 -16.55 61.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.121 -0.987 . . . . 0.0 109.455 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 46' ' ' SER . 2.0 m-85 -173.83 138.29 0.63 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.445 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.41 32.55 3.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.43 161.96 37.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.474 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 31.8 p -110.16 176.08 5.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.433 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.547 HG21 ' CB ' ' A' ' 36' ' ' CYS . 4.2 mm -80.02 75.54 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 109.56 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.15 20.31 11.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.682 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.24 152.65 32.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 85.5 m-20 -66.04 128.64 36.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.446 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 74.9 m-85 62.97 12.25 5.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -52.51 115.76 4.6 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 10' ' ' GLY . 14.4 ttpt -44.04 126.8 5.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.136 . . . . 0.0 109.422 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 16.6 p -118.54 -165.66 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.678 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 m -145.66 122.22 11.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.446 -0.784 . . . . 0.0 109.539 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.2 98.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.08 46.21 1.92 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.7 -119.92 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 2.4 m -76.05 107.47 8.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 6.7 tttt -94.9 167.73 11.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.563 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.81 125.47 24.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -44.24 -67.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -42.71 -65.79 0.44 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.437 -0.789 . . . . 0.0 109.54 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.26 52.62 0.04 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 21' ' ' ARG . 8.5 mmt180 -108.35 145.0 30.62 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.196 -1.179 . . . . 0.0 109.376 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.22 179.07 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.09 1.86 . . . . 0.0 110.282 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -131.04 155.0 47.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.339 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -111.21 133.05 53.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.589 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 m -126.22 -172.48 2.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.485 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.504 ' HB2' ' CG1' ' A' ' 30' ' ' ILE . 1.9 m -89.98 19.47 4.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 76.11 -0.18 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.597 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.504 ' CG1' ' HB2' ' A' ' 28' ' ' SER . 2.0 pt -114.26 1.38 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -0.961 . . . . 0.0 109.567 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 38.8 45.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 33' ' ' ASN . 27.8 p -135.68 124.47 23.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.462 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 32' ' ' THR . 11.1 t30 59.27 116.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.382 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 61.1 m -135.89 171.24 14.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -143.47 120.41 11.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.508 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.547 ' CB ' HG21 ' A' ' 5' ' ' ILE . 25.0 t -60.08 117.25 4.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.74 132.57 29.57 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.39 -174.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.983 1.789 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.46 ' HG3' ' HD2' ' A' ' 23' ' ' ARG . 26.7 mtp180 -83.08 118.92 23.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.414 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.47 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -174.96 -66.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.958 . . . . 0.0 109.537 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 40' ' ' LEU . 2.5 mp 61.36 109.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 109.351 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.446 ' O ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -170.47 -159.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.405 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 42' ' ' MET . 1.8 pt-20 -43.97 166.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.62 -30.44 2.83 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 61.89 -155.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -1.128 . . . . 0.0 109.398 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.6 m -109.88 91.55 3.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.454 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -117.72 48.85 1.3 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.444 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.52 114.83 10.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -136.12 61.16 1.65 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 109.516 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p -162.98 -170.19 2.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 109.569 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 11' ' ' LYS . 6.5 mt -85.55 106.44 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 0.0 109.437 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -119.62 -2.04 10.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.561 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 156.93 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 3.6 m-20 -64.61 138.74 58.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.426 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 56.6 m-85 62.03 12.78 5.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -46.09 107.12 0.16 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 5' ' ' ILE . 26.2 mttt -42.85 130.78 4.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -1.098 . . . . 0.0 109.851 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 14.0 p -134.54 -164.39 1.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 109.354 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -157.11 137.77 13.18 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.537 -0.727 . . . . 0.0 109.319 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.6 107.97 2.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.2 -0.938 . . . . 0.0 109.615 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.79 12.99 33.26 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.55 -127.71 2.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -90.2 111.83 23.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -1.147 . . . . 0.0 109.72 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -92.69 170.5 9.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 108.684 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -47.34 88.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 109.918 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 18' ' ' LYS . 2.0 m 34.63 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.342 0.591 . . . . 0.0 110.251 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -169.55 58.46 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 109.046 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.5 -35.06 0.02 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -119.17 137.58 25.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.969 -1.312 . . . . 0.0 109.876 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 2.5 Cg_endo -68.7 -166.04 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.053 1.835 . . . . 0.0 109.896 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.82 40.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 109.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -146.26 144.62 29.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.567 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' N ' ' HG2' ' A' ' 26' ' ' ARG . 1.2 m -116.28 167.15 11.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 29' ' ' MET . 0.7 OUTLIER -89.5 66.4 7.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.556 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 28' ' ' SER . 26.4 mtp 43.79 28.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.96 -74.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.0 109.361 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 32' ' ' THR . . . 122.5 29.36 1.31 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 31' ' ' GLY . 3.0 p -153.63 -66.27 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.78 114.31 19.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -120.88 156.43 32.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -135.65 113.9 11.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.385 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 22.9 t -43.88 117.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 122.13 52.09 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.106 -0.996 . . . . 0.0 109.705 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.38 -166.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.985 1.79 . . . . 0.0 110.104 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.01 118.52 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -0.802 . . . . 0.0 109.45 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 97.8 mt -46.15 110.6 0.28 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.254 -0.904 . . . . 0.0 109.428 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.744 ' O ' HG23 ' A' ' 41' ' ' ILE . 4.8 tt -51.1 103.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.298 -0.877 . . . . 0.0 109.615 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.415 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 2.4 ttm 174.13 -175.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 42' ' ' MET . 1.6 tm-20 62.31 13.74 6.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.499 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.52 57.47 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -88.84 174.1 8.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -1.185 . . . . 0.0 109.412 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER 73.84 131.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.873 . . . . 0.0 109.499 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.6 m-85 54.42 -176.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 109.488 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.43 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 3' ' ' ASN . 0.9 OUTLIER -97.95 -63.74 1.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.88 . . . . 0.0 109.501 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 2' ' ' ASP . 0.7 OUTLIER -45.42 163.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.942 . . . . 0.0 109.374 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 17.0 p -68.41 -146.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.181 -0.95 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.803 HD13 ' O ' ' A' ' 11' ' ' LYS . 7.1 mt -113.3 91.11 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.06 35.62 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.05 166.43 11.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.56 123.31 15.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.202 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER 43.64 31.9 0.5 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.775 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.54 129.69 7.4 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.803 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -36.7 133.16 0.59 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.589 -0.948 . . . . 0.0 110.316 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.417 ' SG ' ' C ' ' A' ' 35' ' ' GLU . 1.6 p -122.4 -176.22 3.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.378 -0.826 . . . . 0.0 109.37 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.19 136.61 8.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -76.85 85.27 3.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.27 -17.93 7.43 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.32 -128.22 3.3 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.1 m -89.78 106.34 18.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -1.148 . . . . 0.0 109.408 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -166.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.691 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -97.44 175.97 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.091 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 1.1 m -104.78 149.38 25.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -0.988 . . . . 0.0 109.885 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER 77.61 -7.41 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.246 -0.909 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.52 46.76 2.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB3' ' CB ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -93.06 124.48 58.05 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.165 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 23' ' ' ARG . 4.6 Cg_exo -59.89 168.26 5.99 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.997 1.798 . . . . 0.0 110.584 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.5 t -120.98 106.4 11.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.485 -0.759 . . . . 0.0 109.087 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 35' ' ' GLU . 3.4 ttm180 -111.21 177.52 4.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -110.79 -177.85 3.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -87.95 28.73 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.469 ' CB ' ' O ' ' A' ' 28' ' ' SER . 12.5 ttm 72.73 29.54 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.656 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -51.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 109.539 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.43 10.7 9.3 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 p -123.96 -99.25 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -1.186 . . . . 0.0 109.322 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 2.2 m120 -55.19 128.91 36.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.983 -1.073 . . . . 0.0 108.75 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -120.64 124.7 45.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.058 -1.026 . . . . 0.0 110.534 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.2 OUTLIER -110.37 167.44 10.2 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.498 ' C ' ' HA ' ' A' ' 9' ' ' TYR . 3.6 t -69.81 -173.93 0.68 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.77 127.41 0.47 Allowed Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 120.686 -1.258 . . . . 0.0 109.956 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.92 159.55 45.55 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.792 1.662 . . . . 0.0 109.228 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.533 ' CD ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -40.65 143.67 0.32 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.247 -0.908 . . . . 0.0 109.751 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.831 HD23 ' N ' ' A' ' 41' ' ' ILE . 9.8 tt 177.96 150.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.0 109.547 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.831 ' N ' HD23 ' A' ' 40' ' ' LEU . 97.6 mt -150.58 137.41 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.945 . . . . 0.0 109.384 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.1 ptm -160.97 140.87 10.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.571 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 53.46 96.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.499 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.99 164.72 43.19 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.499 ' O ' ' CB ' ' A' ' 46' ' ' SER . 27.4 mt -96.72 133.65 41.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -1.099 . . . . 0.0 109.418 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 45' ' ' LEU . 1.6 t 164.23 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.697 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 61.2 t80 -133.92 104.21 6.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.468 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.247 0.546 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.37 -10.65 14.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.525 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -172.02 -48.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.643 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.2 p -93.84 -155.1 0.43 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.112 -0.993 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.633 HD12 ' HB3' ' A' ' 12' ' ' CYS . 20.4 mt -120.07 82.8 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.403 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -116.21 69.48 0.74 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 0.0 109.68 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.61 -178.7 6.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.282 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 9' ' ' TYR . 2.0 m-20 -61.1 89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.179 -0.951 . . . . 0.0 109.196 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 62.52 46.32 5.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' CG2' ' A' ' 5' ' ' ILE . . . -44.84 146.17 1.94 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.24 105.17 0.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -1.121 . . . . 0.0 109.787 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.633 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.6 p -115.08 176.1 5.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 109.02 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 13' ' ' THR . 22.8 m -159.81 73.76 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.964 -1.085 . . . . 0.0 110.382 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.553 ' O ' ' N ' ' A' ' 16' ' ' GLY . 4.1 m-90 40.64 -147.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.428 -0.795 . . . . 0.0 110.451 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 14' ' ' TRP . . . -22.95 -42.39 0.01 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 14' ' ' TRP . . . -54.36 -165.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.631 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -43.61 100.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.054 -1.262 . . . . 0.0 109.353 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 16' ' ' GLY . 2.0 tttt -70.94 -164.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 109.957 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.422 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -96.18 134.47 39.22 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -44.32 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.165 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -44.34 -26.74 0.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.277 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' A' ' 23' ' ' ARG . . . 105.18 95.84 2.41 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.511 ' HB3' ' NH1' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -157.75 154.5 25.0 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.246 -1.149 . . . . 0.0 109.696 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -167.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.467 2.111 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 6.3 t -142.08 78.62 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.323 -0.861 . . . . 0.0 109.338 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 156.75 17.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.58 179.64 3.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.356 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.527 ' CB ' ' OG1' ' A' ' 32' ' ' THR . 0.3 OUTLIER -58.73 171.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.48 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.422 ' HG3' HG23 ' A' ' 30' ' ' ILE . 5.3 ptp -78.34 -2.84 40.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 HG23 ' HG3' ' A' ' 29' ' ' MET . 9.6 pt -117.25 -26.9 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -0.988 . . . . 0.0 109.435 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.92 67.02 0.29 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -127.82 -158.56 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -1.166 . . . . 0.0 109.51 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' C ' ' OE2' ' A' ' 35' ' ' GLU . 2.9 m-80 -42.97 150.12 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.789 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -107.58 127.35 53.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.295 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 9' ' ' TYR . 8.6 mp0 -119.77 163.32 17.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.032 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.8 t -86.11 116.53 24.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 108.991 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.27 112.78 58.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.7 -1.25 . . . . 0.0 110.034 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -66.72 -167.17 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.857 1.705 . . . . 0.0 110.006 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -104.8 -174.18 2.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 108.981 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 40' ' ' LEU . 8.5 tp -47.08 114.02 0.78 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.005 . . . . 0.0 109.444 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.0 tt -110.74 172.16 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.965 . . . . 0.0 109.561 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.9 mtm -116.34 -27.77 6.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -85.56 162.94 18.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . 160.18 -90.97 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.694 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.8 mm? 61.09 161.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -1.136 . . . . 0.0 109.542 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.561 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 177.94 50.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 109.431 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.706 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 0.1 OUTLIER 39.77 92.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.542 -0.724 . . . . 0.0 109.814 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.506 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.294 0.568 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.56 -82.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 1.4 m120 -171.95 -92.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 3' ' ' ASN . 31.4 p 177.88 -175.88 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.613 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.636 HD11 ' HB ' ' A' ' 17' ' ' THR . 3.8 mt -95.03 80.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.354 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.12 5.22 52.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 109.697 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -70.05 170.8 10.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.161 -0.962 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 1.4 p30 -79.98 123.33 27.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.835 . . . . 0.0 109.365 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 61.5 m-85 61.16 13.39 4.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' TYR . . . -44.32 132.33 7.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.611 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -52.08 151.56 3.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -1.137 . . . . 0.0 109.176 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.5 p -150.12 -167.87 2.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.882 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.79 134.97 10.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 0.0 109.429 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.44 84.24 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.151 -0.968 . . . . 0.0 109.372 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.88 -4.48 4.28 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.44 -125.95 3.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.636 ' HB ' HD11 ' A' ' 5' ' ' ILE . 11.9 m -65.01 118.35 8.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.145 . . . . 0.0 109.735 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.565 ' HG3' ' N ' ' A' ' 19' ' ' CYS . 1.3 tppt? -93.49 160.69 14.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.161 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.565 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -66.74 156.93 34.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.476 -0.765 . . . . 0.0 110.324 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -82.9 158.16 22.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.485 ' HB2' ' NH2' ' A' ' 23' ' ' ARG . 2.6 mmp_? 65.34 8.3 4.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.828 . . . . 0.0 109.849 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . 74.6 98.29 0.1 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -150.94 131.03 6.9 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 108.724 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HG2' ' HG ' ' A' ' 40' ' ' LEU . 1.2 Cg_endo -66.15 -174.83 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.052 1.835 . . . . 0.0 110.62 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -145.33 111.67 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.38 -0.825 . . . . 0.0 109.085 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.589 HH11 HG21 ' A' ' 37' ' ' THR . 28.6 mtt180 -84.89 163.21 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.9 m -138.54 -168.56 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.24 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 30' ' ' ILE . 89.6 p -73.5 -2.22 21.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 28' ' ' SER . 2.1 mtt 67.59 7.18 5.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 0.0 109.689 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 28' ' ' SER . 1.4 pp -131.44 -29.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 110.001 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 32' ' ' THR . . . 123.21 90.29 0.95 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 31' ' ' GLY . 6.8 p -159.74 -74.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -144.56 151.63 39.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.456 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.31 132.74 54.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 0.8 OUTLIER -126.48 138.74 53.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.413 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 34.6 t -73.16 144.15 46.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.887 . . . . 0.0 109.413 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.589 HG21 HH11 ' A' ' 26' ' ' ARG . 0.0 OUTLIER -96.87 136.94 21.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.003 -1.061 . . . . 0.0 109.488 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 39' ' ' ARG . 1.5 Cg_endo -65.16 117.22 4.36 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.233 1.955 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 38' ' ' PRO . 21.4 mtm-85 40.06 51.21 2.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 110.359 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.808 HD22 ' C ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -51.94 151.32 3.65 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.111 -0.993 . . . . 0.0 109.884 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -137.61 22.91 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.936 -1.102 . . . . 0.0 109.611 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.512 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER 44.59 -145.48 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.991 . . . . 0.0 109.415 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' A' ' 42' ' ' MET . 2.0 tt0 76.3 72.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -0.966 . . . . 0.0 109.35 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 45' ' ' LEU . . . -62.46 154.04 42.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' GLY . 26.4 mt 59.55 154.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.135 . . . . 0.0 109.358 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.9 123.83 20.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.35 -149.27 0.28 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.395 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.437 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 2' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.328 0.585 . . . . 0.0 109.637 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.496 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -58.67 -155.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.182 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -145.43 8.44 1.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.904 -1.123 . . . . 0.0 110.492 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 5' ' ' ILE . 9.2 p -114.69 -47.71 2.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.804 -1.185 . . . . 0.0 109.891 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 5' ' ' ILE . 11.4 mt -160.95 64.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.82 56.24 3.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -150.28 151.95 33.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.2 OUTLIER -78.87 146.27 33.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.962 . . . . 0.0 109.33 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.1 m-85 54.75 19.65 2.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.64 128.97 24.52 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 10.5 tttt -52.47 151.35 4.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.124 . . . . 0.0 109.432 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 29.0 p -145.96 -167.68 2.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.8 m -157.4 123.56 4.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.297 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -53.35 110.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.485 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.46 -36.33 4.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.97 -133.38 0.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.585 ' O ' HD11 ' A' ' 5' ' ' ILE . 1.3 m -74.52 84.23 2.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -1.164 . . . . 0.0 109.601 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 20.6 ttpt -65.64 163.65 15.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -60.37 120.65 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.471 -0.768 . . . . 0.0 109.582 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 2.1 m -50.06 146.07 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 1.6 mtt180 77.53 3.01 3.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.93 . . . . 0.0 109.704 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.93 99.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -139.2 155.96 72.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.289 -1.124 . . . . 0.0 109.345 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.503 ' HD3' ' NE ' ' A' ' 39' ' ' ARG . 2.7 Cg_endo -61.37 144.41 98.33 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.206 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.25 116.07 10.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 148.52 25.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.875 . . . . 0.0 109.502 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 36.0 m -119.45 -172.37 2.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 0.0 109.49 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.486 ' O ' HG12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -117.25 44.88 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.887 . . . . 0.0 109.554 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 61.42 22.35 12.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -124.47 -30.48 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.73 36.52 47.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -45.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -1.184 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -106.43 72.0 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.893 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 58.3 m -92.85 114.26 26.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.85 . . . . 0.0 109.299 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.57 125.39 33.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 37' ' ' THR . 16.0 t -81.43 159.47 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.702 HG22 ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -119.71 148.24 45.71 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.638 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.702 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.9 Cg_endo -61.1 176.28 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.229 1.953 . . . . 0.0 110.331 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.503 ' NE ' ' HD3' ' A' ' 24' ' ' PRO . 7.6 mtt180 -149.79 62.55 1.0 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.294 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 22.0 tp 42.97 37.45 1.12 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.349 -0.845 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 40' ' ' LEU . 52.6 mt 43.01 91.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.884 . . . . 0.0 109.548 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 43' ' ' GLU . 6.0 mtp -129.85 121.81 27.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 42' ' ' MET . 10.4 mm-40 -44.34 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.07 63.05 0.84 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -174.23 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -1.177 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.67 -29.2 40.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.495 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -50.63 106.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.192 -0.942 . . . . 0.0 109.498 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.924 -1.036 . . . . 0.0 109.456 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 2.2 t0 -133.14 -72.5 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 2.6 t-20 170.5 128.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.3 p -107.33 153.55 22.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 11' ' ' LYS . 5.3 mt -81.49 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.918 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . . . -98.99 47.76 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.95 176.82 7.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.1 130.25 36.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 47.2 m-85 58.34 19.54 6.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.37 133.48 52.67 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.593 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -46.78 144.5 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -1.182 . . . . 0.0 109.491 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.45 -168.42 3.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.569 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 m -154.71 137.49 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.448 -0.782 . . . . 0.0 109.459 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -63.36 92.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.35 43.79 1.96 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.28 -116.45 0.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 3' ' ' ASN . 12.2 m -84.48 96.95 9.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -1.132 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 1.9 ttmt -70.59 167.82 17.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.334 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -65.48 139.22 58.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.424 -0.797 . . . . 0.0 109.257 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.918 ' SG ' ' HB2' ' A' ' 6' ' ' ALA . 73.9 m -44.17 -62.47 1.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 109.147 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.66 -73.72 0.05 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.462 -0.774 . . . . 0.0 109.453 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.29 82.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' CZ ' ' HA ' ' A' ' 39' ' ' ARG . 3.2 mmt-85 -138.38 155.16 74.04 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.133 -1.216 . . . . 0.0 109.546 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HD2' ' HD2' ' A' ' 23' ' ' ARG . 2.1 Cg_endo -62.42 -174.82 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.23 1.954 . . . . 0.0 110.195 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.11 153.72 36.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.379 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -126.74 164.44 21.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.566 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 m -136.4 -172.01 3.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.514 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 29' ' ' MET . 0.4 OUTLIER -85.28 5.06 32.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.688 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' SER . 0.2 OUTLIER 75.2 17.63 2.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 109.414 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.427 ' CG1' ' HB3' ' A' ' 28' ' ' SER . 0.3 OUTLIER -141.83 26.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 32' ' ' THR . . . 43.51 86.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.9 p -158.28 -41.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.104 . . . . 0.0 109.434 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.92 139.44 6.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.59 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 26' ' ' ARG . 28.2 m -130.2 168.56 16.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 109.226 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 8.3 mm-40 -142.44 155.89 45.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.178 -0.952 . . . . 0.0 109.717 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 36.4 t -86.91 145.27 26.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.319 -0.863 . . . . 0.0 109.367 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.48 123.57 36.95 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.001 . . . . 0.0 109.613 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.07 -169.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.898 1.732 . . . . 0.0 110.106 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.52 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 1.2 tmm_? -53.47 124.62 15.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.408 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -177.74 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -137.83 40.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.387 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.86 154.44 17.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.344 -0.848 . . . . 0.0 109.467 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.02 91.6 1.95 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.22 164.93 24.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 51.57 39.01 23.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -1.126 . . . . 0.0 109.402 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 t -108.66 98.72 8.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 58.19 43.01 21.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.444 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.37 113.72 25.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.529 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -116.66 126.19 52.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.499 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.2 p -126.46 -175.86 3.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.554 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.521 HG23 ' HA3' ' A' ' 10' ' ' GLY . 88.2 mt -99.56 73.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.91 -12.39 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.75 146.42 52.95 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.243 -0.911 . . . . 0.0 109.508 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 7.7 p-10 -65.97 130.19 42.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 52.5 m-85 62.86 12.2 5.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -45.09 121.78 4.74 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.264 -1.535 . . . . 0.0 109.264 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -42.78 125.19 3.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -1.069 . . . . 0.0 109.563 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.4 p -115.59 -170.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.64 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.09 134.2 7.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.332 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -72.09 100.29 2.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.47 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.3 -8.52 13.83 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.51 -140.3 8.79 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.58 148.02 35.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.198 -1.178 . . . . 0.0 109.531 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 -164.52 0.93 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.868 . . . . 0.0 109.816 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.483 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.8 139.21 32.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.553 -0.717 . . . . 0.0 109.57 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -53.51 145.34 15.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.216 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 25.6 mtp180 83.02 -42.59 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.553 -0.717 . . . . 0.0 109.735 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 83.18 0.84 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 6.9 mmt-85 -124.79 141.45 38.16 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.234 -1.156 . . . . 0.0 109.215 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.517 ' HD3' ' CG2' ' A' ' 41' ' ' ILE . 1.4 Cg_endo -64.01 169.84 9.87 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.094 1.863 . . . . 0.0 110.467 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.1 OUTLIER -134.04 172.3 13.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 9.3 ttm-85 -140.81 139.0 34.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.898 . . . . 0.0 109.342 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 31' ' ' GLY . 64.3 m -133.64 -167.99 2.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.967 . . . . 0.0 109.743 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.3 m -67.89 -36.27 79.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.409 -0.807 . . . . 0.0 109.745 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 30' ' ' ILE . 2.5 ptp -43.32 -27.42 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 29' ' ' MET . 0.6 OUTLIER -156.2 27.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.629 ' O ' HG23 ' A' ' 32' ' ' THR . . . -169.72 -93.48 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 31' ' ' GLY . 1.1 p -160.4 -92.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -1.148 . . . . 0.0 109.332 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 26' ' ' ARG . 30.7 m120 -102.57 162.54 12.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.172 -0.955 . . . . 0.0 108.907 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 72.7 m -79.66 104.09 10.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 9' ' ' TYR . 3.3 mt-10 -136.26 143.42 44.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 53.9 t -60.57 121.29 11.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.263 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.468 ' HB ' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.02 120.33 60.2 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.558 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.0 85.58 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.868 1.712 . . . . 0.0 110.079 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.468 ' HG2' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -146.07 125.99 13.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.708 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.919 ' O ' HD12 ' A' ' 40' ' ' LEU . 4.6 pp -68.13 141.7 55.99 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.271 -0.893 . . . . 0.0 109.669 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.517 ' CG2' ' HD3' ' A' ' 24' ' ' PRO . 3.1 tp -155.67 146.2 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.347 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.419 ' N ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -98.82 92.8 5.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.43 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 56.4 -148.24 0.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.18 -0.95 . . . . 0.0 109.391 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.26 -126.74 6.37 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 54.27 -168.69 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 109.466 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 47' ' ' PHE . 5.7 t -102.99 72.84 1.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.449 ' O ' ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 45.91 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.445 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -113.9 167.21 10.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.468 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.63 1.33 23.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.902 . . . . 0.0 109.47 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.8 p -83.02 171.62 13.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.964 . . . . 0.0 109.456 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 5' ' ' ILE . 26.7 mt -87.6 63.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.12 -11.16 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.531 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -54.99 152.5 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -64.08 127.02 29.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.883 . . . . 0.0 109.411 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 18.6 m-85 53.05 24.55 3.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 0.0 109.365 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.66 123.3 10.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -49.36 123.26 7.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.247 -1.149 . . . . 0.0 109.501 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 15.9 p -113.87 -171.65 1.94 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.888 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.13 148.94 45.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 13.7 m0 -77.17 89.26 3.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.14 9.66 19.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.9 -136.92 9.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -84.92 116.38 23.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 109.437 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -166.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.78 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -92.62 155.46 17.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.309 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -44.17 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 109.537 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -23.31 1.03 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.29 57.59 1.0 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 mtt-85 -96.38 152.06 38.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.665 ' HG2' HD12 ' A' ' 40' ' ' LEU . 2.0 Cg_endo -62.44 173.36 3.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.23 1.953 . . . . 0.0 110.303 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -139.96 86.12 2.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.447 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -68.96 163.98 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 32' ' ' THR . 1.2 m -117.94 -171.9 2.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 t -68.9 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.375 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.42 41.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -159.87 -38.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.364 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.18 45.92 0.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -105.73 -156.8 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.349 -1.089 . . . . 0.0 109.469 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.416 ' ND2' ' H ' ' A' ' 33' ' ' ASN . 9.2 m-80 -42.4 150.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -0.932 . . . . 0.0 109.702 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -118.02 165.33 13.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.435 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -141.33 142.3 33.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 11.2 t -68.14 120.75 14.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 121.51 55.58 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.614 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 2.0 Cg_endo -64.51 119.32 6.33 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.875 1.716 . . . . 0.0 110.245 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 3.7 ttm180 70.24 154.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.638 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.665 HD12 ' HG2' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -178.63 105.34 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.307 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.0 148.44 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.944 . . . . 0.0 109.766 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.5 mmt 59.57 110.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -114.94 102.92 10.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.9 135.45 13.23 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.54 179.83 5.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -1.115 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.39 -14.75 39.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -48.37 107.53 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.918 . . . . 0.0 109.42 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.506 -179.993 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 3.4 t0 -101.39 168.07 9.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 17.4 m120 61.21 -167.65 0.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p -170.17 -162.76 0.32 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 109.15 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 19' ' ' CYS . 44.7 mt -78.97 83.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.71 -5.02 59.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -68.66 167.81 14.42 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 0.0 109.404 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 44.2 p-10 -88.17 128.41 35.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.775 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 22.8 m-85 55.33 21.42 4.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.861 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' LYS . . . -53.28 135.99 39.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 24.9 ttmt -42.54 111.69 0.28 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.422 -1.046 . . . . 0.0 109.445 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 36' ' ' CYS . 16.8 p -94.06 -167.58 1.71 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.477 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.51 ' N ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -158.38 156.52 30.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.436 -0.79 . . . . 0.0 109.641 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -99.16 51.71 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 148.54 39.7 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.24 -139.75 3.3 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 m -69.91 85.14 0.5 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -1.156 . . . . 0.0 109.307 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.564 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 16.8 ttmt -48.03 167.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.564 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -158.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.48 -0.762 . . . . 0.0 109.667 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 73.8 m -106.35 141.59 37.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.866 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER 71.48 0.58 3.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.627 -0.671 . . . . 0.0 110.156 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.512 ' HA2' ' HD3' ' A' ' 18' ' ' LYS . . . 91.88 109.09 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.126 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HB2' ' CB ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -150.66 140.06 13.54 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.31 -1.112 . . . . 0.0 109.301 179.906 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.51 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.332 2.021 . . . . 0.0 110.724 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.541 ' HB2' ' CD1' ' A' ' 14' ' ' TRP . 0.0 OUTLIER -120.27 99.28 6.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.499 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 36.4 ttt85 -71.15 152.68 43.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.033 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -137.99 -171.85 3.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.428 -0.795 . . . . 0.0 109.367 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.585 ' HB2' HD11 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -93.99 28.04 2.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.582 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 66.07 25.82 10.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.0 OUTLIER -128.42 -35.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 0.0 109.403 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.2 8.73 11.19 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -130.94 165.24 23.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -1.189 . . . . 0.0 108.997 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 32' ' ' THR . 23.2 t-20 45.33 85.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.126 -0.983 . . . . 0.0 108.555 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -102.45 107.93 19.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 0.0 110.698 -179.834 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 26' ' ' ARG . 6.2 mm-40 -85.43 156.43 20.84 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 42.6 t -76.48 157.44 32.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.39 116.16 35.46 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.157 -0.964 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.18 100.23 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.719 1.613 . . . . 0.0 110.183 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 40' ' ' LEU . 5.5 mtt180 65.95 120.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.376 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.638 HD13 ' C ' ' A' ' 40' ' ' LEU . 1.6 tm? -44.59 112.27 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.288 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.577 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.3 pt -53.12 146.75 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.528 ' HG2' ' CG ' ' A' ' 43' ' ' GLU . 6.0 ttp -158.51 147.92 19.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.0 109.558 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.528 ' CG ' ' HG2' ' A' ' 42' ' ' MET . 1.4 mt-10 73.89 17.13 3.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.627 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.891 ' C ' HD13 ' A' ' 45' ' ' LEU . . . 151.66 153.69 6.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.891 HD13 ' C ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -116.27 -59.98 1.91 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -1.151 . . . . 0.0 109.348 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 47' ' ' PHE . 33.5 m -166.46 -158.47 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -0.891 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 61.46 129.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 -179.967 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.458 -179.997 . . . . . . . . 0 0 . 1 stop_ save_